data_2lu3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lu3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.798 0.332 . . . . 73.010000000000005 111.087 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 75.329999999999998 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.439999999999998 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.158 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.163 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 65.450000000000003 111.129 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.530000000000001 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 62.140000000000001 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 70.510000000000005 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.916 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.141 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 74.109999999999999 111.101 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 75.409999999999997 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 110.961 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.814 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.868 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.153 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 111.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.918 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 65.329999999999998 110.881 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 72.019999999999996 110.916 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 75.230000000000004 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 73.340000000000003 110.905 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 71.439999999999998 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.430000000000007 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 73.530000000000001 111.158 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 74.430000000000007 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 64.030000000000001 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.229999999999997 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.109999999999999 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.109999999999999 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 71.019999999999996 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 75.209999999999994 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 111.113 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.845 0.355 . . . . 75.219999999999999 111.129 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.450000000000003 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 75.150000000000006 110.916 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.0 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.099999999999994 111.074 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.812 0.339 . . . . 73.010000000000005 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 75.329999999999998 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.439999999999998 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 111.151 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.239999999999995 111.133 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 74.030000000000001 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.439999999999998 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.239999999999995 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.094 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 65.450000000000003 111.095 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.530000000000001 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 70.510000000000005 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 74.310000000000002 110.873 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.109999999999999 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.203 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 74.109999999999999 111.118 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 75.409999999999997 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.450000000000003 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 75.010000000000005 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.519999999999996 110.928 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 61.0 111.151 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.169 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 110.909 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.855 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 72.019999999999996 110.896 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 75.230000000000004 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.140000000000001 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 73.340000000000003 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.430000000000007 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 73.530000000000001 111.147 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.340000000000003 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 74.430000000000007 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.030000000000001 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 110.843 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.109999999999999 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.109999999999999 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 71.019999999999996 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.530000000000001 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 75.209999999999994 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.019999999999996 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.450000000000003 111.13 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 75.219999999999999 111.062 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 75.150000000000006 110.935 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 74.0 111.156 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 111.14 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.804 0.335 . . . . 73.010000000000005 111.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 75.329999999999998 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.439999999999998 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.218 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.329999999999998 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.439999999999998 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 111.129 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.510000000000005 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 65.450000000000003 111.188 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 62.140000000000001 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 70.510000000000005 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.86 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.119 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 74.109999999999999 111.135 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 75.409999999999997 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.839 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.209999999999994 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.010000000000005 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 64.219999999999999 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.904 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 61.0 111.141 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.162 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.966 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 110.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 72.019999999999996 110.954 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 75.230000000000004 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.140000000000001 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 73.340000000000003 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 71.439999999999998 109.573 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.430000000000007 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.319999999999993 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.530000000000001 111.134 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 74.430000000000007 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.872 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.109999999999999 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.109999999999999 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 71.019999999999996 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 75.209999999999994 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.019999999999996 111.074 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.450000000000003 111.124 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.844 0.354 . . . . 75.219999999999999 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 75.150000000000006 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.0 111.164 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 111.126 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.761 0.315 . . . . 73.010000000000005 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 75.329999999999998 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 111.093 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.329999999999998 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.439999999999998 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 111.211 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 65.450000000000003 111.15 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 62.140000000000001 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 70.510000000000005 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.948 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.109999999999999 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.120000000000005 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 111.172 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 74.109999999999999 111.108 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 75.409999999999997 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.921 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.430000000000007 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.129999999999995 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.450000000000003 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 75.010000000000005 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 64.219999999999999 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.924 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 61.0 111.09 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.120000000000005 110.867 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.915 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 72.019999999999996 110.884 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 75.230000000000004 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.140000000000001 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 73.340000000000003 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 71.439999999999998 109.568 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.430000000000007 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.430000000000007 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 73.530000000000001 111.18 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.340000000000003 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 74.430000000000007 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.030000000000001 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 110.84 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.109999999999999 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.109999999999999 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 71.019999999999996 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.530000000000001 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 75.209999999999994 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.134 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 111.147 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 75.219999999999999 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.450000000000003 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.150000000000006 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.230000000000004 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.099999999999994 111.111 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.712 0.291 . . . . 73.010000000000005 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 75.329999999999998 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.409999999999997 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.510000000000005 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 111.094 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.439999999999998 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.120000000000005 111.139 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 65.450000000000003 111.133 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.530000000000001 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 62.140000000000001 112.465 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 70.510000000000005 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 74.310000000000002 110.862 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 110.879 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 111.111 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 73.129999999999995 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 74.109999999999999 111.124 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 75.409999999999997 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.922 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 73.129999999999995 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 75.010000000000005 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 64.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.944 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.204 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.137 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.944 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.329999999999998 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 72.019999999999996 110.947 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 75.230000000000004 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.140000000000001 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 73.340000000000003 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 71.439999999999998 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.430000000000007 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.430000000000007 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.171 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 74.430000000000007 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 64.030000000000001 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.109999999999999 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.109999999999999 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 71.019999999999996 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.530000000000001 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 75.209999999999994 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 74.450000000000003 111.16 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.783 0.325 . . . . 75.219999999999999 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.109999999999999 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.099999999999994 111.147 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 73.010000000000005 111.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 75.329999999999998 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.439999999999998 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.409999999999997 111.071 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 111.155 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.329999999999998 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.439999999999998 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.239999999999995 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 111.105 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 65.450000000000003 111.09 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 62.140000000000001 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 70.510000000000005 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.889 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.230000000000004 111.155 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 73.129999999999995 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 74.109999999999999 111.18 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 75.409999999999997 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.319999999999993 110.972 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 73.129999999999995 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.450000000000003 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.887 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 61.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 111.156 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.85 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 65.329999999999998 110.909 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 72.019999999999996 110.94 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 75.230000000000004 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.140000000000001 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 73.340000000000003 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.439999999999998 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.430000000000007 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.430000000000007 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 73.530000000000001 111.128 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 74.430000000000007 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 64.030000000000001 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.109999999999999 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.019999999999996 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.530000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 75.209999999999994 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 74.450000000000003 111.136 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 111.122 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.450000000000003 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 75.150000000000006 110.904 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.0 111.121 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.909 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 73.010000000000005 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 75.329999999999998 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.439999999999998 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.239999999999995 111.109 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.329999999999998 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.439999999999998 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.239999999999995 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 111.087 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 65.450000000000003 111.126 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.530000000000001 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 62.140000000000001 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 70.510000000000005 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.121 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 74.109999999999999 111.148 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 75.409999999999997 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.949 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 73.129999999999995 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 75.209999999999994 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.450000000000003 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 110.924 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 111.149 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 61.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.111 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.939 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 65.329999999999998 110.85 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 72.019999999999996 110.997 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 75.230000000000004 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.140000000000001 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 73.340000000000003 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 71.439999999999998 109.603 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.430000000000007 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 73.530000000000001 111.133 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 74.430000000000007 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.875 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.109999999999999 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.109999999999999 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 71.019999999999996 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.530000000000001 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 75.209999999999994 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 111.09 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.87 0.367 . . . . 75.219999999999999 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 110.885 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.450000000000003 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 75.150000000000006 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 74.0 111.12 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.230000000000004 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.099999999999994 111.084 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 73.010000000000005 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 75.329999999999998 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.439999999999998 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 111.147 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.510000000000005 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 111.115 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.109999999999999 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.329999999999998 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.439999999999998 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.106 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.450000000000003 111.066 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 62.140000000000001 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 70.510000000000005 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.888 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.176 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 74.109999999999999 111.184 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 75.409999999999997 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.956 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.872 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.010000000000005 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 64.219999999999999 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.896 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 61.0 111.069 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.154 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.891 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 65.329999999999998 110.854 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 72.019999999999996 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 75.230000000000004 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.140000000000001 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 73.340000000000003 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 71.439999999999998 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.430000000000007 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.340000000000003 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.510000000000005 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 74.319999999999993 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.092 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 74.430000000000007 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 110.865 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.109999999999999 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.019999999999996 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.530000000000001 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 75.209999999999994 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.450000000000003 111.128 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 75.219999999999999 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.450000000000003 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 75.150000000000006 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.0 111.192 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.099999999999994 111.141 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 73.010000000000005 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 75.329999999999998 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.439999999999998 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.510000000000005 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.885 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.908 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.030000000000001 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.329999999999998 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.439999999999998 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.239999999999995 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 75.120000000000005 111.171 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.510000000000005 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 65.450000000000003 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.530000000000001 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 62.140000000000001 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 70.510000000000005 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 74.310000000000002 110.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.109999999999999 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.120000000000005 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.230000000000004 111.13 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 74.109999999999999 111.088 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 75.409999999999997 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.85 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.188 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.129999999999995 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 75.209999999999994 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.450000000000003 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 75.010000000000005 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 61.0 111.166 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.116 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.120000000000005 110.939 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 65.329999999999998 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 72.019999999999996 110.877 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 75.230000000000004 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.140000000000001 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 73.340000000000003 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 71.439999999999998 109.588 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.430000000000007 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.430000000000007 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 73.530000000000001 111.123 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.340000000000003 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 64.030000000000001 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.229999999999997 110.848 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.109999999999999 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.019999999999996 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.530000000000001 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 75.209999999999994 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.116 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 111.197 179.854 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.450000000000003 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 75.150000000000006 110.91 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.0 111.176 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.866 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.099999999999994 111.152 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.728 0.299 . . . . 73.010000000000005 111.121 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 75.329999999999998 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.439999999999998 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.239999999999995 111.111 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 74.030000000000001 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.329999999999998 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.439999999999998 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 111.153 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 65.450000000000003 111.112 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 62.140000000000001 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 70.510000000000005 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.904 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.111 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 74.109999999999999 111.171 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 75.409999999999997 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.909 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.450000000000003 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 64.219999999999999 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.874 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 61.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 111.189 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.006 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 65.329999999999998 110.901 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 72.019999999999996 110.954 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 75.230000000000004 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.140000000000001 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 73.340000000000003 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 71.439999999999998 109.577 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.430000000000007 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.340000000000003 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 73.530000000000001 111.14 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.340000000000003 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 74.430000000000007 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 64.030000000000001 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.019999999999996 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 75.209999999999994 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.019999999999996 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 74.450000000000003 111.132 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.791 0.329 . . . . 75.219999999999999 111.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.0 111.127 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 111.146 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.71 0.291 . . . . 73.010000000000005 111.129 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 75.329999999999998 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.439999999999998 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.409999999999997 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.13 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 74.030000000000001 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.329999999999998 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.439999999999998 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 111.134 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.510000000000005 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 65.450000000000003 111.184 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.530000000000001 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 70.510000000000005 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.120000000000005 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.230000000000004 111.219 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 73.129999999999995 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 74.109999999999999 111.14 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.945 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 73.129999999999995 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 75.209999999999994 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.450000000000003 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 75.010000000000005 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.519999999999996 110.868 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 111.166 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 61.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.171 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 110.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.329999999999998 110.917 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 72.019999999999996 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 75.230000000000004 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.140000000000001 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 73.340000000000003 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.439999999999998 109.632 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.430000000000007 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.510000000000005 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 74.430000000000007 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 64.030000000000001 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.229999999999997 110.778 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.109999999999999 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 71.019999999999996 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 75.209999999999994 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 74.450000000000003 111.139 179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.809 0.337 . . . . 75.219999999999999 111.137 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.450000000000003 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.099999999999994 111.176 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.752 0.311 . . . . 73.010000000000005 111.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 75.329999999999998 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.510000000000005 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.239999999999995 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.430000000000007 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 74.030000000000001 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.439999999999998 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 75.120000000000005 111.109 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 65.450000000000003 111.114 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 70.510000000000005 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.85 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 111.159 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 74.109999999999999 111.114 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 75.409999999999997 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.975 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.430000000000007 111.118 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.450000000000003 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 64.219999999999999 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 61.0 111.113 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.439999999999998 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.120000000000005 110.96 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 72.019999999999996 110.936 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 75.230000000000004 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 73.340000000000003 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 71.439999999999998 109.628 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.430000000000007 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 73.530000000000001 111.143 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 74.120000000000005 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 64.030000000000001 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.229999999999997 110.859 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.109999999999999 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 75.209999999999994 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 111.109 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.450000000000003 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.150000000000006 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.0 111.144 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.099999999999994 111.103 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.74 0.305 . . . . 73.010000000000005 111.109 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 75.329999999999998 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.439999999999998 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.084 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.430000000000007 110.898 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.979 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 74.030000000000001 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.329999999999998 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.439999999999998 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 75.120000000000005 111.177 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.510000000000005 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 65.450000000000003 111.119 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.530000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.478 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 70.510000000000005 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.892 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.120000000000005 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 74.109999999999999 111.125 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 75.409999999999997 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.93 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 73.129999999999995 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.010000000000005 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.148 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 61.0 111.071 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.144 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.884 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 110.883 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 72.019999999999996 110.935 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 75.230000000000004 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.140000000000001 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 73.340000000000003 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 71.439999999999998 109.534 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.430000000000007 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.430000000000007 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.530000000000001 111.176 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 74.430000000000007 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.875 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.109999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 75.209999999999994 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.019999999999996 111.123 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.127 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.757 0.313 . . . . 75.219999999999999 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.450000000000003 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.099999999999994 111.061 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.778 0.323 . . . . 73.010000000000005 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 75.329999999999998 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.409999999999997 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.131 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.430000000000007 110.853 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.109999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.329999999999998 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 75.120000000000005 111.107 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 65.450000000000003 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.530000000000001 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 62.140000000000001 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 70.510000000000005 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 110.894 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 111.146 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.129999999999995 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 74.109999999999999 111.081 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.883 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.430000000000007 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.450000000000003 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 75.010000000000005 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 64.219999999999999 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.214 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.099 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.120000000000005 110.925 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 110.838 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 72.019999999999996 110.948 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 75.230000000000004 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.140000000000001 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 73.340000000000003 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.439999999999998 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.430000000000007 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.340000000000003 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.319999999999993 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.530000000000001 111.148 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.229999999999997 110.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.109999999999999 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.109999999999999 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 71.019999999999996 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.530000000000001 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 75.209999999999994 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.019999999999996 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 74.450000000000003 111.085 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.806 0.336 . . . . 75.219999999999999 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.93 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 75.150000000000006 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 74.0 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.127 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.783 0.325 . . . . 73.010000000000005 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 75.329999999999998 110.875 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.439999999999998 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.15 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.329999999999998 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.439999999999998 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.239999999999995 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 75.120000000000005 111.076 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.510000000000005 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 65.450000000000003 111.11 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.530000000000001 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 62.140000000000001 112.52 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 70.510000000000005 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 110.871 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.886 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.099 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 73.129999999999995 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 74.109999999999999 111.153 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 75.409999999999997 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.96 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.209999999999994 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.450000000000003 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 64.219999999999999 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.519999999999996 110.916 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 61.0 111.083 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.139 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.120000000000005 110.944 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 65.329999999999998 110.904 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 72.019999999999996 110.998 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 75.230000000000004 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.140000000000001 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 73.340000000000003 110.908 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 71.439999999999998 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 73.530000000000001 111.115 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.340000000000003 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 74.430000000000007 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 64.030000000000001 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.109999999999999 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.109999999999999 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 71.019999999999996 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.530000000000001 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 75.209999999999994 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 74.450000000000003 111.057 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.844 0.354 . . . . 75.219999999999999 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.922 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.450000000000003 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 75.150000000000006 110.93 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.0 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 111.152 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.79 0.329 . . . . 73.010000000000005 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 75.329999999999998 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.439999999999998 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.409999999999997 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.167 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 74.030000000000001 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.329999999999998 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.439999999999998 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.120000000000005 111.161 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 65.450000000000003 111.158 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.530000000000001 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 62.140000000000001 112.501 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 70.510000000000005 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.951 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.109999999999999 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.230000000000004 111.133 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 74.109999999999999 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.319999999999993 110.926 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.450000000000003 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 64.219999999999999 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.114 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 61.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 111.087 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.861 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 65.329999999999998 110.906 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 72.019999999999996 110.94 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 75.230000000000004 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 73.340000000000003 110.886 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 71.439999999999998 109.624 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.430000000000007 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 73.530000000000001 111.155 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 74.430000000000007 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 64.030000000000001 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.229999999999997 110.914 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.109999999999999 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.109999999999999 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 71.019999999999996 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.530000000000001 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 75.209999999999994 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 111.132 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 N--CA 1.459 -0.01 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 110.938 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.128 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 73.010000000000005 111.1 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 75.329999999999998 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.439999999999998 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.239999999999995 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 110.926 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 74.030000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.329999999999998 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 111.165 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 65.450000000000003 111.08 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.530000000000001 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 62.140000000000001 112.53 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 70.510000000000005 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.917 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.898 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.109999999999999 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.120000000000005 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 74.109999999999999 111.103 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 75.409999999999997 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.924 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.450000000000003 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.010000000000005 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.846 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 61.0 111.057 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.127 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.97 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.868 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 72.019999999999996 110.94 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 75.230000000000004 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.140000000000001 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 73.340000000000003 110.866 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 71.439999999999998 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.430000000000007 110.859 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 73.530000000000001 111.098 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.340000000000003 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 74.430000000000007 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 64.030000000000001 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.819 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.109999999999999 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.109999999999999 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 71.019999999999996 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 75.209999999999994 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.116 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.450000000000003 111.168 179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.0 mm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.781 0.324 . . . . 75.219999999999999 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 75.150000000000006 110.938 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.909 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.099999999999994 111.119 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 73.010000000000005 111.089 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 75.329999999999998 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.439999999999998 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 74.030000000000001 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.329999999999998 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 75.120000000000005 111.094 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 65.450000000000003 111.115 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 62.140000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 70.510000000000005 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 74.310000000000002 110.891 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.91 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 111.12 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 74.109999999999999 111.053 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 75.409999999999997 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.899 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 75.209999999999994 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.450000000000003 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 75.010000000000005 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 64.219999999999999 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.89 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.140000000000001 111.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.0 111.176 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.158 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.965 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.87 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 72.019999999999996 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 75.230000000000004 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.140000000000001 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 73.340000000000003 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 71.439999999999998 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.430000000000007 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.142 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.813 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.109999999999999 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 71.019999999999996 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.530000000000001 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 75.209999999999994 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.019999999999996 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 111.095 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.450000000000003 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.150000000000006 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.068 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 73.010000000000005 111.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 75.329999999999998 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.439999999999998 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.126 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.329999999999998 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.439999999999998 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 111.135 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.510000000000005 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 65.450000000000003 111.097 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.530000000000001 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 62.140000000000001 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.863 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.109999999999999 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 111.156 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 73.129999999999995 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 111.138 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 75.409999999999997 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.319999999999993 110.924 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 111.147 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.450000000000003 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.924 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.151 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 61.0 111.149 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.099 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 110.979 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 65.329999999999998 110.875 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 72.019999999999996 110.889 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 75.230000000000004 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.140000000000001 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 73.340000000000003 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 71.439999999999998 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.430000000000007 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.430000000000007 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.530000000000001 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.340000000000003 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 74.430000000000007 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 74.120000000000005 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 64.030000000000001 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.229999999999997 110.824 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.109999999999999 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.019999999999996 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 75.209999999999994 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.083 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 74.450000000000003 111.143 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.791 0.329 . . . . 75.219999999999999 111.111 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.150000000000006 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 74.0 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.230000000000004 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.099999999999994 111.149 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.752 0.31 . . . . 73.010000000000005 111.11 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 75.329999999999998 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.409999999999997 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.239999999999995 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.430000000000007 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.329999999999998 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.439999999999998 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 111.117 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.510000000000005 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 65.450000000000003 111.08 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.530000000000001 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 62.140000000000001 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 70.510000000000005 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 74.310000000000002 110.893 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.418 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.109999999999999 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 111.159 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 73.129999999999995 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 74.109999999999999 111.081 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 75.409999999999997 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.949 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 111.08 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 73.129999999999995 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 111.117 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 61.0 111.125 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.173 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.953 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 65.329999999999998 110.904 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 72.019999999999996 110.905 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 75.230000000000004 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.140000000000001 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 73.340000000000003 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.439999999999998 109.6 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.430000000000007 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 111.076 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.030000000000001 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.109999999999999 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.109999999999999 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 71.019999999999996 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 75.209999999999994 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.019999999999996 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 111.12 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 75.150000000000006 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 74.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.099999999999994 111.164 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.497 -0.241 . . . . 63.340000000000003 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.21 151.16 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 65.140000000000001 111.109 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.41 162.55 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.902 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.66 -155.78 53.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.439999999999998 112.471 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.19 158.61 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 72.409999999999997 111.185 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -70.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 110.891 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -113.46 170.8 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 110.87 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -107.65 160.31 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 74.329999999999998 110.874 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.32 -26.26 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 74.450000000000003 110.894 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -74.11 173.56 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 64.120000000000005 110.854 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.33 155.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 73.329999999999998 111.096 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 70.11 79.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 72.310000000000002 110.907 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -24.78 29.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.258 . . . . 71.310000000000002 112.359 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 p -51.87 167.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.179 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -74.31 -176.43 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.420000000000002 110.875 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.29 151.83 41.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 65.140000000000001 110.918 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.71 154.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.087 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 75.329999999999998 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.439999999999998 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.158 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.163 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 65.450000000000003 111.129 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.530000000000001 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 62.140000000000001 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 70.510000000000005 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.916 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.141 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 74.109999999999999 111.101 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 75.409999999999997 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 110.961 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.814 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.868 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 61.0 111.153 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 111.123 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.918 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 65.329999999999998 110.881 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 72.019999999999996 110.916 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 75.230000000000004 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 73.340000000000003 110.905 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 71.439999999999998 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.430000000000007 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 73.530000000000001 111.158 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 74.430000000000007 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 64.030000000000001 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.229999999999997 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.109999999999999 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.109999999999999 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 71.019999999999996 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 75.209999999999994 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.28 143.1 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 111.113 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.8 m -79.77 108.43 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -58.43 171.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 72.230000000000004 110.871 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -23.15 67.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.439999999999998 110.931 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.98 11.11 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.948 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 10.16 81.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 51.299999999999997 112.477 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 p -97.35 118.82 34.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.748 0.309 . . . . 72.120000000000005 111.088 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.0 mm -67.69 134.62 29.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 111.129 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.450000000000003 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 75.150000000000006 110.916 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.0 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.93 144.1 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.099999999999994 111.074 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -174.61 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 65.040000000000006 110.861 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.82 160.48 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.905 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -117.25 26.29 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 72.340000000000003 110.833 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.17 -31.84 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 72.120000000000005 110.875 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.09 -31.41 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 74.400000000000006 110.916 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.05 -24.95 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 64.109999999999999 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.62 141.67 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.0 111.159 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -86.78 -31.46 20.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.010000000000005 110.855 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 50.340000000000003 110.912 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.242 . . . . 63.340000000000003 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.64 135.97 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 65.140000000000001 111.098 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 mmt -126.7 154.55 43.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.833 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.39 70.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 74.439999999999998 112.466 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.39 106.77 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.742 0.306 . . . . 72.409999999999997 111.18 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -84.04 126.79 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 75.209999999999994 110.953 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -106.39 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 63.130000000000003 110.959 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -111.57 179.88 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.329999999999998 110.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -81.1 -60.14 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 74.450000000000003 110.801 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -155.8 139.38 15.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 64.120000000000005 110.87 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.15 138.9 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -131.43 69.0 81.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.557 0.694 . . . . 72.310000000000002 110.961 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 -23.45 31.57 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 71.310000000000002 112.355 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 p -101.31 171.3 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 73.25 111.165 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.24 -179.88 6.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 110.884 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.01 131.72 41.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.140000000000001 110.918 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.58 151.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 73.010000000000005 111.079 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 75.329999999999998 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.439999999999998 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 111.151 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.239999999999995 111.133 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 74.030000000000001 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.439999999999998 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.239999999999995 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.094 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 65.450000000000003 111.095 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.530000000000001 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 62.140000000000001 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 70.510000000000005 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 74.310000000000002 110.873 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.109999999999999 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.203 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 73.129999999999995 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 74.109999999999999 111.118 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 75.409999999999997 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.209999999999994 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.450000000000003 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 75.010000000000005 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.519999999999996 110.928 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 61.0 111.151 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.169 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 110.909 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 65.329999999999998 110.855 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 72.019999999999996 110.896 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 75.230000000000004 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.140000000000001 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 73.340000000000003 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.430000000000007 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 74.319999999999993 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 73.530000000000001 111.147 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.340000000000003 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 74.430000000000007 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 74.120000000000005 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 64.030000000000001 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 110.843 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.109999999999999 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.109999999999999 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 71.019999999999996 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.530000000000001 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 75.209999999999994 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.019999999999996 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.91 148.42 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 74.450000000000003 111.13 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -79.9 110.27 15.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.074 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m -67.3 171.18 6.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 110.907 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -63.86 -16.1 60.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.907 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.29 3.69 34.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.530000000000001 110.887 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.88 7.64 86.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.668 -0.777 . . . . 51.299999999999997 112.41 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.4 p -112.22 132.29 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 72.120000000000005 111.131 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm -66.12 147.21 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 111.062 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 75.150000000000006 110.935 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 74.0 111.156 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.44 145.2 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 111.14 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.92 -175.46 2.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.040000000000006 110.923 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -93.1 161.74 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.868 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -117.74 6.1 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.872 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.27 -10.23 16.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -74.7 -55.87 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 74.400000000000006 110.873 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.08 -39.8 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 64.109999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.03 130.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.0 111.19 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.07 -36.21 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 73.010000000000005 110.872 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 50.340000000000003 110.881 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.475 -0.25 . . . . 63.340000000000003 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.0 164.9 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.335 . . . . 65.140000000000001 111.088 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -103.15 -59.57 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.881 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.15 167.13 21.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 74.439999999999998 112.457 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -97.82 105.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 72.409999999999997 111.1 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -125.87 47.23 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 110.888 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.44 -26.24 12.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m 62.84 49.23 3.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.854 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.9 -26.65 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 t -69.92 165.77 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 64.120000000000005 110.821 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.49 132.58 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.329999999999998 111.104 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -118.24 71.59 9.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 72.310000000000002 110.893 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -20.2 35.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.338 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.01 165.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.099 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -58.33 179.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.93 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -101.96 157.24 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 65.140000000000001 110.926 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.44 4.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 111.072 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 75.329999999999998 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.439999999999998 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.218 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 74.030000000000001 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.329999999999998 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.439999999999998 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 111.129 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.510000000000005 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 65.450000000000003 111.188 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 62.140000000000001 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 70.510000000000005 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.86 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.119 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 74.109999999999999 111.135 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 75.409999999999997 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.839 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.209999999999994 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.010000000000005 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 64.219999999999999 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.904 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.16 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 61.0 111.141 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.162 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.966 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 110.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 72.019999999999996 110.954 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 75.230000000000004 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.140000000000001 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 73.340000000000003 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 71.439999999999998 109.573 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.430000000000007 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.319999999999993 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.530000000000001 111.134 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 74.430000000000007 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.872 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.109999999999999 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.109999999999999 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 71.019999999999996 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 75.209999999999994 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.019999999999996 111.074 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.58 140.87 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.450000000000003 111.124 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -80.53 117.27 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 73.200000000000003 111.125 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.74 166.06 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.230000000000004 110.813 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -59.53 -22.73 62.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 110.931 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.75 3.39 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.955 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.55 77.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 51.299999999999997 112.483 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.6 p -107.07 124.84 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 72.120000000000005 111.102 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm -74.95 131.95 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 111.157 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 75.150000000000006 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.0 111.164 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.65 141.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 111.126 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -115.91 -174.44 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 65.040000000000006 110.952 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -103.22 158.7 16.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.887 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 p -114.41 26.33 10.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.835 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.0 -19.79 13.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.888 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -98.93 -70.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 74.400000000000006 110.917 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -49.76 -38.94 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 110.842 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.89 124.89 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 73.0 111.11 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -96.55 -30.99 12.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.466 . . . . 73.010000000000005 110.887 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 50.340000000000003 110.822 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 48.52 10.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.715 0.293 . . . . 65.140000000000001 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mtt -108.37 141.15 40.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.5 110.922 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.88 -179.47 48.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 74.439999999999998 112.463 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.6 mm -121.36 129.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 72.409999999999997 111.14 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.8 ttp85 -112.58 59.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.874 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -101.65 156.9 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 63.130000000000003 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m 52.19 52.13 14.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.876 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -61.86 -52.24 64.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.848 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 t -169.76 173.74 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.120000000000005 110.864 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.4 m -148.15 153.74 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.118 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 68.34 9.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.557 0.694 . . . . 72.310000000000002 110.913 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -11.73 31.4 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.225 . . . . 71.310000000000002 112.311 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 p -54.34 174.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.25 111.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -57.41 -179.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -94.49 152.02 18.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 65.140000000000001 110.882 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.04 161.99 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.076 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 75.329999999999998 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 111.093 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.329999999999998 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.439999999999998 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 111.211 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 65.450000000000003 111.15 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 62.140000000000001 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 70.510000000000005 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.948 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.109999999999999 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.120000000000005 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 111.172 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 74.109999999999999 111.108 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 75.409999999999997 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.921 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.430000000000007 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.129999999999995 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 75.209999999999994 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.450000000000003 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 75.010000000000005 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 64.219999999999999 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.924 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 61.0 111.09 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.128 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.120000000000005 110.867 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.915 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 72.019999999999996 110.884 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 75.230000000000004 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.140000000000001 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 73.340000000000003 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 71.439999999999998 109.568 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.430000000000007 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.430000000000007 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 73.530000000000001 111.18 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.340000000000003 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 74.430000000000007 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.030000000000001 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 110.84 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.109999999999999 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.109999999999999 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 71.019999999999996 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.530000000000001 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 75.209999999999994 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.134 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.81 148.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 111.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.71 110.76 15.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.200000000000003 111.139 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -67.46 173.39 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 110.841 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -65.35 -15.57 62.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.844 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -85.85 5.66 31.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.907 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.59 8.68 81.49 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.733 . . . . 51.299999999999997 112.491 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 p -112.04 131.12 55.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 72.120000000000005 111.119 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.69 144.96 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 111.153 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.450000000000003 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.150000000000006 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.230000000000004 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t -96.77 145.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.099999999999994 111.111 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -121.14 -174.74 2.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.897 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -97.08 155.91 16.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 110.843 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 8.6 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 110.852 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.84 -11.85 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 72.120000000000005 110.876 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.86 -56.25 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 74.400000000000006 110.84 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.7 -33.61 76.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.109999999999999 110.835 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.39 122.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 73.0 111.117 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -88.74 -33.93 17.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.010000000000005 110.836 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 50.340000000000003 110.786 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.456 -0.257 . . . . 63.340000000000003 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.62 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 65.140000000000001 111.124 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -68.07 136.9 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.906 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.47 -178.03 32.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 74.439999999999998 112.492 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 tp -172.53 133.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.409999999999997 111.175 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 61.45 51.35 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.851 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.39 166.33 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 63.130000000000003 110.93 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -175.35 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -88.52 -29.35 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.947 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 p 46.19 54.95 7.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 64.120000000000005 110.884 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.11 123.13 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.07 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 73.52 77.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 72.310000000000002 110.908 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -16.47 37.23 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.609 2.206 . . . . 71.310000000000002 112.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -73.14 151.86 41.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 73.25 111.209 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 50.7 49.23 21.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 110.939 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -99.15 176.48 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.908 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.93 167.54 29.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.113 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 75.329999999999998 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.409999999999997 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.510000000000005 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 111.094 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 74.030000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.439999999999998 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.120000000000005 111.139 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 65.450000000000003 111.133 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.530000000000001 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 62.140000000000001 112.465 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 70.510000000000005 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 74.310000000000002 110.862 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 110.879 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 111.111 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 73.129999999999995 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 74.109999999999999 111.124 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 75.409999999999997 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.922 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 73.129999999999995 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 75.010000000000005 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 64.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.944 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.204 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 61.0 111.106 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.137 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.944 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 65.329999999999998 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 72.019999999999996 110.947 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 75.230000000000004 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.140000000000001 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 73.340000000000003 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 71.439999999999998 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.430000000000007 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.430000000000007 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.171 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 74.430000000000007 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 64.030000000000001 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.109999999999999 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.109999999999999 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 71.019999999999996 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.530000000000001 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 75.209999999999994 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.72 140.82 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 74.450000000000003 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -79.74 119.71 23.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 111.132 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 166.56 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 72.230000000000004 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -24.06 63.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.89 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.02 3.1 35.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 110.919 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.23 79.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 51.299999999999997 112.497 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.8 p -105.4 121.8 44.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 72.120000000000005 111.134 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.37 133.49 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 111.072 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.109999999999999 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 75.150000000000006 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.67 142.19 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.099999999999994 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.13 156.88 45.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 65.040000000000006 110.881 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.17 160.14 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -110.24 25.41 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.855 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -106.06 -20.21 13.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.492 . . . . 72.120000000000005 110.843 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.84 -64.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.894 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -51.15 -48.67 61.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 64.109999999999999 110.939 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.41 137.46 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 73.0 111.162 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -96.29 -25.75 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.010000000000005 110.951 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 50.340000000000003 110.903 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.489 -0.245 . . . . 63.340000000000003 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 151.95 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 65.140000000000001 111.1 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 ttm -167.93 146.91 4.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 74.5 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.64 79.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 74.439999999999998 112.515 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 tt -129.48 141.97 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 72.409999999999997 111.174 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -128.19 155.77 43.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.829 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -134.63 45.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 63.130000000000003 110.885 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t 62.76 41.63 8.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.487 . . . . 74.329999999999998 110.813 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -53.5 -57.38 10.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.866 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m 61.1 49.02 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 64.120000000000005 110.86 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -127.58 131.09 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 111.115 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -122.36 68.17 28.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 72.310000000000002 110.886 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.8 24.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.614 2.209 . . . . 71.310000000000002 112.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 m -51.52 146.64 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.126 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -58.76 -176.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.942 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.94 146.34 44.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.15 146.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 73.010000000000005 111.102 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 75.329999999999998 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.439999999999998 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.409999999999997 111.071 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 111.155 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.329999999999998 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.439999999999998 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.239999999999995 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 111.105 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 65.450000000000003 111.09 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 62.140000000000001 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 70.510000000000005 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.889 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.230000000000004 111.155 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 73.129999999999995 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 74.109999999999999 111.18 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 75.409999999999997 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.319999999999993 110.972 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 73.129999999999995 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.450000000000003 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.887 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 61.0 111.135 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 111.156 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.85 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 65.329999999999998 110.909 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 72.019999999999996 110.94 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 75.230000000000004 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.140000000000001 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 73.340000000000003 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.439999999999998 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.430000000000007 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.430000000000007 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 73.530000000000001 111.128 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 74.430000000000007 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 74.120000000000005 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 64.030000000000001 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.109999999999999 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.019999999999996 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.530000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 75.209999999999994 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.2 140.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 74.450000000000003 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 m -79.98 115.39 19.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 73.200000000000003 111.159 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.48 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 110.831 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.23 -22.69 61.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 72.439999999999998 110.93 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.26 4.54 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.897 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.2 19.54 79.79 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.825 -0.702 . . . . 51.299999999999997 112.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -110.08 117.2 33.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.686 0.279 . . . . 72.120000000000005 111.138 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mm -66.82 136.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.122 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.450000000000003 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 75.150000000000006 110.904 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.0 111.121 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.909 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t -99.88 142.45 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -115.35 179.63 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.040000000000006 110.884 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -113.81 159.94 19.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.836 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -117.73 35.46 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.814 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 11.95 31.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 72.120000000000005 110.922 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -115.21 -33.22 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 74.400000000000006 110.914 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -48.76 -35.47 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 64.109999999999999 110.901 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.9 124.07 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 73.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -86.55 -31.68 21.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 73.010000000000005 110.944 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 50.340000000000003 110.875 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.436 -0.266 . . . . 63.340000000000003 112.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.39 -70.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.353 . . . . 65.140000000000001 111.142 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.2 mtp -52.48 138.52 27.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.879 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.63 30.47 0.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 74.439999999999998 112.465 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -166.92 138.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 72.409999999999997 111.114 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -151.63 129.88 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 75.209999999999994 110.887 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -106.12 120.29 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.861 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -79.42 171.02 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.891 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.89 -36.06 8.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 110.913 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 61.35 51.68 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 64.120000000000005 110.846 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.51 136.04 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.329999999999998 111.13 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -140.43 69.26 32.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.62 0.724 . . . . 72.310000000000002 110.882 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -8.53 23.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.698 2.265 . . . . 71.310000000000002 112.299 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -51.52 167.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 73.25 111.117 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -54.33 169.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.913 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.94 154.67 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 65.140000000000001 110.906 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.45 145.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.022 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HB2' ' HD2' ' A' ' 19' ' ' PRO . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 75.329999999999998 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.439999999999998 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.239999999999995 111.109 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.329999999999998 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.439999999999998 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.239999999999995 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 111.087 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 65.450000000000003 111.126 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.530000000000001 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 62.140000000000001 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 70.510000000000005 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 110.88 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.121 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 74.109999999999999 111.148 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 75.409999999999997 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.949 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 73.129999999999995 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 75.209999999999994 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.450000000000003 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 110.924 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 111.149 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 61.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.111 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.939 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 65.329999999999998 110.85 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 72.019999999999996 110.997 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 75.230000000000004 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.140000000000001 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 73.340000000000003 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 71.439999999999998 109.603 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.430000000000007 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 73.530000000000001 111.133 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 74.430000000000007 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.875 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.109999999999999 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.109999999999999 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 71.019999999999996 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.530000000000001 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 75.209999999999994 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.73 143.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 111.09 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -79.91 110.32 15.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.200000000000003 111.162 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -60.79 173.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.907 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.76 -22.51 66.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.881 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.16 9.91 23.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 74.530000000000001 110.965 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.13 81.75 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 51.299999999999997 112.457 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.0 p -102.34 118.73 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.731 0.301 . . . . 72.120000000000005 111.142 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mm -66.45 141.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 111.162 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 110.885 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.450000000000003 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 75.150000000000006 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 74.0 111.12 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.230000000000004 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.6 t -85.01 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.099999999999994 111.084 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.52 -176.24 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 110.948 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -91.97 158.57 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 74.239999999999995 110.913 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -117.12 30.28 7.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.859 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.18 -21.22 13.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.821 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.51 -61.84 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.400000000000006 110.926 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -51.78 -43.23 62.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 64.109999999999999 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.78 144.06 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 73.0 111.169 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.4 -30.21 15.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.877 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 50.340000000000003 110.911 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.244 . . . . 63.340000000000003 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.45 165.02 37.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 111.067 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.8 ptm -148.25 131.58 16.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.58 148.85 20.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.762 -0.733 . . . . 74.439999999999998 112.517 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt -75.85 89.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 72.409999999999997 111.203 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -121.03 82.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.871 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -124.91 168.31 13.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 63.130000000000003 110.964 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 p -129.91 176.23 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 74.329999999999998 110.909 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.94 -45.01 75.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.875 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 51.91 47.03 25.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 64.120000000000005 110.87 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.98 128.03 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.071 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -127.77 74.3 78.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.705 . . . . 72.310000000000002 110.9 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -14.94 36.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 71.310000000000002 112.393 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.4 p -71.27 90.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 73.25 111.119 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.94 179.97 5.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 110.906 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.28 130.54 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.949 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.85 149.61 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.1 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 75.329999999999998 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.439999999999998 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 111.147 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.510000000000005 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 111.115 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.109999999999999 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.329999999999998 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.439999999999998 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.106 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.450000000000003 111.066 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 62.140000000000001 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 70.510000000000005 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.888 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.176 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 74.109999999999999 111.184 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 75.409999999999997 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.956 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.872 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.010000000000005 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 64.219999999999999 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.896 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 61.0 111.069 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.154 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.891 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 65.329999999999998 110.854 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 72.019999999999996 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 75.230000000000004 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.140000000000001 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 73.340000000000003 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 71.439999999999998 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.430000000000007 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.340000000000003 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.510000000000005 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 74.319999999999993 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.092 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 74.430000000000007 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 110.865 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.109999999999999 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 71.019999999999996 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.530000000000001 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 75.209999999999994 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.65 141.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.450000000000003 111.128 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -79.98 110.61 15.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 111.137 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -64.81 166.82 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 72.230000000000004 110.854 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.91 -16.81 60.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 110.929 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.28 0.81 53.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.946 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 16.87 75.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 51.299999999999997 112.547 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 p -112.89 128.96 56.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.793 0.33 . . . . 72.120000000000005 111.157 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm -75.04 136.14 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 111.147 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.450000000000003 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 75.150000000000006 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 74.0 111.192 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.53 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.099999999999994 111.141 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -115.79 -174.82 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.040000000000006 110.898 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -110.55 158.81 18.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.941 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -111.96 35.11 3.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.807 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -105.74 -24.32 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 72.120000000000005 110.848 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -73.87 -32.78 63.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.897 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -48.94 -35.39 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.41 142.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 73.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -95.6 -31.51 13.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 73.010000000000005 110.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 50.340000000000003 110.853 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.512 -0.235 . . . . 63.340000000000003 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.44 176.54 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 65.140000000000001 111.083 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.26 164.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 74.5 110.899 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.19 -36.88 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 74.439999999999998 112.501 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.14 -31.78 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -106.98 85.1 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 75.209999999999994 110.929 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -89.26 -29.77 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 63.130000000000003 110.841 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 t -106.47 121.44 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 110.827 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.2 -26.24 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 74.450000000000003 110.856 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 p -95.38 86.9 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 64.120000000000005 110.843 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.74 71.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.133 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -157.74 73.61 4.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.556 0.693 . . . . 72.310000000000002 110.939 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -43.36 2.65 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.713 2.275 . . . . 71.310000000000002 112.354 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.67 134.04 48.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.133 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -164.13 113.52 1.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -122.81 128.77 50.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 65.140000000000001 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.0 154.51 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.079 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 75.329999999999998 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.439999999999998 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.510000000000005 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.885 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.908 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.030000000000001 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.329999999999998 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.439999999999998 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.239999999999995 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 75.120000000000005 111.171 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.510000000000005 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 65.450000000000003 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.530000000000001 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 62.140000000000001 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 70.510000000000005 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 74.310000000000002 110.831 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.109999999999999 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.120000000000005 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.230000000000004 111.13 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 74.109999999999999 111.088 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 75.409999999999997 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.85 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.188 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.129999999999995 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 75.209999999999994 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.450000000000003 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 75.010000000000005 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.122 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 61.0 111.166 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.116 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.120000000000005 110.939 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 65.329999999999998 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 72.019999999999996 110.877 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 75.230000000000004 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.140000000000001 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 73.340000000000003 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 71.439999999999998 109.588 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.430000000000007 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.430000000000007 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 73.530000000000001 111.123 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.340000000000003 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 64.030000000000001 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.229999999999997 110.848 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.109999999999999 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.019999999999996 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.530000000000001 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 75.209999999999994 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.116 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.82 146.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 111.197 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -79.92 112.2 16.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 111.202 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -69.34 171.59 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 72.230000000000004 110.872 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -63.77 -16.44 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 110.94 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.0 2.97 36.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.908 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.57 86.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.696 . . . . 51.299999999999997 112.474 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -111.7 140.4 46.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.742 0.306 . . . . 72.120000000000005 111.191 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.04 134.42 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.219999999999999 111.06 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.450000000000003 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 75.150000000000006 110.91 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.0 111.176 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.866 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t -98.38 141.28 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.099999999999994 111.152 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -125.0 -174.31 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 65.040000000000006 110.911 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -113.16 161.54 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.899 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.2 t -129.25 34.02 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.78 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.41 -24.0 12.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 72.120000000000005 110.917 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -106.15 -38.57 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.400000000000006 110.896 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.8 -23.08 50.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 64.109999999999999 110.925 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 p -100.38 144.57 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 73.0 111.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -81.38 -29.24 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.010000000000005 110.911 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 50.340000000000003 110.872 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.469 -0.252 . . . . 63.340000000000003 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.14 45.47 17.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 65.140000000000001 111.083 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 tpt -105.35 63.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.06 -28.51 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.439999999999998 112.433 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.7 170.54 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.863 0.363 . . . . 72.409999999999997 111.098 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -109.73 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 75.209999999999994 110.875 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -111.17 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 63.130000000000003 110.889 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -65.91 105.89 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 110.798 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.38 -31.84 10.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.450000000000003 110.864 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.24 94.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.901 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.48 113.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.329999999999998 111.063 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -148.77 68.2 9.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.58 0.705 . . . . 72.310000000000002 110.873 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -13.05 34.1 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.727 2.284 . . . . 71.310000000000002 112.306 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 p -51.65 111.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.117 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.96 179.23 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -93.12 140.65 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 65.140000000000001 110.909 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.22 148.85 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 73.010000000000005 111.121 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 75.329999999999998 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.439999999999998 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.239999999999995 111.111 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 74.030000000000001 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.329999999999998 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.439999999999998 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 75.120000000000005 111.153 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 65.450000000000003 111.112 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 62.140000000000001 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 70.510000000000005 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.904 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.111 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 74.109999999999999 111.171 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 75.409999999999997 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.909 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.450000000000003 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 64.219999999999999 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.874 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 61.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 111.189 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 111.006 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 65.329999999999998 110.901 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 72.019999999999996 110.954 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 75.230000000000004 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.140000000000001 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 73.340000000000003 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 71.439999999999998 109.577 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.430000000000007 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.340000000000003 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 73.530000000000001 111.14 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.340000000000003 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 74.430000000000007 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 64.030000000000001 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.019999999999996 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 75.209999999999994 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.019999999999996 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.45 140.6 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 74.450000000000003 111.132 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -80.69 108.92 14.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.096 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -60.19 163.91 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 72.230000000000004 110.83 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.52 -18.5 59.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.903 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -84.02 0.93 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.948 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.2 15.41 76.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 51.299999999999997 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.0 p -111.64 129.85 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 72.120000000000005 111.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm -74.71 146.09 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.0 111.127 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -91.27 136.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 111.146 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.08 -179.07 4.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 65.040000000000006 110.842 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -105.37 160.87 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.892 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.7 p -117.31 25.09 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.85 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -105.47 -20.3 13.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.892 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.45 -63.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.400000000000006 110.909 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -53.04 -29.01 27.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 64.109999999999999 110.977 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.69 141.29 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 73.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -83.59 -45.47 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 110.919 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 50.340000000000003 110.89 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.01 145.03 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 65.140000000000001 111.14 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mmt 55.61 49.8 15.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.975 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.36 121.09 24.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.639 -0.791 . . . . 74.439999999999998 112.539 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 pt -119.67 44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 72.409999999999997 111.126 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.75 71.99 8.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 75.209999999999994 110.883 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -147.49 -175.97 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 63.130000000000003 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 t -87.91 69.85 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -69.62 -42.52 74.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 74.450000000000003 110.811 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.8 m -69.21 133.37 47.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.120000000000005 110.871 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.25 136.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 73.329999999999998 111.068 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -148.92 74.55 10.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.634 0.731 . . . . 72.310000000000002 110.94 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -39.2 6.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.76 2.307 . . . . 71.310000000000002 112.335 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.55 171.59 13.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -105.03 180.0 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.917 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.43 157.01 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.866 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.81 148.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.010000000000005 111.129 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 75.329999999999998 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.439999999999998 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.409999999999997 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.13 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 74.030000000000001 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.329999999999998 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.439999999999998 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 111.134 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.510000000000005 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 65.450000000000003 111.184 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.530000000000001 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 70.510000000000005 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.873 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.120000000000005 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.230000000000004 111.219 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 73.129999999999995 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 74.109999999999999 111.14 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.945 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 73.129999999999995 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 75.209999999999994 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.450000000000003 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 75.010000000000005 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.519999999999996 110.868 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 111.166 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 61.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.171 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 110.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.329999999999998 110.917 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 72.019999999999996 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 75.230000000000004 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.140000000000001 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 73.340000000000003 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.439999999999998 109.632 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.430000000000007 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.510000000000005 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 74.430000000000007 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 64.030000000000001 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.229999999999997 110.778 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.109999999999999 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 71.019999999999996 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 75.209999999999994 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.72 143.86 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 74.450000000000003 111.139 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 m -80.12 109.25 14.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 73.200000000000003 111.188 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 p -59.82 179.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.878 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -77.59 -4.23 44.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.973 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -103.08 9.28 38.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.91 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.99 15.99 80.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.779 -0.724 . . . . 51.299999999999997 112.5 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.4 p -112.23 122.94 49.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 72.120000000000005 111.054 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.74 137.99 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 75.219999999999999 111.137 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.450000000000003 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 74.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.98 142.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.099999999999994 111.176 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 175.88 8.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 65.040000000000006 110.929 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -108.3 161.59 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -127.49 6.79 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.471 . . . . 72.340000000000003 110.9 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.24 -7.64 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 72.120000000000005 110.858 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -73.74 -31.29 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 74.400000000000006 110.823 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -56.28 -25.2 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.88 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.84 123.13 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 73.0 111.184 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.57 -28.61 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 73.010000000000005 110.924 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 50.340000000000003 110.847 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.28 -35.73 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 65.140000000000001 111.156 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 mmm -76.12 78.8 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.5 110.93 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.9 113.87 0.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.439999999999998 112.473 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -163.2 147.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 72.409999999999997 111.135 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -77.39 -174.95 3.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.26 163.34 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 63.130000000000003 110.904 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 p -139.88 130.64 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 74.329999999999998 110.838 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.47 -36.35 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.450000000000003 110.841 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -75.75 132.94 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 64.120000000000005 110.854 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.49 135.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -172.48 68.7 0.4 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 72.310000000000002 110.869 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -14.33 35.73 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.622 2.215 . . . . 71.310000000000002 112.289 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.8 p -51.75 163.2 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.171 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -68.62 179.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.883 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -89.44 149.78 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 110.84 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.82 147.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.010000000000005 111.133 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 75.329999999999998 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.510000000000005 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.239999999999995 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.430000000000007 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 74.030000000000001 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.439999999999998 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 75.120000000000005 111.109 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 65.450000000000003 111.114 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 70.510000000000005 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.85 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 111.159 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.129999999999995 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 74.109999999999999 111.114 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 75.409999999999997 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.975 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.430000000000007 111.118 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.450000000000003 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 64.219999999999999 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 61.0 111.113 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.439999999999998 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.120000000000005 110.96 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 72.019999999999996 110.936 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 75.230000000000004 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 73.340000000000003 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 71.439999999999998 109.628 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.430000000000007 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 73.530000000000001 111.143 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 74.430000000000007 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 74.120000000000005 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 64.030000000000001 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.229999999999997 110.859 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.109999999999999 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 75.209999999999994 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -154.41 139.83 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 111.109 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -80.04 111.46 16.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.198 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.71 171.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.903 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -23.04 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 72.439999999999998 110.892 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.48 9.78 25.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.95 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.38 81.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 51.299999999999997 112.468 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.7 p -98.08 116.49 30.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 72.120000000000005 111.154 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm -67.03 142.63 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.219999999999999 111.123 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.450000000000003 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 75.150000000000006 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.0 111.144 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.19 142.04 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.099999999999994 111.103 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -119.54 -174.38 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.892 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -113.92 161.49 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.903 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.2 t -95.73 29.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.811 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.58 -18.37 14.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.883 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -86.02 -64.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 74.400000000000006 110.868 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -51.3 -48.21 62.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 64.109999999999999 110.885 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.3 t -80.09 119.29 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.0 111.191 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -93.22 -32.55 14.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 73.010000000000005 110.894 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 50.340000000000003 110.856 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.418 -0.273 . . . . 63.340000000000003 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.42 119.25 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 65.140000000000001 111.049 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.73 121.69 13.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.887 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.71 105.36 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.565 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tp -175.18 137.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 72.409999999999997 111.098 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -138.84 148.1 43.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 75.209999999999994 110.841 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -163.35 131.53 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 63.130000000000003 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.2 p -162.21 158.47 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.907 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -108.35 -34.17 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 110.836 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 63.19 52.5 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 110.861 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.94 129.77 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 73.329999999999998 111.164 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 68.3 9.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 72.310000000000002 110.942 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -14.27 35.96 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.716 2.277 . . . . 71.310000000000002 112.368 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -125.36 178.34 5.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.25 111.188 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -51.81 169.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 110.931 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -161.34 129.16 4.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.428 . . . . 65.140000000000001 110.921 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.32 132.66 35.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.109 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 75.329999999999998 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.439999999999998 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.084 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.430000000000007 110.898 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.979 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 74.030000000000001 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.329999999999998 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.439999999999998 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 75.120000000000005 111.177 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.510000000000005 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 65.450000000000003 111.119 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.530000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.478 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 70.510000000000005 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.892 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.120000000000005 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 74.109999999999999 111.125 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 75.409999999999997 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.93 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 73.129999999999995 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.010000000000005 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 64.219999999999999 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.148 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 61.0 111.071 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.144 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.884 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 110.883 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 72.019999999999996 110.935 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 75.230000000000004 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.140000000000001 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 73.340000000000003 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 71.439999999999998 109.534 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.430000000000007 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.430000000000007 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.530000000000001 111.176 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 74.430000000000007 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.875 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.109999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 75.209999999999994 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.019999999999996 111.123 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -155.91 147.58 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.127 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.81 109.6 14.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 111.165 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -66.34 170.72 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.230000000000004 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.55 -16.47 60.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.909 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.46 3.11 33.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 74.530000000000001 110.891 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.52 7.74 87.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 51.299999999999997 112.524 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.3 p -111.74 135.29 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 72.120000000000005 111.156 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.75 145.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 111.175 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.450000000000003 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.0 111.117 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.58 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.099999999999994 111.061 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.06 177.04 6.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.895 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.02 158.14 16.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.951 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -121.45 2.99 10.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 72.340000000000003 110.859 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.39 -6.85 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 72.120000000000005 110.885 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -73.58 -26.38 60.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 110.904 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -58.22 -22.75 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 64.109999999999999 110.964 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.47 124.02 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -94.38 -32.26 13.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.010000000000005 110.886 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 50.340000000000003 110.881 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.453 -0.259 . . . . 63.340000000000003 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.79 170.0 15.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 65.140000000000001 111.08 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -150.91 177.6 9.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.885 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 82.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 74.439999999999998 112.519 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.72 -26.26 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.389 . . . . 72.409999999999997 111.197 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -52.93 148.69 7.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.908 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -167.07 172.76 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 63.130000000000003 110.857 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 36.15 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 74.329999999999998 110.909 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.5 -38.43 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 74.450000000000003 110.848 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.9 p -71.46 -175.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 64.120000000000005 110.858 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -133.97 113.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 111.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -173.66 71.45 0.36 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.571 0.7 . . . . 72.310000000000002 110.894 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -46.82 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.702 2.268 . . . . 71.310000000000002 112.373 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.35 107.54 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 73.25 111.141 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -130.26 129.01 42.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 74.420000000000002 110.974 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -132.28 128.51 37.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 65.140000000000001 110.932 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.44 152.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.068 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 75.329999999999998 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.409999999999997 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.131 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.430000000000007 110.853 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.109999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 74.030000000000001 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.329999999999998 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 75.120000000000005 111.107 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 65.450000000000003 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.530000000000001 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 62.140000000000001 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 70.510000000000005 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.310000000000002 110.894 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 111.146 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.129999999999995 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 74.109999999999999 111.081 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.883 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.430000000000007 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.450000000000003 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 75.010000000000005 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 64.219999999999999 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.214 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.099 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.120000000000005 110.925 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 65.329999999999998 110.838 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 72.019999999999996 110.948 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 75.230000000000004 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.140000000000001 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 73.340000000000003 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 71.439999999999998 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.430000000000007 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.340000000000003 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 74.319999999999993 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.530000000000001 111.148 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 74.430000000000007 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 74.120000000000005 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 64.030000000000001 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.229999999999997 110.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.109999999999999 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.109999999999999 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 71.019999999999996 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.530000000000001 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 75.209999999999994 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.019999999999996 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.22 143.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 74.450000000000003 111.085 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -80.25 117.23 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 73.200000000000003 111.125 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -69.22 168.28 14.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 72.230000000000004 110.885 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.5 -23.02 62.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 72.439999999999998 110.928 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 8.08 28.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 74.530000000000001 110.932 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.67 81.43 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 51.299999999999997 112.45 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.4 p -101.37 119.06 38.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 72.120000000000005 111.148 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.77 139.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 111.158 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.93 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 75.150000000000006 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 74.0 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.04 139.64 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.127 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.84 150.41 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 65.040000000000006 110.917 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -72.58 160.57 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 74.239999999999995 110.927 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.0 p -122.51 29.6 6.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.845 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.08 -21.51 12.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.1 -70.95 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 74.400000000000006 110.888 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -49.66 -38.85 34.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.58 126.0 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 73.0 111.178 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -84.44 -31.35 24.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.010000000000005 110.899 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 50.340000000000003 110.88 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.495 -0.242 . . . . 63.340000000000003 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.36 125.36 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 65.140000000000001 111.075 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.0 mtm -64.65 -67.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.27 106.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.505 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.24 138.15 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 72.409999999999997 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -106.83 131.51 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.835 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -80.4 164.05 23.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 63.130000000000003 110.856 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -53.93 165.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 74.329999999999998 110.876 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.1 -42.72 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 110.843 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 p -156.7 130.87 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 64.120000000000005 110.858 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -147.83 142.49 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 73.329999999999998 111.093 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 70.24 67.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.653 0.74 . . . . 72.310000000000002 110.918 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -17.62 37.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 71.310000000000002 112.386 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.05 162.1 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.25 111.152 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -66.54 179.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.946 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.33 137.34 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 65.140000000000001 110.902 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.14 146.04 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 73.010000000000005 111.091 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 75.329999999999998 110.875 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.439999999999998 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.15 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.329999999999998 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.439999999999998 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.239999999999995 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 75.120000000000005 111.076 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.510000000000005 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 65.450000000000003 111.11 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.530000000000001 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 62.140000000000001 112.52 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 70.510000000000005 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 74.310000000000002 110.871 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.886 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.099 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 73.129999999999995 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 74.109999999999999 111.153 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 75.409999999999997 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.96 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 75.209999999999994 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.450000000000003 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 64.219999999999999 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.519999999999996 110.916 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 61.0 111.083 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.139 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.120000000000005 110.944 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 65.329999999999998 110.904 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 72.019999999999996 110.998 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 75.230000000000004 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.140000000000001 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 73.340000000000003 110.908 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 71.439999999999998 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 74.319999999999993 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 73.530000000000001 111.115 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.340000000000003 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 74.430000000000007 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 64.030000000000001 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.109999999999999 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.109999999999999 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 71.019999999999996 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.530000000000001 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 75.209999999999994 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 139.33 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 74.450000000000003 111.057 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 m -80.64 111.43 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 73.200000000000003 111.148 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 165.45 17.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.851 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.26 -21.89 60.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.52 5.84 33.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.943 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.1 19.31 79.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 51.299999999999997 112.519 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 p -107.09 120.09 41.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 72.120000000000005 111.16 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 mm -73.6 126.35 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 111.201 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.922 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.450000000000003 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 75.150000000000006 110.93 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.0 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.7 t -97.43 144.37 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 111.152 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -118.37 -174.49 2.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.91 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -108.27 160.55 15.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 74.239999999999995 110.925 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.9 m -128.46 38.48 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 110.858 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.2 -29.54 21.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.120000000000005 110.903 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -87.52 -32.41 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.918 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.64 -25.74 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 64.109999999999999 110.866 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.92 148.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -90.65 -38.52 13.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.010000000000005 110.854 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 50.340000000000003 110.898 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.527 -0.229 . . . . 63.340000000000003 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.48 166.47 11.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 65.140000000000001 111.134 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mtm -80.8 123.35 28.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 74.5 110.918 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.41 -166.76 41.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.794 -0.717 . . . . 74.439999999999998 112.449 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.55 148.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.409999999999997 111.105 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -158.4 117.12 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.209999999999994 110.918 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -174.73 177.73 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 63.130000000000003 110.947 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -79.24 133.4 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.852 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.32 -45.14 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 74.450000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.6 t -68.23 117.44 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 64.120000000000005 110.911 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.06 147.87 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.329999999999998 111.085 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 69.87 4.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 72.310000000000002 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 -48.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.747 2.298 . . . . 71.310000000000002 112.294 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.1 p -125.8 -177.37 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 73.25 111.166 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.65 179.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -93.58 134.34 35.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 65.140000000000001 110.904 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 146.69 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.010000000000005 111.09 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 75.329999999999998 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.439999999999998 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.409999999999997 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.167 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 74.030000000000001 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.329999999999998 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.439999999999998 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.120000000000005 111.161 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 65.450000000000003 111.158 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.530000000000001 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 62.140000000000001 112.501 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 70.510000000000005 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.951 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.109999999999999 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.230000000000004 111.133 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 74.109999999999999 111.096 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 75.409999999999997 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.319999999999993 110.926 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.450000000000003 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 64.219999999999999 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.114 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 61.0 111.083 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 111.087 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.861 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 65.329999999999998 110.906 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 72.019999999999996 110.94 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 75.230000000000004 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 73.340000000000003 110.886 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 71.439999999999998 109.624 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.430000000000007 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 73.530000000000001 111.155 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 74.430000000000007 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 64.030000000000001 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.229999999999997 110.914 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.109999999999999 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.109999999999999 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 71.019999999999996 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.530000000000001 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 75.209999999999994 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.87 138.1 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 111.132 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -80.02 110.83 15.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 73.200000000000003 111.138 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 164.86 16.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 72.230000000000004 110.901 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.06 -21.78 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.915 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.32 4.57 34.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.89 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 18.39 79.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 51.299999999999997 112.483 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -107.76 123.87 49.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 72.120000000000005 111.196 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.8 mm -76.37 131.52 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 111.081 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 110.938 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 74.0 111.093 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t -100.93 144.19 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -174.68 2.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 65.040000000000006 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -117.61 161.28 19.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.868 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -122.91 26.14 8.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.811 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.69 -34.55 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 72.120000000000005 110.852 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -78.87 -32.74 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 74.400000000000006 110.906 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.71 -24.74 64.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 64.109999999999999 110.891 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.12 148.58 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -101.95 -28.71 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.815 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 50.340000000000003 110.846 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.502 -0.239 . . . . 63.340000000000003 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.72 47.1 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 65.140000000000001 111.107 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 ptm -134.18 177.16 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.894 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.05 21.74 56.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 74.439999999999998 112.506 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.26 95.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 72.409999999999997 111.154 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.6 57.68 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.92 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.37 145.96 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.130000000000003 110.89 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -70.9 110.57 5.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 110.907 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -59.26 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 74.450000000000003 110.895 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -158.52 167.35 29.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 64.120000000000005 110.902 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 m -117.66 125.64 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 73.329999999999998 111.106 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.52 71.42 15.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 72.310000000000002 110.852 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -48.46 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 71.310000000000002 112.371 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.73 124.27 7.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 73.25 111.154 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -171.35 125.97 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 74.420000000000002 110.861 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -125.68 129.06 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 65.140000000000001 110.881 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.1 141.04 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 73.010000000000005 111.1 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 75.329999999999998 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.439999999999998 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.239999999999995 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 110.926 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 74.030000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.329999999999998 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 111.165 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 65.450000000000003 111.08 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.530000000000001 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 62.140000000000001 112.53 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 70.510000000000005 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.917 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.898 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.109999999999999 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.120000000000005 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 74.109999999999999 111.103 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 75.409999999999997 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.924 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.450000000000003 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 75.010000000000005 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.846 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 61.0 111.057 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.127 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.97 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 65.329999999999998 110.868 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 72.019999999999996 110.94 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 75.230000000000004 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.140000000000001 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 73.340000000000003 110.866 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 71.439999999999998 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.430000000000007 110.859 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 73.530000000000001 111.098 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.340000000000003 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 74.430000000000007 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 64.030000000000001 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.819 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.109999999999999 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.109999999999999 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 71.019999999999996 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 75.209999999999994 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.116 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.33 146.31 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.450000000000003 111.168 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.61 125.29 29.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.167 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -75.07 -169.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.92 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -70.95 -34.06 71.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.904 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -90.68 16.96 8.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.935 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.6 5.58 68.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 51.299999999999997 112.506 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 p -79.86 112.03 16.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 72.120000000000005 111.18 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.0 mm -68.15 129.17 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 111.144 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 75.150000000000006 110.938 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.909 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.1 141.92 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.099999999999994 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -100.86 -174.32 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 65.040000000000006 110.929 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -94.7 161.44 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.239999999999995 110.855 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -126.62 27.68 6.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.05 -20.56 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -73.99 -59.84 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 74.400000000000006 110.82 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.45 -38.91 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 64.109999999999999 110.93 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.37 135.71 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 73.0 111.102 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -102.57 -33.27 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.010000000000005 110.92 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 50.340000000000003 110.853 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.532 -0.227 . . . . 63.340000000000003 112.532 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.23 25.57 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 65.140000000000001 111.107 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mmm -96.62 111.0 23.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.898 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.29 65.96 0.55 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.829 -0.7 . . . . 74.439999999999998 112.5 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -84.82 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 72.409999999999997 111.112 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -105.65 172.44 6.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 75.209999999999994 110.822 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -74.08 126.91 31.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 110.869 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.0 p -78.85 167.61 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.897 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.37 -59.6 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.875 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.8 p -164.64 136.66 4.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 64.120000000000005 110.845 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.8 p -173.14 136.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.124 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.29 69.44 0.8 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.502 0.668 . . . . 72.310000000000002 110.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -14.18 35.8 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.7 2.267 . . . . 71.310000000000002 112.361 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.87 157.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.25 111.141 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.03 172.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -100.27 144.49 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 65.140000000000001 110.967 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.15 159.68 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 73.010000000000005 111.089 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 75.329999999999998 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.439999999999998 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 74.030000000000001 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.329999999999998 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 75.120000000000005 111.094 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 65.450000000000003 111.115 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 62.140000000000001 112.513 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 70.510000000000005 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 74.310000000000002 110.891 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.91 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 111.12 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 74.109999999999999 111.053 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 75.409999999999997 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.899 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 75.209999999999994 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.450000000000003 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 75.010000000000005 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 64.219999999999999 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.89 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.140000000000001 111.148 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 61.0 111.176 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.158 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.965 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.87 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 72.019999999999996 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 75.230000000000004 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.140000000000001 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 73.340000000000003 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 71.439999999999998 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.430000000000007 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.142 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 74.430000000000007 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 64.030000000000001 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.813 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.109999999999999 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 71.019999999999996 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.530000000000001 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 75.209999999999994 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.019999999999996 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.71 141.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 111.095 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 m -80.63 117.81 21.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 73.200000000000003 111.114 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -178.71 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.899 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -22.93 62.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.92 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.0 7.86 29.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.530000000000001 110.8 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.22 13.82 81.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.813 -0.708 . . . . 51.299999999999997 112.48 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 p -99.48 120.73 40.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.738 0.304 . . . . 72.120000000000005 111.142 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm -73.11 132.42 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 111.122 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.450000000000003 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.150000000000006 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.48 145.3 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.068 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.3 165.15 24.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.040000000000006 110.934 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -90.04 161.35 15.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.917 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.3 m -129.54 31.44 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.340000000000003 110.874 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.6 -35.76 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.841 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -91.63 -32.06 15.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.400000000000006 110.9 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -57.82 -25.4 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 64.109999999999999 110.891 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.37 144.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.14 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -87.78 -31.08 19.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 73.010000000000005 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.0 t0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 50.340000000000003 110.894 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 63.340000000000003 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 119.62 21.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 65.140000000000001 111.03 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.5 ptp -67.95 -32.2 72.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.915 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.34 75.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.623 -0.798 . . . . 74.439999999999998 112.461 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.0 mt -101.86 114.89 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 72.409999999999997 111.119 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 176.64 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.853 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 63.01 25.55 15.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 63.130000000000003 110.853 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 110.846 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -103.54 -30.56 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 74.450000000000003 110.911 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m 51.88 88.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 64.120000000000005 110.843 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -146.07 109.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.113 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.68 76.99 0.29 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.51 0.671 . . . . 72.310000000000002 110.861 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -11.01 29.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.704 2.269 . . . . 71.310000000000002 112.377 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -111.1 163.31 14.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 73.25 111.141 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -95.81 163.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.889 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -99.96 130.39 46.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 65.140000000000001 110.914 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.09 141.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 111.108 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 75.329999999999998 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.439999999999998 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.126 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.329999999999998 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.439999999999998 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 111.135 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.510000000000005 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 65.450000000000003 111.097 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.530000000000001 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 62.140000000000001 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.863 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.109999999999999 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 111.156 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 73.129999999999995 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 111.138 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 75.409999999999997 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.319999999999993 110.924 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 111.147 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.450000000000003 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.924 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.151 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 61.0 111.149 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.099 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.120000000000005 110.979 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 65.329999999999998 110.875 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 72.019999999999996 110.889 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 75.230000000000004 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.140000000000001 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 73.340000000000003 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 71.439999999999998 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.430000000000007 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.430000000000007 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.530000000000001 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.340000000000003 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 74.430000000000007 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 74.120000000000005 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 64.030000000000001 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.229999999999997 110.824 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.109999999999999 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.019999999999996 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 75.209999999999994 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.083 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.91 148.31 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 74.450000000000003 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -79.8 110.2 14.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 73.200000000000003 111.144 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -66.48 170.82 5.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 110.839 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -63.84 -16.02 60.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 72.439999999999998 110.934 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.0 3.41 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.945 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.08 86.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 51.299999999999997 112.456 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 p -112.56 132.09 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 72.120000000000005 111.14 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm -65.52 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.219999999999999 111.111 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.150000000000006 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 74.0 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.230000000000004 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.86 144.4 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.099999999999994 111.149 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -133.24 156.82 46.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 65.040000000000006 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 161.21 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.891 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -115.86 32.29 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 72.340000000000003 110.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.7 -18.54 17.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.888 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.89 -57.79 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 74.400000000000006 110.863 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.56 -32.09 73.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 64.109999999999999 110.816 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.15 122.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.0 111.161 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -81.04 -31.1 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 73.010000000000005 110.833 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 50.340000000000003 110.881 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.445 -0.262 . . . . 63.340000000000003 112.445 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.23 34.84 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 65.140000000000001 111.081 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -29.52 70.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.922 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.39 -164.09 1.6 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 74.439999999999998 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 tp -74.65 135.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 72.409999999999997 111.093 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 -117.56 154.57 31.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -64.56 167.17 7.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 63.130000000000003 110.857 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t 59.67 27.13 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.901 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.41 -26.02 67.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.450000000000003 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.11 112.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.120000000000005 110.895 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.87 119.24 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.11 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -149.32 73.57 9.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 72.310000000000002 110.92 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.744 2.296 . . . . 71.310000000000002 112.351 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -94.77 35.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 73.25 111.14 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -87.08 124.45 33.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 110.95 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -105.11 127.83 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 65.140000000000001 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.45 141.38 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.010000000000005 111.11 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 75.329999999999998 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.409999999999997 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.239999999999995 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.430000000000007 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 74.030000000000001 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.329999999999998 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.439999999999998 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 111.117 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.510000000000005 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 65.450000000000003 111.08 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.530000000000001 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 62.140000000000001 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 70.510000000000005 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 74.310000000000002 110.893 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.109999999999999 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 111.159 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 73.129999999999995 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 74.109999999999999 111.081 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 75.409999999999997 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.949 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 111.08 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 73.129999999999995 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 111.117 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 61.0 111.125 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.173 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.953 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 65.329999999999998 110.904 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 72.019999999999996 110.905 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 75.230000000000004 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.140000000000001 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 73.340000000000003 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.439999999999998 109.6 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.430000000000007 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 111.076 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 74.120000000000005 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 64.030000000000001 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.109999999999999 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.109999999999999 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 71.019999999999996 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 75.209999999999994 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.019999999999996 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.2 142.72 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 111.12 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -80.42 111.22 16.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 73.200000000000003 111.141 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -61.85 178.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.844 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -75.79 -5.99 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.439999999999998 110.894 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.56 0.1 44.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.530000000000001 110.908 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.24 9.03 80.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 51.299999999999997 112.457 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 p -106.53 128.52 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 72.120000000000005 111.123 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 mm -74.39 143.61 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 111.228 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 75.150000000000006 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 74.0 111.125 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.15 143.84 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.099999999999994 111.164 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -114.17 -174.43 2.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 65.040000000000006 110.949 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -104.69 160.52 14.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 74.239999999999995 110.901 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -131.0 30.01 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.340000000000003 110.829 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.38 -22.29 12.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.87 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -101.86 -28.51 12.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 74.400000000000006 110.899 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -58.54 -22.25 54.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.109999999999999 110.884 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.28 150.96 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 73.0 111.173 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -89.34 -30.49 18.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.010000000000005 110.865 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 50.340000000000003 110.827 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.798 0.332 . . . . 62.44 111.087 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 74.52 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.44 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.41 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.51 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.613 HG12 HD12 ' A' ' 33' ' ' ILE . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.24 111.158 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 73.05 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.44 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.685 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.163 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.613 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 63.03 111.129 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.53 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 51.1 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 64.21 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 64.25 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.11 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.11 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.12 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.141 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 62.32 111.101 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 74.3 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.685 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.961 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.814 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.1 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 62.31 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 46' ' ' LEU . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.868 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 54.01 111.153 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.44 111.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.003 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.918 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.43 110.881 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.003 HD21 HD12 ' A' ' 57' ' ' LEU . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 70.11 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 72.32 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.14 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' CG ' HD11 ' A' ' 93' ' ' LEU . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 71.45 110.905 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 51.01 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.43 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.43 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.51 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 64.4 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 31' ' ' VAL . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 53.12 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 52.31 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 73.11 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 53.15 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.11 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.11 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 44.53 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.53 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 71.33 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.02 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.11 111.113 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.845 0.355 . . . . 75.22 111.129 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.45 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' A' ' 63' ' ' GLU . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.916 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 53.44 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.1 111.074 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.812 0.339 . . . . 62.44 111.079 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 74.52 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.44 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.433 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.151 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.51 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.66 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.24 111.133 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.43 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 73.05 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 70' ' ' VAL . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.33 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.44 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.24 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 46' ' ' LEU . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 74.23 111.094 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.03 111.095 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.53 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 51.1 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 64.21 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.12 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.203 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 62.32 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 74.3 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.901 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 64.1 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 72.14 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.1 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 62.31 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 46' ' ' LEU . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.928 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.14 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.548 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.01 111.151 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.634 ' C ' HD23 ' A' ' 57' ' ' LEU . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.169 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.94 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.909 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.855 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.94 HD21 HD12 ' A' ' 57' ' ' LEU . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 70.11 110.896 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 72.32 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.14 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.418 ' CG ' HD11 ' A' ' 93' ' ' LEU . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 71.45 110.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 51.01 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.43 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 64.4 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 31' ' ' VAL . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 53.12 111.147 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.34 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 52.31 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 73.11 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 53.15 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.23 110.843 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.11 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.11 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 44.53 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.53 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 71.33 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.02 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.13 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 75.22 111.062 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.11 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.418 HD11 ' CG ' ' A' ' 63' ' ' GLU . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.935 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.433 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.156 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.1 111.14 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.804 0.335 . . . . 62.44 111.072 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 74.52 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.44 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.41 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.51 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.218 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.33 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.44 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.714 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.129 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.51 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.03 111.188 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.53 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 51.1 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 64.21 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.25 110.86 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.516 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.23 111.119 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 62.32 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 74.3 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.714 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.839 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.3 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 64.1 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 72.14 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.45 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.1 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 62.31 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB3' HD23 ' A' ' 46' ' ' LEU . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.16 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 54.01 111.141 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.162 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.035 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.01 110.966 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.893 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 70.11 110.954 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 72.32 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.14 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 71.45 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 51.01 109.573 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.43 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 31' ' ' VAL . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 53.12 111.134 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 52.31 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 53.15 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.23 110.872 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.11 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.11 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 44.53 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.53 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 71.33 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.02 111.074 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 63.11 111.124 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.844 0.354 . . . . 75.22 111.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.45 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 74.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 53.44 111.164 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.1 111.126 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.761 0.315 . . . . 62.44 111.076 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 74.52 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.44 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.41 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.24 111.093 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.05 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.33 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.44 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.24 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 46' ' ' LEU . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.211 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 63.03 111.15 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.53 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 51.1 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 64.21 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.11 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.12 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.23 111.172 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.59 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 62.32 111.108 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.3 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.921 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.3 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 64.1 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 72.14 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.45 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 71.1 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 62.31 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' HD23 ' A' ' 46' ' ' LEU . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.924 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 54.01 111.09 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.128 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.037 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.867 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.915 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 57' ' ' LEU . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 70.11 110.884 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 72.32 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.14 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 71.45 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 51.01 109.568 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.43 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.43 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 64.4 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 31' ' ' VAL . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 53.12 111.18 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.34 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 52.31 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.11 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 53.15 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.23 110.84 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.11 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.11 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 44.53 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.53 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 71.33 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.134 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 63.11 111.147 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 75.22 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.45 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 53.44 111.124 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.1 111.111 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.712 0.291 . . . . 62.44 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 74.52 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.44 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.41 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.24 111.094 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 73.05 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.33 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.44 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.139 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 63.03 111.133 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.53 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 51.1 112.465 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 64.21 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 64.25 110.862 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.511 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.11 110.879 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.23 111.111 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 62.32 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 74.3 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.32 110.922 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.3 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.1 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.45 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 71.1 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.31 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' A' ' 46' ' ' LEU . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.944 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 22' ' ' ILE . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.204 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 54.01 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.636 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.44 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.04 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.944 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.04 HD21 HD12 ' A' ' 57' ' ' LEU . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 70.11 110.947 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 72.32 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.14 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 71.45 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 51.01 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.43 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.51 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 31' ' ' VAL . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 53.12 111.171 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.34 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 52.31 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 53.15 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.11 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.11 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 44.53 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.53 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 71.33 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 63.11 111.16 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.783 0.325 . . . . 75.22 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.11 110.855 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.45 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 74.14 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 53.44 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.1 111.147 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 62.44 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 74.52 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.44 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.447 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.071 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.51 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.155 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 73.05 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.33 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.44 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.724 ' CG1' HD22 ' A' ' 46' ' ' LEU . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.23 111.105 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 63.03 111.09 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.53 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 51.1 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 64.21 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.25 110.889 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.11 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.11 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.465 HG22 ' OD1' ' A' ' 38' ' ' ASN . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.23 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 62.32 111.18 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 74.3 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.32 110.972 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.3 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 64.1 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 72.14 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.45 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 71.1 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' HD23 ' A' ' 46' ' ' LEU . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.52 110.887 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.14 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 54.01 111.135 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.44 111.156 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.956 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.01 110.85 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.909 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.956 HD21 HD12 ' A' ' 57' ' ' LEU . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 70.11 110.94 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 72.32 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.14 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 71.45 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 51.01 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.43 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.43 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.51 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 64.4 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 31' ' ' VAL . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 53.12 111.128 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 52.31 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 53.15 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.23 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.11 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.11 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 44.53 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.53 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 71.33 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.02 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 63.11 111.136 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.805 0.336 . . . . 75.22 111.122 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.45 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 95' ' ' HIS . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.904 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 53.44 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.679 ' CE1' HD22 ' A' ' 93' ' ' LEU . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.909 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.1 111.119 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 62.44 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NE ' HG13 ' A' ' 96' ' ' VAL . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 74.52 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.44 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.51 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.24 111.109 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.43 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.05 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.33 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG11 HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.087 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 63.03 111.126 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.53 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 51.1 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 64.21 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.5 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 64.25 110.88 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.11 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.12 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.121 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.24 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 62.32 111.148 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 74.3 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.32 110.949 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 64.1 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 71.1 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 62.31 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 46' ' ' LEU . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.924 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 22' ' ' ILE . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 111.149 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 54.01 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.637 ' C ' HD23 ' A' ' 57' ' ' LEU . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.111 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.028 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.939 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 63.43 110.85 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 57' ' ' LEU . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 70.11 110.997 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 72.32 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.14 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 71.45 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 51.01 109.603 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.43 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.43 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.4 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 31' ' ' VAL . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 53.12 111.133 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 52.31 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 73.11 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 53.15 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.23 110.875 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.11 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.11 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 44.53 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.53 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 71.33 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 63.11 111.09 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.87 0.367 . . . . 75.22 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.885 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.45 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 53.44 111.12 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.23 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG13 ' NE ' ' A' ' 18' ' ' ARG . 95.6 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.1 111.084 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 62.44 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 74.52 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.44 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' HD13 ' A' ' 94' ' ' ILE . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.41 111.147 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.51 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.24 111.115 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.05 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.33 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.44 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 46' ' ' LEU . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.106 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.51 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 63.03 111.066 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.53 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 51.1 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 64.21 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.25 110.888 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.12 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.176 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.613 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 62.32 111.184 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 74.3 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.956 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.1 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.872 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 71.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 62.31 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB3' HD23 ' A' ' 46' ' ' LEU . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.52 110.896 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.14 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 54.01 111.069 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.647 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.154 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.104 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.891 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.854 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.104 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 70.11 110.918 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 72.32 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.14 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 71.45 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 51.01 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.43 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.34 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.43 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.51 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 64.4 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 31' ' ' VAL . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 53.12 111.092 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 52.31 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.23 110.865 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.11 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.11 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 44.53 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.53 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 71.33 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.02 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 63.11 111.128 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 75.22 111.147 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.11 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.45 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.14 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.462 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 53.44 111.192 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.1 111.141 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 62.44 111.079 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 74.52 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.44 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.41 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.51 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.24 111.136 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' HG12 ' A' ' 54' ' ' VAL . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.43 110.885 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 70' ' ' VAL . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.908 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 73.05 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.33 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.44 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.24 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG11 HD22 ' A' ' 46' ' ' LEU . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 74.23 111.171 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.51 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 22' ' ' ILE . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 63.03 111.116 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.53 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 51.1 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 64.21 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 64.25 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.11 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.11 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.12 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.23 111.13 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 62.32 111.088 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 74.3 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.721 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.32 110.85 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.3 111.188 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 64.1 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 72.14 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.45 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.52 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 23' ' ' ARG . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.14 111.122 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 54.01 111.166 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.648 ' C ' HD23 ' A' ' 57' ' ' LEU . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.995 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.01 110.939 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.995 HD21 HD12 ' A' ' 57' ' ' LEU . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 70.11 110.877 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 72.32 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.14 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 71.45 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 51.01 109.588 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.43 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.43 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 64.4 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 24' ' ' TRP . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 53.12 111.123 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.34 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 52.31 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.15 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.23 110.848 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.11 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.11 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 44.53 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.53 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 71.33 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.116 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 63.11 111.197 179.854 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.857 0.361 . . . . 75.22 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.45 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.447 HD21 ' NE2' ' A' ' 95' ' ' HIS . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 74.14 110.91 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 93' ' ' LEU . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 53.44 111.176 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.447 ' NE2' HD21 ' A' ' 93' ' ' LEU . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.866 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.1 111.152 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.728 0.299 . . . . 62.44 111.121 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 74.52 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.44 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.24 111.111 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.05 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.33 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.44 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.72 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.153 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.628 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 63.03 111.112 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.53 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 51.1 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 64.21 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CB ' HD22 ' A' ' 59' ' ' LEU . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 64.25 110.904 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.519 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.519 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.23 111.111 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 62.32 111.171 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 74.3 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.32 110.909 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.3 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 72.14 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.45 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 71.1 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 62.31 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB3' HD23 ' A' ' 46' ' ' LEU . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.874 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 54.01 111.154 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.612 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.44 111.189 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.986 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.006 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.986 HD21 HD12 ' A' ' 57' ' ' LEU . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 70.11 110.954 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 72.32 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.14 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 71.45 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.406 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 51.01 109.577 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.43 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.34 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.51 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 64.4 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 31' ' ' VAL . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 53.12 111.14 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.34 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 52.31 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 53.15 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.11 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.11 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 44.53 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.53 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 71.33 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.02 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.132 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.791 0.329 . . . . 75.22 111.131 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.45 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.44 111.127 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.1 111.146 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.71 0.291 . . . . 62.44 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 74.52 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.44 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.41 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.51 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.13 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 73.05 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.33 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.44 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.689 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.134 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.51 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 63.03 111.184 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.53 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 51.1 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 64.21 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 64.25 110.873 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.12 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.23 111.219 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 72.24 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.511 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 62.32 111.14 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 74.3 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.945 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.3 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 64.1 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 72.14 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.45 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 71.1 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 62.31 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 46' ' ' LEU . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.52 110.868 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.14 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 54.01 111.102 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.44 111.171 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.847 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.917 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 70.11 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 72.32 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.14 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 71.45 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.01 109.632 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.43 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.51 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 64.4 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 31' ' ' VAL . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 53.12 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 52.31 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 53.15 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.23 110.778 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.11 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.11 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 44.53 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.53 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 71.33 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.02 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 63.11 111.139 179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.809 0.337 . . . . 75.22 111.137 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.45 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 53.44 111.081 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.1 111.176 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.752 0.311 . . . . 62.44 111.133 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 74.52 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.44 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.41 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.51 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.24 111.095 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.43 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 73.05 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.33 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.44 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.24 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 74.23 111.109 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.03 111.114 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.53 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 51.1 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.21 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CB ' HD22 ' A' ' 59' ' ' LEU . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.25 110.85 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.12 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.515 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.159 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.24 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 62.32 111.114 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 74.3 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.975 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.118 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 64.1 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.45 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 71.1 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.31 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.52 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.547 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 54.01 111.113 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.44 111.099 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.041 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.01 110.96 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.041 HD21 HD12 ' A' ' 57' ' ' LEU . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 70.11 110.936 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 72.32 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.14 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 71.45 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 51.01 109.628 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.43 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 64.4 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 31' ' ' VAL . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 53.12 111.143 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 52.31 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 73.11 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 53.15 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.23 110.859 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.11 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.11 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 44.53 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.53 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 71.33 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.11 111.109 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 75.22 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.45 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 53.44 111.144 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.1 111.103 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.74 0.305 . . . . 62.44 111.109 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 74.52 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.44 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.51 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.24 111.084 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 54' ' ' VAL . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.43 110.898 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CE2' HG21 ' A' ' 70' ' ' VAL . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.979 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.33 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.44 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.727 ' CG1' HD22 ' A' ' 46' ' ' LEU . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.177 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.51 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 22' ' ' ILE . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 63.03 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.53 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 51.1 112.478 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 64.21 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 64.25 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.11 110.892 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.11 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.12 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.23 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 62.32 111.125 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 74.3 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.93 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.3 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 64.1 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 72.14 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.1 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 62.31 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 46' ' ' LEU . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.52 110.827 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.148 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.01 111.071 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.585 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.144 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.883 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 57' ' ' LEU . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 70.11 110.935 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 72.32 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.14 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 71.45 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 51.01 109.534 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.43 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.43 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 64.4 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 24' ' ' TRP . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 53.12 111.176 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 52.31 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 73.11 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.875 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.11 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.11 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 44.53 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.53 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 71.33 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.02 111.123 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 63.11 111.127 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.757 0.313 . . . . 75.22 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.11 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.45 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 53.44 111.117 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.1 111.061 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.778 0.323 . . . . 62.44 111.068 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 74.52 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.44 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.41 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.51 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.608 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.24 111.131 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG2' HG12 ' A' ' 54' ' ' VAL . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.853 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 73.05 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.33 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.44 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 74.23 111.107 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 63.03 111.122 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.53 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 64.21 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 64.25 110.894 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.11 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.11 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.508 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.23 111.146 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 62.32 111.081 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 74.3 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.883 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.3 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.1 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.45 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.214 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 54.01 111.112 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.589 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.44 111.099 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.058 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.925 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.838 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.058 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 70.11 110.948 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 72.32 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.14 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 71.45 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 51.01 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.43 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.34 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.43 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 64.4 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 31' ' ' VAL . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 53.12 111.148 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 52.31 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 73.11 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 53.15 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.23 110.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.11 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.11 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 44.53 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.53 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 71.33 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.02 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 63.11 111.085 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.806 0.336 . . . . 75.22 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.93 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.14 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 53.44 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.1 111.127 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.783 0.325 . . . . 62.44 111.091 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.6 ' HD2' HG13 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 74.52 110.875 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.44 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.41 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.51 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.619 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.15 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.33 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.44 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 74.23 111.076 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.51 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 63.03 111.11 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.53 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 51.1 112.52 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 64.21 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' CB ' HD22 ' A' ' 59' ' ' LEU . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 64.25 110.871 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.503 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.886 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.11 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.12 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.503 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.099 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 72.24 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.506 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 62.32 111.153 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 74.3 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.32 110.96 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.1 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.45 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.1 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 62.31 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 46' ' ' LEU . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.916 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.14 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 54.01 111.083 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.56 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.139 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.944 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.904 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.941 HD21 HD12 ' A' ' 57' ' ' LEU . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 70.11 110.998 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 72.32 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.14 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 93' ' ' LEU . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 71.45 110.908 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 51.01 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.43 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.43 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.4 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 53.12 111.115 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.34 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 52.31 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 53.15 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.23 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.11 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.11 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 44.53 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.53 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 71.33 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.02 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 63.11 111.057 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.844 0.354 . . . . 75.22 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.922 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.45 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.93 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 53.44 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.6 HG13 ' HD2' ' A' ' 18' ' ' ARG . 95.7 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.1 111.152 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.79 0.329 . . . . 62.44 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 74.52 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.44 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.167 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.11 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.05 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.33 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.44 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 70' ' ' VAL . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.161 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 63.03 111.158 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.53 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.501 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 64.21 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 64.25 110.866 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.951 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.11 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.23 111.133 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 62.32 111.096 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.3 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.926 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.3 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 64.1 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.45 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 71.1 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 62.31 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 22' ' ' ILE . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.114 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 54.01 111.083 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 55' ' ' ALA . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.44 111.087 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.861 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.613 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.43 110.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 70.11 110.94 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 72.32 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.14 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.438 ' CG ' HD11 ' A' ' 93' ' ' LEU . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 71.45 110.886 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 51.01 109.624 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.43 110.887 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.43 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.51 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 64.4 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 31' ' ' VAL . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 53.12 111.155 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 52.31 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 53.15 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.23 110.914 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.11 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.11 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 44.53 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.53 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 71.33 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.02 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 63.11 111.132 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 N--CA 1.459 -0.01 0 CA-C-O 120.856 0.36 . . . . 75.22 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.45 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.938 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 53.44 111.093 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.128 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 62.44 111.1 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 74.52 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.44 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.51 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.65 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.24 111.128 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CE2' HG21 ' A' ' 70' ' ' VAL . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.11 110.926 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 73.05 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.33 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.44 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.165 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 22' ' ' ILE . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.03 111.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.53 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 51.1 112.53 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 64.21 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 64.25 110.917 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.11 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.11 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.23 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' HG23 ' A' ' 33' ' ' ILE . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 62.32 111.103 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 74.3 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.924 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.3 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 64.1 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.14 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.45 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.1 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.31 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 46' ' ' LEU . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.846 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 54.01 111.057 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.44 111.127 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.935 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.01 110.97 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.868 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.935 HD21 HD12 ' A' ' 57' ' ' LEU . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 70.11 110.94 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 72.32 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.14 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 95' ' ' HIS . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 71.45 110.866 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 51.01 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' CG ' HD22 ' A' ' 93' ' ' LEU . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.43 110.859 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.43 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.51 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 64.4 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 HG22 ' A' ' 31' ' ' VAL . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 53.12 111.098 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 52.31 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 53.15 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.819 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.11 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.11 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 44.53 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.53 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 71.33 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.116 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.11 111.168 179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.0 mm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.781 0.324 . . . . 75.22 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.45 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' CG ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.14 110.938 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 93' ' ' LEU . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 53.44 111.131 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.485 ' CE1' HD12 ' A' ' 93' ' ' LEU . 31.7 m80 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.23 110.909 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.1 111.119 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 62.44 111.089 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 74.52 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.44 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.41 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.51 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.676 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 73.05 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.33 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.44 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 74.23 111.094 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 22' ' ' ILE . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 63.03 111.115 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 51.1 112.513 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 64.21 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 64.25 110.891 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.11 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.12 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.23 111.12 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 62.32 111.053 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 74.3 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.677 HD23 ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.899 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.14 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.45 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 71.1 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.31 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB3' HD23 ' A' ' 46' ' ' LEU . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.89 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 22' ' ' ILE . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.148 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.564 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 54.01 111.176 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.639 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.158 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.014 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.965 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 63.43 110.87 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 57' ' ' LEU . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 70.11 110.959 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 72.32 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.14 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 71.45 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 51.01 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.43 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.43 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 64.4 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 53.12 111.142 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 52.31 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.813 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.11 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.11 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 44.53 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.53 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 71.33 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.02 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 63.11 111.095 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.872 0.368 . . . . 75.22 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.45 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 53.44 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.068 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 62.44 111.108 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 74.52 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.44 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.41 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.51 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.621 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.24 111.126 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.33 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.44 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.655 ' CG1' HD22 ' A' ' 46' ' ' LEU . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.135 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.51 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 111.097 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 51.1 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 64.21 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 64.25 110.863 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.11 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.513 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.23 111.156 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 72.24 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 62.32 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 74.3 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.655 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.32 110.924 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.3 111.147 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 64.1 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.45 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 71.1 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.31 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HB3' HD23 ' A' ' 46' ' ' LEU . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.924 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 22' ' ' ILE . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.151 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 54.01 111.149 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.633 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.099 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.002 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.01 110.979 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.875 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.002 HD21 HD12 ' A' ' 57' ' ' LEU . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 70.11 110.889 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 72.32 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.14 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 71.45 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 51.01 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.43 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.43 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 53.12 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.34 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 52.31 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 53.15 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.23 110.824 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.11 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.11 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 44.53 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.53 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 71.33 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.083 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 63.11 111.143 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.791 0.329 . . . . 75.22 111.111 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.45 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 53.44 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.23 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.1 111.149 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.752 0.31 . . . . 62.44 111.11 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 74.52 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.44 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.51 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.24 111.151 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 73.05 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.33 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.44 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 74.23 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.51 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.03 111.08 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.53 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 51.1 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 64.21 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 59' ' ' LEU . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 64.25 110.893 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.11 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.11 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.12 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.23 111.159 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 72.24 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 62.32 111.081 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 74.3 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.734 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.32 110.949 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.3 111.08 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 64.1 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 72.14 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.1 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 62.31 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 22' ' ' ILE . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.117 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 54.01 111.125 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.44 111.173 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.953 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 63.43 110.904 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 57' ' ' LEU . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 70.11 110.905 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 72.32 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.14 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 71.45 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 51.01 109.6 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.43 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 31' ' ' VAL . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 53.12 111.076 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 52.31 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 53.15 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.23 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.11 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.11 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 44.53 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.53 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 71.33 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.02 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 63.11 111.12 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 75.22 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.11 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.45 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 74.14 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 53.44 111.125 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.1 111.164 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.497 -0.241 . . . . 63.34 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.21 151.16 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 65.14 111.109 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.41 162.55 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.902 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.66 -155.78 53.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.44 112.471 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.19 158.61 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 72.31 111.185 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -70.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.891 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -113.46 170.8 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 45.33 110.87 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -107.65 160.31 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 74.3 110.874 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.32 -26.26 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 74.45 110.894 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -74.11 173.56 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 60.54 110.854 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.33 155.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 73.33 111.096 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 70.11 79.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.22 110.907 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -24.78 29.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.258 . . . . 71.31 112.359 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 p -51.87 167.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.179 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -74.31 -176.43 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 73.42 110.875 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.29 151.83 41.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 65.14 110.918 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -175.71 154.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 62.44 111.087 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 74.52 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.44 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.41 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.51 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.613 HG12 HD12 ' A' ' 33' ' ' ILE . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.24 111.158 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 73.05 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.44 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.685 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.23 111.163 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.613 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 63.03 111.129 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.53 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 51.1 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 64.21 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 64.25 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.11 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.11 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.12 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.23 111.141 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.24 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 62.32 111.101 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 74.3 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.685 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.961 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.3 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.814 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.1 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 62.31 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 46' ' ' LEU . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.868 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.14 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 54.01 111.153 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.44 111.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.003 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.918 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.43 110.881 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.003 HD21 HD12 ' A' ' 57' ' ' LEU . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 70.11 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 72.32 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.14 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' CG ' HD11 ' A' ' 93' ' ' LEU . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 71.45 110.905 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 51.01 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.43 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.34 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.43 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.51 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 64.4 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 31' ' ' VAL . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 53.12 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 52.31 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 73.11 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 53.15 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.11 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.11 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 44.53 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.53 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 71.33 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.02 111.113 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.28 143.1 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.11 111.113 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.489 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.8 m -79.77 108.43 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.2 111.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -58.43 171.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 72.23 110.871 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -62.88 -23.15 67.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.44 110.931 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.406 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.98 11.11 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.948 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 10.16 81.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 45.44 112.477 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 p -97.35 118.82 34.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.748 0.309 . . . . 52.51 111.088 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 84' ' ' THR . 27.0 mm -67.69 134.62 29.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.22 111.129 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.45 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' A' ' 63' ' ' GLU . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.916 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 53.44 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.93 144.1 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.1 111.074 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -174.61 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 65.04 110.861 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.82 160.48 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 74.24 110.905 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -117.25 26.29 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 72.34 110.833 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.17 -31.84 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 72.12 110.875 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.09 -31.41 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 65.45 110.916 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.05 -24.95 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 64.11 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 105' ' ' ASP . 13.1 p -89.62 141.67 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 63.24 111.159 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -86.78 -31.46 20.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.44 110.855 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 103' ' ' VAL . 3.0 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 44.53 110.912 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.242 . . . . 63.34 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.64 135.97 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 65.14 111.098 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 mmt -126.7 154.55 43.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.833 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.39 70.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 74.44 112.466 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.39 106.77 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.742 0.306 . . . . 72.31 111.18 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -84.04 126.79 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.953 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -106.39 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 45.33 110.959 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -111.57 179.88 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.3 110.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -81.1 -60.14 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 74.45 110.801 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -155.8 139.38 15.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 60.54 110.87 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.15 138.9 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -131.43 69.0 81.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.557 0.694 . . . . 63.22 110.961 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 -23.45 31.57 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 71.31 112.355 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 p -101.31 171.3 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 73.25 111.165 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.24 -179.88 6.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 73.42 110.884 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.01 131.72 41.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.14 110.918 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -176.58 151.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 62.44 111.079 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 74.52 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.44 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.433 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.41 111.151 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.51 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.66 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.24 111.133 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.43 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 73.05 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 70' ' ' VAL . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.33 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.44 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.24 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 46' ' ' LEU . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 74.23 111.094 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.03 111.095 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.53 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 51.1 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 64.21 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.11 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.12 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.203 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 62.32 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 74.3 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.901 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 64.1 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 72.14 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.1 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 62.31 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 46' ' ' LEU . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.928 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.14 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.548 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.01 111.151 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.634 ' C ' HD23 ' A' ' 57' ' ' LEU . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.44 111.169 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.94 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.909 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.855 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.94 HD21 HD12 ' A' ' 57' ' ' LEU . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 70.11 110.896 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 72.32 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.14 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.418 ' CG ' HD11 ' A' ' 93' ' ' LEU . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 71.45 110.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 51.01 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.43 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.43 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.51 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 64.4 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 31' ' ' VAL . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 53.12 111.147 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.34 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 52.31 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 73.11 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 53.15 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.23 110.843 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.11 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.11 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 44.53 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.53 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 71.33 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.02 111.122 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.91 148.42 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.11 111.13 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -79.9 110.27 15.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.074 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m -67.3 171.18 6.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.907 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -63.86 -16.1 60.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.907 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 87' ' ' LEU . 1.9 mm? -84.29 3.69 34.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.53 110.887 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.88 7.64 86.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.668 -0.777 . . . . 45.44 112.41 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.4 p -112.22 132.29 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 52.51 111.131 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm -66.12 147.21 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 75.22 111.062 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.11 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.45 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.418 HD11 ' CG ' ' A' ' 63' ' ' GLU . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 74.14 110.935 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.433 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.156 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.44 145.2 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.1 111.14 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.92 -175.46 2.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.04 110.923 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -93.1 161.74 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.868 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -117.74 6.1 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.34 110.872 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.27 -10.23 16.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 72.12 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -74.7 -55.87 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 65.45 110.873 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.08 -39.8 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 64.11 110.88 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.03 130.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.24 111.19 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.07 -36.21 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 72.44 110.872 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 44.53 110.881 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.475 -0.25 . . . . 63.34 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.0 164.9 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.335 . . . . 65.14 111.088 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -103.15 -59.57 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.881 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.15 167.13 21.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 74.44 112.457 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -97.82 105.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 72.31 111.1 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -125.87 47.23 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.888 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.44 -26.24 12.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 45.33 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m 62.84 49.23 3.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 74.3 110.854 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.9 -26.65 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.881 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 t -69.92 165.77 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 60.54 110.821 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.683 HG12 ' HD3' ' A' ' 13' ' ' PRO . 21.6 t -130.49 132.58 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.104 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -118.24 71.59 9.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 63.22 110.893 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.683 ' HD3' HG12 ' A' ' 11' ' ' VAL . 53.9 Cg_endo -69.78 -20.2 35.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.69 2.26 . . . . 71.31 112.338 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.01 165.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.099 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -58.33 179.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.42 110.93 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -101.96 157.24 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 65.14 110.926 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -169.94 153.44 4.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.072 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 74.52 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.44 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.41 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.51 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.218 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 73.05 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.33 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.44 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.714 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.23 111.129 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.51 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.03 111.188 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.53 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 51.1 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 64.21 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.25 110.86 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.11 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.12 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.516 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.23 111.119 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 62.32 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 74.3 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.714 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.839 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.3 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 64.1 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 72.14 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.45 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.1 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 62.31 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB3' HD23 ' A' ' 46' ' ' LEU . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.14 111.16 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 54.01 111.141 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.162 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.035 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.01 110.966 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.893 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 70.11 110.954 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 72.32 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.14 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 71.45 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 51.01 109.573 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.43 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 31' ' ' VAL . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 53.12 111.134 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 52.31 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.11 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 53.15 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.23 110.872 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.11 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.11 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 44.53 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.53 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 71.33 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.02 111.074 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.58 140.87 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 63.11 111.124 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 HD13 ' A' ' 90' ' ' ILE . 2.9 m -80.53 117.27 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 73.2 111.125 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.74 166.06 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.23 110.813 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.2 pt20 -59.53 -22.73 62.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.931 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -84.75 3.39 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.955 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.55 77.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 45.44 112.483 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.6 p -107.07 124.84 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 52.51 111.102 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 84' ' ' THR . 27.2 mm -74.95 131.95 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.22 111.157 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.45 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 74.14 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 53.44 111.164 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.23 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.65 141.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.1 111.126 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -115.91 -174.44 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 65.04 110.952 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -103.22 158.7 16.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.887 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 p -114.41 26.33 10.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.835 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.0 -19.79 13.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.12 110.888 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -98.93 -70.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 65.45 110.917 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -49.76 -38.94 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.842 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.89 124.89 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 63.24 111.11 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -96.55 -30.99 12.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.466 . . . . 72.44 110.887 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 44.53 110.822 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.493 -0.243 . . . . 63.34 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 48.52 10.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.715 0.293 . . . . 65.14 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mtt -108.37 141.15 40.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.5 110.922 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 5' ' ' ILE . . . -178.88 -179.47 48.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 74.44 112.463 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 4' ' ' GLY . 31.6 mm -121.36 129.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 72.31 111.14 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.8 ttp85 -112.58 59.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.22 110.874 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -101.65 156.9 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 45.33 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m 52.19 52.13 14.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.876 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -61.86 -52.24 64.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 74.45 110.848 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 t -169.76 173.74 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 60.54 110.864 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.4 m -148.15 153.74 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.33 111.118 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 68.34 9.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.557 0.694 . . . . 63.22 110.913 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -11.73 31.4 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.225 . . . . 71.31 112.311 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 p -54.34 174.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.25 111.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -57.41 -179.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 73.42 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -94.49 152.02 18.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 65.14 110.882 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.04 161.99 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 62.44 111.076 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 74.52 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.44 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.41 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.24 111.093 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.05 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.33 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.44 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.24 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 46' ' ' LEU . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.211 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 63.03 111.15 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.53 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 51.1 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 64.21 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.11 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.11 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.12 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.23 111.172 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.59 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 62.32 111.108 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.3 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.921 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.3 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 64.1 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 72.14 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.45 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 71.1 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 62.31 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' HD23 ' A' ' 46' ' ' LEU . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.924 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 54.01 111.09 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.128 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.037 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.01 110.867 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.915 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 57' ' ' LEU . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 70.11 110.884 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 72.32 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.14 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 71.45 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 51.01 109.568 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.43 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.43 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 64.4 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 31' ' ' VAL . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 53.12 111.18 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.34 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 52.31 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.11 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 53.15 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.23 110.84 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.11 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.11 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 44.53 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.53 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 71.33 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.134 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.81 148.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 63.11 111.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.71 110.76 15.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.2 111.139 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -67.46 173.39 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 72.23 110.841 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HG3' HD22 ' A' ' 87' ' ' LEU . 1.4 pt20 -65.35 -15.57 62.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.44 110.844 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 86' ' ' GLN . 1.1 mm? -85.85 5.66 31.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.907 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.59 8.68 81.49 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.733 . . . . 45.44 112.491 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 p -112.04 131.12 55.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 52.51 111.119 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.69 144.96 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 75.22 111.153 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.45 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 53.44 111.124 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t -96.77 145.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.1 111.111 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -121.14 -174.74 2.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 65.04 110.897 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -97.08 155.91 16.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.843 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 8.6 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.852 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.84 -11.85 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 72.12 110.876 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.86 -56.25 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 65.45 110.84 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.7 -33.61 76.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.11 110.835 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.39 122.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 63.24 111.117 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -88.74 -33.93 17.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 72.44 110.836 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 44.53 110.786 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.456 -0.257 . . . . 63.34 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.62 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 65.14 111.124 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -68.07 136.9 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.906 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.47 -178.03 32.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 74.44 112.492 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 tp -172.53 133.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.31 111.175 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 61.45 51.35 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.851 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.39 166.33 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 45.33 110.93 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -175.35 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.6 p30 -88.52 -29.35 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.947 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 p 46.19 54.95 7.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 60.54 110.884 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.63 HG22 ' OD1' ' A' ' 9' ' ' ASP . 12.1 m -113.11 123.13 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 73.33 111.07 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 73.52 77.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 63.22 110.908 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -16.47 37.23 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.609 2.206 . . . . 71.31 112.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -73.14 151.86 41.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 73.25 111.209 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 50.7 49.23 21.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.42 110.939 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -99.15 176.48 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 65.14 110.908 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -153.93 167.54 29.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 62.44 111.113 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 74.52 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.44 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.41 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.51 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.24 111.094 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 73.05 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.33 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.44 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.139 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 63.03 111.133 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.53 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 51.1 112.465 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 64.21 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 64.25 110.862 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.511 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.11 110.879 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.23 111.111 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 62.32 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 74.3 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.32 110.922 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.3 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.1 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.14 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.45 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 71.1 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.31 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' A' ' 46' ' ' LEU . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.944 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 22' ' ' ILE . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.14 111.204 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 54.01 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.636 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.44 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.04 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.944 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.04 HD21 HD12 ' A' ' 57' ' ' LEU . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 70.11 110.947 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 72.32 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.14 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 71.45 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 51.01 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.43 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.51 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 31' ' ' VAL . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 53.12 111.171 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.34 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 52.31 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 53.15 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.884 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.11 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.11 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 44.53 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.53 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 71.33 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.72 140.82 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 63.11 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -79.74 119.71 23.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.2 111.132 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 166.56 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 72.23 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -59.34 -24.06 63.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 72.44 110.89 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -84.02 3.1 35.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.919 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.23 79.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 45.44 112.497 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.8 p -105.4 121.8 44.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 52.51 111.134 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 mm -72.37 133.49 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.22 111.072 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.11 110.855 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.45 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 74.14 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 53.44 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.67 142.19 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.1 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.13 156.88 45.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 65.04 110.881 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.17 160.14 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -110.24 25.41 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.34 110.855 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -106.06 -20.21 13.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.492 . . . . 72.12 110.843 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.84 -64.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 65.45 110.894 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -51.15 -48.67 61.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 64.11 110.939 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.41 137.46 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 63.24 111.162 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -96.29 -25.75 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.951 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 44.53 110.903 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.489 -0.245 . . . . 63.34 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 151.95 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 65.14 111.1 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 ttm -167.93 146.91 4.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 74.5 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.64 79.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 74.44 112.515 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 tt -129.48 141.97 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 72.31 111.174 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -128.19 155.77 43.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.829 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -134.63 45.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 45.33 110.885 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t 62.76 41.63 8.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.487 . . . . 74.3 110.813 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -53.5 -57.38 10.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.866 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m 61.1 49.02 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 60.54 110.86 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -127.58 131.09 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 73.33 111.115 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -122.36 68.17 28.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 63.22 110.886 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.8 24.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.614 2.209 . . . . 71.31 112.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 m -51.52 146.64 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.126 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -58.76 -176.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.942 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.94 146.34 44.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 65.14 110.926 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -170.15 146.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 62.44 111.102 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 74.52 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.44 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.447 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.41 111.071 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.51 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.24 111.155 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 73.05 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.33 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.44 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.24 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.724 ' CG1' HD22 ' A' ' 46' ' ' LEU . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.23 111.105 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.51 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 63.03 111.09 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.53 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 51.1 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 64.21 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.25 110.889 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.11 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.11 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.11 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.465 HG22 ' OD1' ' A' ' 38' ' ' ASN . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.23 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 72.24 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 62.32 111.18 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 74.3 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.32 110.972 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.3 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 64.1 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 72.14 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.45 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 71.1 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' HD23 ' A' ' 46' ' ' LEU . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.52 110.887 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.14 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 54.01 111.135 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.44 111.156 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.956 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.01 110.85 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.909 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.956 HD21 HD12 ' A' ' 57' ' ' LEU . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 70.11 110.94 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 72.32 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.14 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 71.45 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 51.01 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.43 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.43 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.51 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 64.4 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 31' ' ' VAL . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 53.12 111.128 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 52.31 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 53.15 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.23 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.11 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.11 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 44.53 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.53 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 71.33 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.02 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.2 140.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 63.11 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.1 m -79.98 115.39 19.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 73.2 111.159 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.48 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.831 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.498 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -59.23 -22.69 61.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 72.44 110.93 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -85.26 4.54 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 74.53 110.897 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.2 19.54 79.79 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.825 -0.702 . . . . 45.44 112.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -110.08 117.2 33.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.686 0.279 . . . . 52.51 111.138 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 84' ' ' THR . 29.9 mm -66.82 136.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 75.22 111.122 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.45 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 95' ' ' HIS . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.904 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 53.44 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.679 ' CE1' HD22 ' A' ' 93' ' ' LEU . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.909 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t -99.88 142.45 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.1 111.119 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -115.35 179.63 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.04 110.884 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -113.81 159.94 19.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.836 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -117.73 35.46 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.814 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 11.95 31.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 72.12 110.922 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -115.21 -33.22 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 65.45 110.914 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -48.76 -35.47 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 64.11 110.901 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.9 124.07 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 63.24 111.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -86.55 -31.68 21.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 72.44 110.944 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 44.53 110.875 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.436 -0.266 . . . . 63.34 112.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.39 -70.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.353 . . . . 65.14 111.142 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.2 mtp -52.48 138.52 27.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.879 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.63 30.47 0.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 74.44 112.465 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -166.92 138.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 72.31 111.114 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -151.63 129.88 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 73.22 110.887 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -106.12 120.29 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 45.33 110.861 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -79.42 171.02 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 74.3 110.891 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.89 -36.06 8.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 74.45 110.913 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 61.35 51.68 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 60.54 110.846 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.51 136.04 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.33 111.13 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -140.43 69.26 32.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.62 0.724 . . . . 63.22 110.882 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -8.53 23.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.698 2.265 . . . . 71.31 112.299 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -51.52 167.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 73.25 111.117 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -54.33 169.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 73.42 110.913 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.94 154.67 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 65.14 110.906 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.45 145.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 62.44 111.022 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NE ' HG13 ' A' ' 96' ' ' VAL . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 74.52 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.44 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.51 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.24 111.109 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.43 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.05 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.33 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG11 HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.087 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.51 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 63.03 111.126 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.53 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 51.1 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 64.21 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.5 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 64.25 110.88 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.11 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.12 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.121 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.24 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 62.32 111.148 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 74.3 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.32 110.949 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 64.1 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 72.14 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.45 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 71.1 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 62.31 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 46' ' ' LEU . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.924 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 22' ' ' ILE . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 111.149 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 54.01 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.637 ' C ' HD23 ' A' ' 57' ' ' LEU . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.111 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.028 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.939 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 63.43 110.85 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 57' ' ' LEU . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 70.11 110.997 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 72.32 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.14 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 71.45 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 51.01 109.603 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.43 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.43 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.4 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 31' ' ' VAL . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 53.12 111.133 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 52.31 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 73.11 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 53.15 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.23 110.875 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.11 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.11 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 44.53 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.53 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 71.33 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.73 143.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 63.11 111.09 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.5 m -79.91 110.32 15.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.2 111.162 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 1.3 p -60.79 173.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.907 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.43 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -65.76 -22.51 66.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.881 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.16 9.91 23.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 74.53 110.965 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.13 81.75 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 45.44 112.457 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.0 p -102.34 118.73 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.731 0.301 . . . . 52.51 111.142 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 84' ' ' THR . 27.9 mm -66.45 141.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.162 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 85' ' ' SER . 0.1 OUTLIER -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.11 110.885 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.45 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 53.44 111.12 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.23 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG13 ' NE ' ' A' ' 18' ' ' ARG . 95.6 t -85.01 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.1 111.084 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.52 -176.24 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 65.04 110.948 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -91.97 158.57 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 74.24 110.913 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -117.12 30.28 7.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.859 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.18 -21.22 13.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 72.12 110.821 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.51 -61.84 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.926 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -51.78 -43.23 62.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 64.11 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.78 144.06 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 63.24 111.169 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.4 -30.21 15.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 72.44 110.877 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 44.53 110.911 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.244 . . . . 63.34 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.45 165.02 37.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 65.14 111.067 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.8 ptm -148.25 131.58 16.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.58 148.85 20.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.762 -0.733 . . . . 74.44 112.517 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt -75.85 89.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 72.31 111.203 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -121.03 82.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.22 110.871 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -124.91 168.31 13.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 45.33 110.964 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 p -129.91 176.23 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 74.3 110.909 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.599 ' HB2' HG22 ' A' ' 11' ' ' VAL . 3.4 p-10 -67.94 -45.01 75.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.45 110.875 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 51.91 47.03 25.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 60.54 110.87 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 9' ' ' ASP . 23.0 m -133.98 128.03 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 73.33 111.071 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -127.77 74.3 78.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.705 . . . . 63.22 110.9 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -14.94 36.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 71.31 112.393 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.4 p -71.27 90.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 73.25 111.119 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.94 179.97 5.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.906 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.28 130.54 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 65.14 110.949 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -170.85 149.61 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.1 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 74.52 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.44 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' HD13 ' A' ' 94' ' ' ILE . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.41 111.147 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.51 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.24 111.115 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.11 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.05 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.33 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.44 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 46' ' ' LEU . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.106 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.51 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 63.03 111.066 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.53 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 51.1 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 64.21 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.25 110.888 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.12 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.176 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.613 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 62.32 111.184 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 74.3 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.956 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.1 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.14 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.872 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 71.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 62.31 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB3' HD23 ' A' ' 46' ' ' LEU . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.52 110.896 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.14 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 54.01 111.069 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.647 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.154 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.104 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.01 110.891 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.854 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.104 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 70.11 110.918 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 72.32 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.14 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 71.45 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 51.01 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.43 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.34 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.43 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.51 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 64.4 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 31' ' ' VAL . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 53.12 111.092 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 52.31 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.23 110.865 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.11 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.11 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 44.53 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.53 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 71.33 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.02 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.65 141.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 63.11 111.128 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.472 HG23 HD13 ' A' ' 90' ' ' ILE . 1.3 m -79.98 110.61 15.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.2 111.137 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -64.81 166.82 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 72.23 110.854 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.91 -16.81 60.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 72.44 110.929 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD22 ' H ' ' A' ' 87' ' ' LEU . 1.2 mm? -86.28 0.81 53.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.53 110.946 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 16.87 75.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 45.44 112.547 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 p -112.89 128.96 56.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.793 0.33 . . . . 52.51 111.157 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.472 HD13 HG23 ' A' ' 84' ' ' THR . 27.6 mm -75.04 136.14 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.22 111.147 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.11 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.45 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.14 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.462 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 53.44 111.192 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.53 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.1 111.141 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -115.79 -174.82 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.04 110.898 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -110.55 158.81 18.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.941 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -111.96 35.11 3.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.807 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -105.74 -24.32 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 72.12 110.848 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -73.87 -32.78 63.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 65.45 110.897 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -48.94 -35.39 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.41 142.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 63.24 111.183 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -95.6 -31.51 13.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 44.53 110.853 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.512 -0.235 . . . . 63.34 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.44 176.54 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 65.14 111.083 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.26 164.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 74.5 110.899 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.19 -36.88 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 74.44 112.501 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.14 -31.78 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 72.31 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -106.98 85.1 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.22 110.929 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -89.26 -29.77 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 45.33 110.841 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 t -106.47 121.44 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.827 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.2 -26.24 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 74.45 110.856 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 p -95.38 86.9 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 60.54 110.843 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.74 71.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.133 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -157.74 73.61 4.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.556 0.693 . . . . 63.22 110.939 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -43.36 2.65 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.713 2.275 . . . . 71.31 112.354 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.67 134.04 48.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.133 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -164.13 113.52 1.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 73.42 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -122.81 128.77 50.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 65.14 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -175.0 154.51 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.44 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 74.52 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.44 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.41 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.51 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.24 111.136 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' HG12 ' A' ' 54' ' ' VAL . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.43 110.885 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 70' ' ' VAL . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.908 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 73.05 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.33 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.44 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.24 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG11 HD22 ' A' ' 46' ' ' LEU . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 74.23 111.171 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.51 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 22' ' ' ILE . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 63.03 111.116 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.53 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 51.1 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 64.21 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 64.25 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.11 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.11 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.12 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.23 111.13 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.24 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 62.32 111.088 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 74.3 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.721 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.32 110.85 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.3 111.188 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 64.1 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 72.14 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.45 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.52 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 23' ' ' ARG . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.14 111.122 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 54.01 111.166 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.648 ' C ' HD23 ' A' ' 57' ' ' LEU . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.995 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.01 110.939 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.995 HD21 HD12 ' A' ' 57' ' ' LEU . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 70.11 110.877 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 72.32 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.14 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 71.45 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 51.01 109.588 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.43 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.43 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.51 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 64.4 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 24' ' ' TRP . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 53.12 111.123 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.34 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 52.31 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.15 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.23 110.848 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.11 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.11 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 44.53 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.53 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 71.33 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.116 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.82 146.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 63.11 111.197 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -79.92 112.2 16.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.2 111.202 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -69.34 171.59 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 72.23 110.872 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -63.77 -16.44 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.94 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 87' ' ' LEU . 1.8 mm? -84.0 2.97 36.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.908 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.57 86.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.696 . . . . 45.44 112.474 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -111.7 140.4 46.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.742 0.306 . . . . 52.51 111.191 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.04 134.42 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.22 111.06 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.45 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.447 HD21 ' NE2' ' A' ' 95' ' ' HIS . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 74.14 110.91 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 93' ' ' LEU . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 53.44 111.176 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.447 ' NE2' HD21 ' A' ' 93' ' ' LEU . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.866 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t -98.38 141.28 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.1 111.152 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -125.0 -174.31 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 65.04 110.911 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -113.16 161.54 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.899 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.2 t -129.25 34.02 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.78 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.41 -24.0 12.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.917 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -106.15 -38.57 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 65.45 110.896 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.8 -23.08 50.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 64.11 110.925 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 105' ' ' ASP . 12.9 p -100.38 144.57 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 63.24 111.14 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -81.38 -29.24 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.911 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.633 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.7 t70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 44.53 110.872 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.469 -0.252 . . . . 63.34 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.14 45.47 17.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 65.14 111.083 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 tpt -105.35 63.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.06 -28.51 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.44 112.433 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.7 170.54 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.863 0.363 . . . . 72.31 111.098 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -109.73 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 73.22 110.875 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -111.17 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 45.33 110.889 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -65.91 105.89 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.3 110.798 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.38 -31.84 10.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.45 110.864 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.24 94.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 60.54 110.901 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 11' ' ' VAL . 4.0 p -75.48 113.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.33 111.063 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -148.77 68.2 9.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.58 0.705 . . . . 63.22 110.873 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -13.05 34.1 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.727 2.284 . . . . 71.31 112.306 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 p -51.65 111.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.117 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.96 179.23 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -93.12 140.65 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 65.14 110.909 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -162.22 148.85 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 74.52 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.44 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.41 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.51 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.24 111.111 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.05 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.33 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.44 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.72 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.23 111.153 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.628 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 63.03 111.112 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.53 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 51.1 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 64.21 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CB ' HD22 ' A' ' 59' ' ' LEU . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 64.25 110.904 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.519 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.11 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.11 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.519 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.23 111.111 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 62.32 111.171 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 74.3 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.32 110.909 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.3 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.1 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 72.14 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.45 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 71.1 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 62.31 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB3' HD23 ' A' ' 46' ' ' LEU . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.874 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.14 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 54.01 111.154 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.612 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.44 111.189 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.986 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.01 111.006 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.986 HD21 HD12 ' A' ' 57' ' ' LEU . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 70.11 110.954 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 72.32 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.14 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 71.45 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.406 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 51.01 109.577 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.43 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.34 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.51 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 64.4 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 31' ' ' VAL . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 53.12 111.14 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.34 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 52.31 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 53.15 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.835 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.11 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.11 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 44.53 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.53 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 71.33 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.02 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.45 140.6 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 63.11 111.132 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.515 HG23 HD13 ' A' ' 90' ' ' ILE . 1.3 m -80.69 108.92 14.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 73.2 111.096 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -60.19 163.91 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 72.23 110.83 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.52 -18.5 59.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 72.44 110.903 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 87' ' ' LEU . 1.3 mm? -84.02 0.93 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.53 110.948 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.2 15.41 76.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 45.44 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.0 p -111.64 129.85 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 52.51 111.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 84' ' ' THR . 27.2 mm -74.71 146.09 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 75.22 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.45 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.44 111.127 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -91.27 136.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.1 111.146 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.08 -179.07 4.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 65.04 110.842 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -105.37 160.87 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.892 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.7 p -117.31 25.09 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.85 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -105.47 -20.3 13.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 72.12 110.892 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.45 -63.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 65.45 110.909 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -53.04 -29.01 27.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 64.11 110.977 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.69 141.29 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.24 111.133 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -83.59 -45.47 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.44 110.919 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 44.53 110.89 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 63.34 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.01 145.03 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 65.14 111.14 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mmt 55.61 49.8 15.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.975 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.36 121.09 24.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.639 -0.791 . . . . 74.44 112.539 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 pt -119.67 44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 72.31 111.126 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.75 71.99 8.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.883 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -147.49 -175.97 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 45.33 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 t -87.91 69.85 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 74.3 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -69.62 -42.52 74.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 74.45 110.811 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.8 m -69.21 133.37 47.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 60.54 110.871 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.81 HG22 ' HD3' ' A' ' 13' ' ' PRO . 9.9 p -174.25 136.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 73.33 111.068 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -148.92 74.55 10.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.634 0.731 . . . . 63.22 110.94 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HD3' HG22 ' A' ' 11' ' ' VAL . 53.5 Cg_endo -69.77 -39.2 6.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.76 2.307 . . . . 71.31 112.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.55 171.59 13.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -105.03 180.0 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.42 110.917 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.43 157.01 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 65.14 110.866 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.81 148.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 62.44 111.129 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 74.52 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.44 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.41 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.51 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.13 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 73.05 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.33 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.44 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.24 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.689 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.23 111.134 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.51 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 63.03 111.184 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.53 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 51.1 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 64.21 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 64.25 110.873 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.12 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.23 111.219 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 72.24 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.511 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 62.32 111.14 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 74.3 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.945 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.3 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 64.1 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 72.14 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.45 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 71.1 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 62.31 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 46' ' ' LEU . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.52 110.868 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.14 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 54.01 111.102 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.44 111.171 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.01 110.847 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.917 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 70.11 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 72.32 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.14 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 71.45 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.01 109.632 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.43 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.51 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 64.4 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 31' ' ' VAL . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 53.12 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 52.31 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 53.15 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.23 110.778 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.11 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.11 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 44.53 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.53 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 71.33 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.02 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.72 143.86 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 63.11 111.139 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.5 m -80.12 109.25 14.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 73.2 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 p -59.82 179.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.23 110.878 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HG2' HD22 ' A' ' 87' ' ' LEU . 1.4 pm0 -77.59 -4.23 44.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.973 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 86' ' ' GLN . 1.2 mm? -103.08 9.28 38.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.53 110.91 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.99 15.99 80.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.779 -0.724 . . . . 45.44 112.5 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.4 p -112.23 122.94 49.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 52.51 111.054 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' THR . 31.2 mm -69.74 137.99 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 75.22 111.137 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.11 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.45 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 53.44 111.081 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.98 142.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.1 111.176 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 175.88 8.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 65.04 110.929 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -108.3 161.59 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -127.49 6.79 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.471 . . . . 72.34 110.9 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.24 -7.64 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 72.12 110.858 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -73.74 -31.29 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 65.45 110.823 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -56.28 -25.2 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.11 110.88 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.84 123.13 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 63.24 111.184 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.57 -28.61 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.44 110.924 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 44.53 110.847 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 63.34 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.28 -35.73 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 65.14 111.156 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 mmm -76.12 78.8 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.5 110.93 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.9 113.87 0.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.44 112.473 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -163.2 147.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 72.31 111.135 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -77.39 -174.95 3.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.22 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.26 163.34 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 45.33 110.904 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 p -139.88 130.64 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 74.3 110.838 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.47 -36.35 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.841 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -75.75 132.94 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 60.54 110.854 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.49 135.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 73.33 111.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -172.48 68.7 0.4 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 63.22 110.869 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -14.33 35.73 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.622 2.215 . . . . 71.31 112.289 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.8 p -51.75 163.2 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.171 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -68.62 179.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 73.42 110.883 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -89.44 149.78 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 65.14 110.84 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.82 147.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 62.44 111.133 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 74.52 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.44 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.41 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.51 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.24 111.095 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.43 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 73.05 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.33 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.44 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.24 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 74.23 111.109 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.03 111.114 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.53 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 51.1 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.21 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CB ' HD22 ' A' ' 59' ' ' LEU . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.25 110.85 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.11 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.12 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.515 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.159 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.24 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 62.32 111.114 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 74.3 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.975 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.118 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 64.1 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.45 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 71.1 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.31 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.52 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.14 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.547 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 54.01 111.113 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.44 111.099 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.041 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.01 110.96 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.041 HD21 HD12 ' A' ' 57' ' ' LEU . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 70.11 110.936 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 72.32 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.14 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 71.45 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 51.01 109.628 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.43 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 64.4 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 31' ' ' VAL . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 53.12 111.143 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 52.31 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 73.11 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 53.15 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.23 110.859 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.11 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.11 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 44.53 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.53 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 71.33 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -154.41 139.83 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.11 111.109 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.457 HG23 HD13 ' A' ' 90' ' ' ILE . 2.7 m -80.04 111.46 16.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.2 111.198 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.71 171.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.903 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.428 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -62.84 -23.04 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.892 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.48 9.78 25.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.53 110.95 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.38 81.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 45.44 112.468 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.7 p -98.08 116.49 30.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 52.51 111.154 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.457 HD13 HG23 ' A' ' 84' ' ' THR . 31.2 mm -67.03 142.63 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.22 111.123 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.11 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.45 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.14 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 53.44 111.144 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.19 142.04 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.1 111.103 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -119.54 -174.38 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 65.04 110.892 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -113.92 161.49 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 74.24 110.903 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.2 t -95.73 29.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.811 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.58 -18.37 14.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 72.12 110.883 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -86.02 -64.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 65.45 110.868 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.572 ' HG3' HG23 ' A' ' 103' ' ' VAL . 18.0 pt-20 -51.3 -48.21 62.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 64.11 110.885 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.572 HG23 ' HG3' ' A' ' 102' ' ' GLU . 15.3 t -80.09 119.29 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 63.24 111.191 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -93.22 -32.55 14.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.894 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 44.53 110.856 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.418 -0.273 . . . . 63.34 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.42 119.25 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 65.14 111.049 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.73 121.69 13.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.887 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.71 105.36 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 74.44 112.565 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tp -175.18 137.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 72.31 111.098 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -138.84 148.1 43.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.22 110.841 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -163.35 131.53 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 45.33 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.2 p -162.21 158.47 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.3 110.907 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -108.35 -34.17 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.836 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 63.19 52.5 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 60.54 110.861 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.94 129.77 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 73.33 111.164 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 68.3 9.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 63.22 110.942 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -14.27 35.96 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.716 2.277 . . . . 71.31 112.368 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -125.36 178.34 5.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.25 111.188 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -51.81 169.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.931 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -161.34 129.16 4.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.428 . . . . 65.14 110.921 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . -90.32 132.66 35.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 62.44 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 74.52 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.44 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.51 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.24 111.084 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 54' ' ' VAL . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.43 110.898 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CE2' HG21 ' A' ' 70' ' ' VAL . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.979 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 73.05 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.33 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.44 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.727 ' CG1' HD22 ' A' ' 46' ' ' LEU . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.177 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.51 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 22' ' ' ILE . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 63.03 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.53 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 51.1 112.478 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 64.21 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 64.25 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.11 110.892 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.11 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.11 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.12 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.23 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 62.32 111.125 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 74.3 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.93 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.3 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 64.1 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 72.14 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.1 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 62.31 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 46' ' ' LEU . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.52 110.827 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.148 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.01 111.071 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.585 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.44 111.144 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.01 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.883 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 57' ' ' LEU . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 70.11 110.935 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 72.32 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.14 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 71.45 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 51.01 109.534 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.43 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.43 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 64.4 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 24' ' ' TRP . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 53.12 111.176 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.34 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 52.31 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 73.11 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.23 110.875 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.11 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.11 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 44.53 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.53 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 71.33 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.02 111.123 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -155.91 147.58 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 63.11 111.127 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.81 109.6 14.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 73.2 111.165 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -66.34 170.72 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.55 -16.47 60.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.909 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.46 3.11 33.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.891 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.52 7.74 87.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 45.44 112.524 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.3 p -111.74 135.29 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 52.51 111.156 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.75 145.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.22 111.175 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.11 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.45 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 53.44 111.117 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.23 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.58 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.1 111.061 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.06 177.04 6.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 65.04 110.895 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.02 158.14 16.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.951 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -121.45 2.99 10.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 72.34 110.859 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.39 -6.85 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 72.12 110.885 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -73.58 -26.38 60.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.904 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -58.22 -22.75 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 64.11 110.964 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.47 124.02 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 63.24 111.177 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -94.38 -32.26 13.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 72.44 110.886 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.53 110.881 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.453 -0.259 . . . . 63.34 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.79 170.0 15.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 65.14 111.08 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -150.91 177.6 9.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.885 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 82.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 74.44 112.519 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.72 -26.26 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.389 . . . . 72.31 111.197 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -52.93 148.69 7.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.908 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -167.07 172.76 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 45.33 110.857 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 36.15 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 74.3 110.909 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.5 -38.43 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.848 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.9 p -71.46 -175.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 60.54 110.858 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -133.97 113.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 73.33 111.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -173.66 71.45 0.36 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.571 0.7 . . . . 63.22 110.894 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -46.82 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.702 2.268 . . . . 71.31 112.373 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.35 107.54 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 73.25 111.141 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -130.26 129.01 42.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 73.42 110.974 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -132.28 128.51 37.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 65.14 110.932 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -174.44 152.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 62.44 111.068 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 74.52 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.44 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.41 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.51 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.608 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.24 111.131 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG2' HG12 ' A' ' 54' ' ' VAL . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.853 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.11 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 73.05 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.33 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.44 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 74.23 111.107 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.51 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 63.03 111.122 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.53 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 64.21 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 64.25 110.894 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.11 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.11 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.508 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.23 111.146 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 72.24 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 62.32 111.081 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 74.3 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.883 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.3 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.1 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.45 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.1 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.14 111.214 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 54.01 111.112 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.589 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.44 111.099 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.058 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.01 110.925 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.838 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.058 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 70.11 110.948 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 72.32 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.14 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 71.45 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 51.01 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.43 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.34 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.43 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 64.4 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 31' ' ' VAL . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 53.12 111.148 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 52.31 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 73.11 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 53.15 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.23 110.842 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.11 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.11 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 44.53 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.53 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 71.33 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.02 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.22 143.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 63.11 111.085 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -80.25 117.23 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 73.2 111.125 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -69.22 168.28 14.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 72.23 110.885 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.447 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.1 pt20 -59.5 -23.02 62.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 72.44 110.928 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.9 mm? -88.11 8.08 28.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 74.53 110.932 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.67 81.43 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 45.44 112.45 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.4 p -101.37 119.06 38.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 52.51 111.148 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm -67.77 139.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 75.22 111.158 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.93 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.14 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 53.44 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.04 139.64 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.1 111.127 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.84 150.41 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 65.04 110.917 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -72.58 160.57 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.0 p -122.51 29.6 6.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.34 110.845 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.08 -21.51 12.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 72.12 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.1 -70.95 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.45 110.888 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -49.66 -38.85 34.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.58 126.0 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 63.24 111.178 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -84.44 -31.35 24.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 72.44 110.899 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 44.53 110.88 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.495 -0.242 . . . . 63.34 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.36 125.36 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 65.14 111.075 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.0 mtm -64.65 -67.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.27 106.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 74.44 112.505 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.24 138.15 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 72.31 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -106.83 131.51 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.835 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -80.4 164.05 23.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 45.33 110.856 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -53.93 165.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 74.3 110.876 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.1 -42.72 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.843 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 p -156.7 130.87 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 60.54 110.858 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -147.83 142.49 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 73.33 111.093 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 70.24 67.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.653 0.74 . . . . 63.22 110.918 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -17.62 37.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 71.31 112.386 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.05 162.1 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.25 111.152 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -66.54 179.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.946 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.33 137.34 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 65.14 110.902 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . -171.14 146.04 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 62.44 111.091 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.6 ' HD2' HG13 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 74.52 110.875 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.44 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.41 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.51 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.619 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.15 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 73.05 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.33 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.44 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 74.23 111.076 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.51 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 63.03 111.11 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.53 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 51.1 112.52 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 64.21 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' CB ' HD22 ' A' ' 59' ' ' LEU . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 64.25 110.871 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.503 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.886 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.11 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.11 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.12 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.503 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.23 111.099 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 72.24 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.506 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 62.32 111.153 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 74.3 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.32 110.96 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.1 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.45 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.1 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 62.31 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 46' ' ' LEU . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.916 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.14 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 54.01 111.083 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.56 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.44 111.139 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.944 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.904 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.941 HD21 HD12 ' A' ' 57' ' ' LEU . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 70.11 110.998 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 72.32 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.14 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 93' ' ' LEU . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 71.45 110.908 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 51.01 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.43 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.34 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.43 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.51 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.4 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 53.12 111.115 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.34 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 52.31 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 73.11 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 53.15 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.23 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.11 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.11 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 44.53 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.53 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 71.33 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.02 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 139.33 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 63.11 111.057 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.1 m -80.64 111.43 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 73.2 111.148 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 165.45 17.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.851 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.489 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.26 -21.89 60.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.44 110.85 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -86.52 5.84 33.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 74.53 110.943 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.1 19.31 79.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 45.44 112.519 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 p -107.09 120.09 41.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 52.51 111.16 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 84' ' ' THR . 26.5 mm -73.6 126.35 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 75.22 111.201 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.922 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.45 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.93 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 53.44 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.6 HG13 ' HD2' ' A' ' 18' ' ' ARG . 95.7 t -97.43 144.37 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.1 111.152 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -118.37 -174.49 2.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.04 110.91 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -108.27 160.55 15.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.925 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.9 m -128.46 38.48 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 72.34 110.858 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.2 -29.54 21.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.12 110.903 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -87.52 -32.41 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 65.45 110.918 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.64 -25.74 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 64.11 110.866 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.92 148.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 63.24 111.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -90.65 -38.52 13.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.854 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 44.53 110.898 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.527 -0.229 . . . . 63.34 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.48 166.47 11.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 65.14 111.134 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mtm -80.8 123.35 28.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 74.5 110.918 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.41 -166.76 41.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.794 -0.717 . . . . 74.44 112.449 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.55 148.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.31 111.105 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -158.4 117.12 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 73.22 110.918 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -174.73 177.73 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 45.33 110.947 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -79.24 133.4 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.3 110.852 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.32 -45.14 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 74.45 110.92 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.6 t -68.23 117.44 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 60.54 110.911 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.06 147.87 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.33 111.085 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 69.87 4.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 63.22 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 -48.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.747 2.298 . . . . 71.31 112.294 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.1 p -125.8 -177.37 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 73.25 111.166 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.65 179.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -93.58 134.34 35.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 65.14 110.904 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -174.8 146.69 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.44 111.09 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 74.52 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.44 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.41 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.24 111.167 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.11 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.05 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.33 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.44 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.24 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 70' ' ' VAL . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.161 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 63.03 111.158 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.53 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.501 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 64.21 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 64.25 110.866 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.951 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.11 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.23 111.133 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 62.32 111.096 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.3 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.926 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.3 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 64.1 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.14 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.45 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 71.1 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 62.31 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 22' ' ' ILE . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.14 111.114 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 54.01 111.083 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 55' ' ' ALA . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.44 111.087 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.01 110.861 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.613 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.43 110.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 70.11 110.94 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 72.32 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.14 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.438 ' CG ' HD11 ' A' ' 93' ' ' LEU . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 71.45 110.886 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 51.01 109.624 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.43 110.887 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.34 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.43 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.51 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 64.4 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 31' ' ' VAL . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 53.12 111.155 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 52.31 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 53.15 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.23 110.914 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.11 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.11 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 44.53 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.53 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 71.33 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.02 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.87 138.1 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 63.11 111.132 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.467 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.6 m -80.02 110.83 15.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 73.2 111.138 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 164.86 16.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 72.23 110.901 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.535 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.1 pt20 -59.06 -21.78 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.915 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.535 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.7 mm? -85.32 4.57 34.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.89 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 18.39 79.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 45.44 112.483 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -107.76 123.87 49.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 52.51 111.196 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 84' ' ' THR . 25.8 mm -76.37 131.52 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 75.22 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.11 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.45 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 74.14 110.938 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 53.44 111.093 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t -100.93 144.19 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.1 111.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -174.68 2.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 65.04 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -117.61 161.28 19.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.868 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -122.91 26.14 8.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 72.34 110.811 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.69 -34.55 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.852 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -78.87 -32.74 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 65.45 110.906 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.71 -24.74 64.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 64.11 110.891 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.12 148.58 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 63.24 111.12 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -101.95 -28.71 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.815 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 44.53 110.846 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.502 -0.239 . . . . 63.34 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.72 47.1 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 65.14 111.107 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 ptm -134.18 177.16 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.894 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.05 21.74 56.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 74.44 112.506 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.26 95.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 72.31 111.154 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.6 57.68 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.92 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.37 145.96 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 45.33 110.89 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -70.9 110.57 5.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 74.3 110.907 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -59.26 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 74.45 110.895 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -158.52 167.35 29.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 60.54 110.902 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 m -117.66 125.64 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 73.33 111.106 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.52 71.42 15.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 63.22 110.852 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -48.46 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 71.31 112.371 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.73 124.27 7.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 73.25 111.154 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -171.35 125.97 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 73.42 110.861 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -125.68 129.06 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.881 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.1 141.04 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.1 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 74.52 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.44 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.41 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.51 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.24 111.128 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CE2' HG21 ' A' ' 70' ' ' VAL . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.11 110.926 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 73.05 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.33 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.44 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.165 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.51 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 22' ' ' ILE . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.03 111.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.53 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 51.1 112.53 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 64.21 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 64.25 110.917 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.11 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.11 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.11 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.12 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.23 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' HG23 ' A' ' 33' ' ' ILE . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 62.32 111.103 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 74.3 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.924 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.3 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 64.1 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.14 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.45 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.1 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.31 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 46' ' ' LEU . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.846 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 54.01 111.057 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.44 111.127 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.935 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.01 110.97 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.868 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.935 HD21 HD12 ' A' ' 57' ' ' LEU . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 70.11 110.94 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 72.32 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.14 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 95' ' ' HIS . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 71.45 110.866 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 51.01 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' CG ' HD22 ' A' ' 93' ' ' LEU . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.43 110.859 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.43 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.51 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 64.4 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 HG22 ' A' ' 31' ' ' VAL . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 53.12 111.098 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.34 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 52.31 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 53.15 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.819 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.11 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.11 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 44.53 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.53 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 71.33 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.02 111.116 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.33 146.31 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.11 111.168 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.574 HG23 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -79.61 125.29 29.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 73.2 111.167 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -75.07 -169.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 72.23 110.92 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -70.95 -34.06 71.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 72.44 110.904 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.2 mm? -90.68 16.96 8.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.935 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 84' ' ' THR . . . 73.6 5.58 68.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 45.44 112.506 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 p -79.86 112.03 16.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 52.51 111.18 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 84' ' ' THR . 24.0 mm -68.15 129.17 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 75.22 111.144 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.45 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' CG ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.14 110.938 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 93' ' ' LEU . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 53.44 111.131 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.485 ' CE1' HD12 ' A' ' 93' ' ' LEU . 31.7 m80 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.23 110.909 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.1 141.92 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.1 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -100.86 -174.32 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 65.04 110.929 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -94.7 161.44 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.24 110.855 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -126.62 27.68 6.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.05 -20.56 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 72.12 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -73.99 -59.84 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 65.45 110.82 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.45 -38.91 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 64.11 110.93 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.37 135.71 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 63.24 111.102 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -102.57 -33.27 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.44 110.92 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 44.53 110.853 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.532 -0.227 . . . . 63.34 112.532 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.23 25.57 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 65.14 111.107 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mmm -96.62 111.0 23.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.898 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.29 65.96 0.55 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.829 -0.7 . . . . 74.44 112.5 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -84.82 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 72.31 111.112 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -105.65 172.44 6.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 73.22 110.822 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -74.08 126.91 31.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 45.33 110.869 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.0 p -78.85 167.61 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.3 110.897 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.37 -59.6 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.875 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.8 p -164.64 136.66 4.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.845 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.634 HG22 ' HD3' ' A' ' 13' ' ' PRO . 11.8 p -173.14 136.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.124 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.29 69.44 0.8 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.502 0.668 . . . . 63.22 110.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.634 ' HD3' HG22 ' A' ' 11' ' ' VAL . 54.1 Cg_endo -69.73 -14.18 35.8 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.7 2.267 . . . . 71.31 112.361 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.87 157.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.25 111.141 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.03 172.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 73.42 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -100.27 144.49 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.967 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -172.15 159.68 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.44 111.089 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 74.52 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.44 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.41 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.51 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.676 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 73.05 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.33 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.44 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 74.23 111.094 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 22' ' ' ILE . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 63.03 111.115 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 51.1 112.513 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 64.21 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 64.25 110.891 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.11 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.11 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.12 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.23 111.12 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 62.32 111.053 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 74.3 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.677 HD23 ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.899 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.3 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 64.1 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.14 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.45 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 71.1 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.31 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB3' HD23 ' A' ' 46' ' ' LEU . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.89 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 22' ' ' ILE . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.148 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.564 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 54.01 111.176 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.639 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.158 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.014 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.965 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 63.43 110.87 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 57' ' ' LEU . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 70.11 110.959 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 72.32 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.14 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 71.45 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 51.01 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.43 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.43 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.51 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 64.4 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 53.12 111.142 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 52.31 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 53.15 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.813 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.11 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.11 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 44.53 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.53 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 71.33 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.02 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.71 141.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 63.11 111.095 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.438 HG23 HD13 ' A' ' 90' ' ' ILE . 2.1 m -80.63 117.81 21.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 73.2 111.114 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -178.71 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.899 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -71.01 -22.93 62.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 72.44 110.92 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.9 mm? -88.0 7.86 29.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.53 110.8 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.22 13.82 81.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.813 -0.708 . . . . 45.44 112.48 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 p -99.48 120.73 40.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.738 0.304 . . . . 52.51 111.142 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 84' ' ' THR . 27.2 mm -73.11 132.42 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.22 111.122 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.45 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 53.44 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.48 145.3 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.1 111.068 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.3 165.15 24.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.04 110.934 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -90.04 161.35 15.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.917 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.3 m -129.54 31.44 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.34 110.874 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.6 -35.76 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.841 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -91.63 -32.06 15.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 65.45 110.9 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -57.82 -25.4 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 64.11 110.891 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 105' ' ' ASP . 14.8 p -94.37 144.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.24 111.14 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -87.78 -31.08 19.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 103' ' ' VAL . 26.0 t0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 44.53 110.894 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 63.34 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 119.62 21.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 65.14 111.03 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.5 ptp -67.95 -32.2 72.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.915 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.34 75.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.623 -0.798 . . . . 74.44 112.461 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.0 mt -101.86 114.89 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 72.31 111.119 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 176.64 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 73.22 110.853 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 63.01 25.55 15.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 45.33 110.853 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.846 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -103.54 -30.56 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.911 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m 51.88 88.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 60.54 110.843 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -146.07 109.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 73.33 111.113 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.68 76.99 0.29 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.51 0.671 . . . . 63.22 110.861 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -11.01 29.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.704 2.269 . . . . 71.31 112.377 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -111.1 163.31 14.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 73.25 111.141 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -95.81 163.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.889 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -99.96 130.39 46.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 65.14 110.914 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.09 141.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 62.44 111.108 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 74.52 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.44 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.41 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.51 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.621 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.24 111.126 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.33 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.44 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.655 ' CG1' HD22 ' A' ' 46' ' ' LEU . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.23 111.135 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.51 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.03 111.097 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 51.1 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 64.21 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 64.25 110.863 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.11 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.12 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.513 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.23 111.156 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 72.24 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 62.32 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 74.3 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.655 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.32 110.924 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.3 111.147 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 64.1 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.14 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.45 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 71.1 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.31 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HB3' HD23 ' A' ' 46' ' ' LEU . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.52 110.924 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 22' ' ' ILE . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.151 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 54.01 111.149 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.633 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.44 111.099 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.002 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.01 110.979 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.875 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.002 HD21 HD12 ' A' ' 57' ' ' LEU . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 70.11 110.889 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 72.32 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.14 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 71.45 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 51.01 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.43 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.43 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 53.12 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.34 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 52.31 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.11 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 53.15 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.23 110.824 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.11 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.11 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 44.53 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.53 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 71.33 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.083 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.91 148.31 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 63.11 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -79.8 110.2 14.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 73.2 111.144 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -66.48 170.82 5.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.23 110.839 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -63.84 -16.02 60.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 72.44 110.934 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.0 mm? -84.0 3.41 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.53 110.945 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.08 86.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 45.44 112.456 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 p -112.56 132.09 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 52.51 111.14 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm -65.52 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.22 111.111 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.45 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 53.44 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.23 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.86 144.4 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.1 111.149 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -133.24 156.82 46.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 65.04 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 161.21 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 74.24 110.891 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -115.86 32.29 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 72.34 110.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.7 -18.54 17.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 72.12 110.888 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.89 -57.79 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 65.45 110.863 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.56 -32.09 73.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 64.11 110.816 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.15 122.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.24 111.161 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -81.04 -31.1 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.833 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 44.53 110.881 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.445 -0.262 . . . . 63.34 112.445 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.23 34.84 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 65.14 111.081 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -29.52 70.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.922 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.39 -164.09 1.6 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 74.44 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 tp -74.65 135.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 72.31 111.093 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 -117.56 154.57 31.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -64.56 167.17 7.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 45.33 110.857 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t 59.67 27.13 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 74.3 110.901 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.41 -26.02 67.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.45 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.11 112.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 60.54 110.895 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 13' ' ' PRO . 5.3 p -95.87 119.24 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 73.33 111.11 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -149.32 73.57 9.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 63.22 110.92 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HD3' HG22 ' A' ' 11' ' ' VAL . 54.1 Cg_endo -69.68 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.744 2.296 . . . . 71.31 112.351 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -94.77 35.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 73.25 111.14 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -87.08 124.45 33.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.95 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -105.11 127.83 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 65.14 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.45 141.38 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 62.44 111.11 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 74.52 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.44 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.41 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.51 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.24 111.151 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 73.05 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.33 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.44 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.24 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 74.23 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.51 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.03 111.08 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.53 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 51.1 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 64.21 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 59' ' ' LEU . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 64.25 110.893 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.11 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.11 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.12 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.23 111.159 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 72.24 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 62.32 111.081 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 74.3 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.734 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.32 110.949 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.3 111.08 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 64.1 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 72.14 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.45 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.1 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 62.31 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 22' ' ' ILE . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.14 111.117 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 54.01 111.125 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.44 111.173 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.953 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 63.43 110.904 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 57' ' ' LEU . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 70.11 110.905 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 72.32 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.14 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 71.45 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 51.01 109.6 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.43 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.51 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 31' ' ' VAL . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 53.12 111.076 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 52.31 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 53.15 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.23 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.11 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.11 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 44.53 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.53 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 71.33 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.02 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.2 142.72 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 63.11 111.12 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.4 m -80.42 111.22 16.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 73.2 111.141 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -61.85 178.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.844 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.51 ' HG2' HD22 ' A' ' 87' ' ' LEU . 9.8 pt20 -75.79 -5.99 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.44 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 ' HG2' ' A' ' 86' ' ' GLN . 2.3 mm? -98.56 0.1 44.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.53 110.908 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.24 9.03 80.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 45.44 112.457 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 p -106.53 128.52 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 52.51 111.123 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 84' ' ' THR . 28.6 mm -74.39 143.61 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.22 111.228 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.11 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.45 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 74.14 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 53.44 111.125 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.15 143.84 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.1 111.164 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -114.17 -174.43 2.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 65.04 110.949 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -104.69 160.52 14.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 74.24 110.901 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -131.0 30.01 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.34 110.829 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.38 -22.29 12.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.12 110.87 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -101.86 -28.51 12.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 65.45 110.899 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -58.54 -22.25 54.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.11 110.884 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 105' ' ' ASP . 11.7 p -88.28 150.96 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.24 111.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -89.34 -30.49 18.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 72.44 110.865 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' H ' HG22 ' A' ' 103' ' ' VAL . 5.1 t0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 44.53 110.827 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.798 0.332 . . . . 62.439999999999998 111.087 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 74.519999999999996 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.439999999999998 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.613 HG12 HD12 ' A' ' 33' ' ' ILE . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.158 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 73.049999999999997 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.685 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 111.163 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.613 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 63.030000000000001 111.129 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.530000000000001 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 51.100000000000001 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 64.209999999999994 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 64.25 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.141 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.239999999999995 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 62.32 111.101 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.685 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 110.961 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 64.099999999999994 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.814 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.099999999999994 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 62.310000000000002 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 46' ' ' LEU . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.868 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 54.009999999999998 111.153 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 111.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.003 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.010000000000005 110.918 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.43 110.881 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.003 HD21 HD12 ' A' ' 57' ' ' LEU . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 70.109999999999999 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 72.319999999999993 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' CG ' HD11 ' A' ' 93' ' ' LEU . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 71.450000000000003 110.905 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 51.009999999999998 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.430000000000007 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 64.400000000000006 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 31' ' ' VAL . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 53.119999999999997 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 52.310000000000002 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 53.149999999999999 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.0 p-80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.229999999999997 110.889 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.109999999999999 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.109999999999999 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 44.530000000000001 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 71.329999999999998 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 76' ' ' HIS . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.113 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.109999999999999 111.113 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.481 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.0 mm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.845 0.355 . . . . 75.219999999999999 111.129 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.450000000000003 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' A' ' 63' ' ' GLU . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.916 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 53.439999999999998 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.099999999999994 111.074 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.812 0.339 . . . . 62.439999999999998 111.079 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 74.519999999999996 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.439999999999998 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.433 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 111.151 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.66 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.239999999999995 111.133 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 70' ' ' VAL . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.439999999999998 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.239999999999995 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 46' ' ' LEU . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 111.094 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.030000000000001 111.095 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.530000000000001 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 51.100000000000001 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 64.209999999999994 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.109999999999999 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.203 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 62.32 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 74.299999999999997 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.901 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.299999999999997 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 64.099999999999994 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 72.140000000000001 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.450000000000003 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.099999999999994 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 62.310000000000002 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 46' ' ' LEU . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.519999999999996 110.928 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.548 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.009999999999998 111.151 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.634 ' C ' HD23 ' A' ' 57' ' ' LEU . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.169 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.94 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.010000000000005 110.909 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.855 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.94 HD21 HD12 ' A' ' 57' ' ' LEU . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 70.109999999999999 110.896 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 72.319999999999993 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.140000000000001 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.418 ' CG ' HD11 ' A' ' 93' ' ' LEU . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 71.450000000000003 110.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 51.009999999999998 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.430000000000007 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 64.400000000000006 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 31' ' ' VAL . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 53.119999999999997 111.147 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.340000000000003 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 52.310000000000002 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 53.149999999999999 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.0 p-80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 110.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.109999999999999 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.109999999999999 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 44.530000000000001 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.530000000000001 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 71.329999999999998 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 76' ' ' HIS . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.019999999999996 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.109999999999999 111.13 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 75.219999999999999 111.062 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.418 HD11 ' CG ' ' A' ' 63' ' ' GLU . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 74.140000000000001 110.935 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.433 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.156 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 111.14 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.804 0.335 . . . . 62.439999999999998 111.072 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 74.519999999999996 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.439999999999998 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.218 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 73.049999999999997 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.329999999999998 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.439999999999998 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.714 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.129 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.510000000000005 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.030000000000001 111.188 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 51.100000000000001 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 64.209999999999994 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.25 110.86 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.516 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.119 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 62.32 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 74.299999999999997 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.714 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.839 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.299999999999997 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 64.099999999999994 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.099999999999994 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB3' HD23 ' A' ' 46' ' ' LEU . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.16 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 54.009999999999998 111.141 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.162 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.035 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.010000000000005 110.966 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.893 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 70.109999999999999 110.954 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 72.319999999999993 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.140000000000001 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 71.450000000000003 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 51.009999999999998 109.573 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.430000000000007 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.400000000000006 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 31' ' ' VAL . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 53.119999999999997 111.134 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 52.310000000000002 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.109999999999999 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 53.149999999999999 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.536 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.8 p-80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.872 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.109999999999999 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.109999999999999 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 44.530000000000001 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 71.329999999999998 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 76' ' ' HIS . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.019999999999996 111.074 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 63.109999999999999 111.124 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.2 mm . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.844 0.354 . . . . 75.219999999999999 111.157 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 53.439999999999998 111.164 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 111.126 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.761 0.315 . . . . 62.439999999999998 111.076 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 74.519999999999996 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 111.093 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.049999999999997 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.329999999999998 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.439999999999998 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 46' ' ' LEU . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.211 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 63.030000000000001 111.15 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 51.100000000000001 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 64.209999999999994 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.109999999999999 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.120000000000005 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 111.172 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.59 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 62.32 111.108 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.299999999999997 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.921 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.299999999999997 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 72.140000000000001 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.450000000000003 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 71.099999999999994 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 62.310000000000002 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' HD23 ' A' ' 46' ' ' LEU . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.924 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 54.009999999999998 111.09 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.128 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.037 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.010000000000005 110.867 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.915 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 57' ' ' LEU . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 70.109999999999999 110.884 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 72.319999999999993 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.140000000000001 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 71.450000000000003 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 51.009999999999998 109.568 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.430000000000007 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.430000000000007 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 64.400000000000006 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 31' ' ' VAL . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 53.119999999999997 111.18 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.340000000000003 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 52.310000000000002 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.109999999999999 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 53.149999999999999 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.476 ' CD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 110.84 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.109999999999999 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.109999999999999 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.530000000000001 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 71.329999999999998 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 76' ' ' HIS . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.134 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 63.109999999999999 111.147 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.83 0.348 . . . . 75.219999999999999 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.450000000000003 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 53.439999999999998 111.124 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.230000000000004 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.099999999999994 111.111 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.712 0.291 . . . . 62.439999999999998 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 74.519999999999996 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.409999999999997 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.510000000000005 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 111.094 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 73.049999999999997 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.439999999999998 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.139 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 63.030000000000001 111.133 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.530000000000001 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 51.100000000000001 112.465 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 64.209999999999994 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 64.25 110.862 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.511 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 110.879 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 111.111 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 62.32 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 74.299999999999997 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.922 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.299999999999997 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.099999999999994 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 71.099999999999994 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' A' ' 46' ' ' LEU . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.944 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 22' ' ' ILE . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.204 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 54.009999999999998 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.636 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.04 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.944 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.04 HD21 HD12 ' A' ' 57' ' ' LEU . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 70.109999999999999 110.947 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 72.319999999999993 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.140000000000001 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 71.450000000000003 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 51.009999999999998 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.430000000000007 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.430000000000007 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.400000000000006 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 31' ' ' VAL . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 53.119999999999997 111.171 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 52.310000000000002 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 53.149999999999999 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.2 p-80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.109999999999999 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.109999999999999 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 44.530000000000001 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.530000000000001 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 71.329999999999998 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 63.109999999999999 111.16 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 ' CE1' ' A' ' 76' ' ' HIS . 28.8 mm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.783 0.325 . . . . 75.219999999999999 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.109999999999999 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 74.140000000000001 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.099999999999994 111.147 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.789 0.328 . . . . 62.439999999999998 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 74.519999999999996 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.439999999999998 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.447 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.409999999999997 111.071 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 111.155 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 73.049999999999997 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.329999999999998 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.439999999999998 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.239999999999995 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.724 ' CG1' HD22 ' A' ' 46' ' ' LEU . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 111.105 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 63.030000000000001 111.09 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 51.100000000000001 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.25 110.889 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.465 HG22 ' OD1' ' A' ' 38' ' ' ASN . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.230000000000004 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 62.32 111.18 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 74.299999999999997 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.319999999999993 110.972 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.450000000000003 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 71.099999999999994 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 62.310000000000002 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' HD23 ' A' ' 46' ' ' LEU . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.887 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 54.009999999999998 111.135 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 111.156 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.956 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.010000000000005 110.85 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.909 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.956 HD21 HD12 ' A' ' 57' ' ' LEU . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 70.109999999999999 110.94 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 72.319999999999993 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.140000000000001 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 71.450000000000003 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 51.009999999999998 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.430000000000007 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.430000000000007 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 64.400000000000006 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 31' ' ' VAL . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 53.119999999999997 111.128 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 52.310000000000002 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 53.149999999999999 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.109999999999999 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 44.530000000000001 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.530000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 71.329999999999998 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 63.109999999999999 111.136 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.9 mm . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 111.122 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.450000000000003 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 95' ' ' HIS . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 110.904 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 53.439999999999998 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.679 ' CE1' HD22 ' A' ' 93' ' ' LEU . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.909 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 111.022 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NE ' HG13 ' A' ' 96' ' ' VAL . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 74.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.439999999999998 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.239999999999995 111.109 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.049999999999997 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.329999999999998 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.439999999999998 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.239999999999995 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG11 HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 111.087 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 63.030000000000001 111.126 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.530000000000001 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 51.100000000000001 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 64.209999999999994 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.5 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 64.25 110.88 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.121 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 62.32 111.148 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 74.299999999999997 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.949 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 64.099999999999994 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 72.140000000000001 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.450000000000003 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 62.310000000000002 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 46' ' ' LEU . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 110.924 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 22' ' ' ILE . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 111.149 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 54.009999999999998 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.637 ' C ' HD23 ' A' ' 57' ' ' LEU . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.111 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.028 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.939 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 63.43 110.85 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 57' ' ' LEU . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 70.109999999999999 110.997 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 72.319999999999993 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.140000000000001 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 71.450000000000003 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 51.009999999999998 109.603 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.430000000000007 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 31' ' ' VAL . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 53.119999999999997 111.133 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 52.310000000000002 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 73.109999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 53.149999999999999 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.3 p-80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.875 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.109999999999999 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.109999999999999 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 44.530000000000001 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.530000000000001 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 71.329999999999998 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 63.109999999999999 111.09 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.9 mm . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.87 0.367 . . . . 75.219999999999999 111.162 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 110.885 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.450000000000003 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.140000000000001 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 53.439999999999998 111.12 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.230000000000004 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.431 HG13 ' NE ' ' A' ' 18' ' ' ARG . 95.6 t . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.099999999999994 111.084 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 62.439999999999998 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 74.519999999999996 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.439999999999998 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' HD13 ' A' ' 94' ' ' ILE . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 111.147 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.510000000000005 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 111.115 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.109999999999999 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.329999999999998 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.439999999999998 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 46' ' ' LEU . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.106 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 63.030000000000001 111.066 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 51.100000000000001 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 64.209999999999994 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.25 110.888 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.176 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.613 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 62.32 111.184 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 74.299999999999997 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.956 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.099999999999994 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.872 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 71.099999999999994 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 62.310000000000002 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB3' HD23 ' A' ' 46' ' ' LEU . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.896 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 54.009999999999998 111.069 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.647 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.154 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.104 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 110.891 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.854 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.104 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 70.109999999999999 110.918 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 72.319999999999993 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.140000000000001 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 71.450000000000003 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 51.009999999999998 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.430000000000007 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.340000000000003 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.510000000000005 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 64.400000000000006 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 31' ' ' VAL . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 53.119999999999997 111.092 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 52.310000000000002 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.5 p-80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 110.865 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.109999999999999 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 44.530000000000001 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.530000000000001 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 71.329999999999998 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 63.109999999999999 111.128 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.6 mm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.838 0.351 . . . . 75.219999999999999 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.450000000000003 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.140000000000001 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.462 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 53.439999999999998 111.192 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.099999999999994 111.141 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.809 0.338 . . . . 62.439999999999998 111.079 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.439999999999998 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.510000000000005 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.136 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' HG12 ' A' ' 54' ' ' VAL . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.885 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 70' ' ' VAL . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.908 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 73.049999999999997 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.329999999999998 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.439999999999998 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.239999999999995 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.721 HG11 HD22 ' A' ' 46' ' ' LEU . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 111.171 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.510000000000005 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 22' ' ' ILE . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 63.030000000000001 111.116 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.530000000000001 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 51.100000000000001 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 64.25 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.109999999999999 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.120000000000005 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.230000000000004 111.13 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 62.32 111.088 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 74.299999999999997 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.721 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.85 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.188 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 64.099999999999994 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 72.140000000000001 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.450000000000003 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 71.099999999999994 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.310000000000002 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 23' ' ' ARG . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.122 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 54.009999999999998 111.166 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.648 ' C ' HD23 ' A' ' 57' ' ' LEU . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.995 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.010000000000005 110.939 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.995 HD21 HD12 ' A' ' 57' ' ' LEU . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 70.109999999999999 110.877 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 72.319999999999993 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.140000000000001 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 71.450000000000003 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 51.009999999999998 109.588 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.430000000000007 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.430000000000007 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 64.400000000000006 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 24' ' ' TRP . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 53.119999999999997 111.123 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.340000000000003 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 52.310000000000002 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.149999999999999 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.502 ' CD2' HG11 ' A' ' 82' ' ' VAL . 8.6 p-80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.229999999999997 110.848 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.109999999999999 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 44.530000000000001 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.530000000000001 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 71.329999999999998 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 76' ' ' HIS . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.116 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 63.109999999999999 111.197 179.854 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.857 0.361 . . . . 75.219999999999999 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.450000000000003 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.447 HD21 ' NE2' ' A' ' 95' ' ' HIS . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 74.140000000000001 110.91 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 93' ' ' LEU . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 53.439999999999998 111.176 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.447 ' NE2' HD21 ' A' ' 93' ' ' LEU . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.866 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.099999999999994 111.152 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.728 0.299 . . . . 62.439999999999998 111.121 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 74.519999999999996 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.439999999999998 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.239999999999995 111.111 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.049999999999997 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.329999999999998 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.439999999999998 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.72 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.230000000000004 111.153 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.628 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 63.030000000000001 111.112 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 51.100000000000001 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 64.209999999999994 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CB ' HD22 ' A' ' 59' ' ' LEU . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 64.25 110.904 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.519 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.519 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.111 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 62.32 111.171 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 74.299999999999997 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.909 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.099999999999994 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.450000000000003 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 62.310000000000002 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB3' HD23 ' A' ' 46' ' ' LEU . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.874 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 54.009999999999998 111.154 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.612 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 111.189 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.986 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.010000000000005 111.006 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.986 HD21 HD12 ' A' ' 57' ' ' LEU . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 70.109999999999999 110.954 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 72.319999999999993 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.140000000000001 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 71.450000000000003 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.406 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 51.009999999999998 109.577 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.430000000000007 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.340000000000003 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 64.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 31' ' ' VAL . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 53.119999999999997 111.14 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.340000000000003 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 52.310000000000002 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 53.149999999999999 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.7 p-80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 44.530000000000001 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 71.329999999999998 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.019999999999996 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 63.109999999999999 111.132 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.494 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.2 mm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.791 0.329 . . . . 75.219999999999999 111.131 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.439999999999998 111.127 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 111.146 -179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.71 0.291 . . . . 62.439999999999998 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 74.519999999999996 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.439999999999998 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.409999999999997 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.13 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 73.049999999999997 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.329999999999998 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.439999999999998 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.689 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 111.134 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.510000000000005 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 63.030000000000001 111.184 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.530000000000001 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 51.100000000000001 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 64.209999999999994 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 64.25 110.873 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.120000000000005 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.230000000000004 111.219 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.511 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 62.32 111.14 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.945 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.299999999999997 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 64.099999999999994 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 72.140000000000001 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.450000000000003 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 71.099999999999994 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 62.310000000000002 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 46' ' ' LEU . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.519999999999996 110.868 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 54.009999999999998 111.102 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.171 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.010000000000005 110.847 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.917 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 70.109999999999999 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 72.319999999999993 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.140000000000001 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 71.450000000000003 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.009999999999998 109.632 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.430000000000007 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.510000000000005 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 64.400000000000006 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 31' ' ' VAL . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 53.119999999999997 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 52.310000000000002 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 53.149999999999999 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.7 p-80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.229999999999997 110.778 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.109999999999999 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 44.530000000000001 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 71.329999999999998 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 63.109999999999999 111.139 179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG21 ' CE1' ' A' ' 76' ' ' HIS . 31.2 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.809 0.337 . . . . 75.219999999999999 111.137 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.450000000000003 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 53.439999999999998 111.081 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.099999999999994 111.176 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.752 0.311 . . . . 62.439999999999998 111.133 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 74.519999999999996 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.510000000000005 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.239999999999995 111.095 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.430000000000007 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 73.049999999999997 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.439999999999998 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 74.230000000000004 111.109 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.030000000000001 111.114 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 51.100000000000001 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.209999999999994 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CB ' HD22 ' A' ' 59' ' ' LEU . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.25 110.85 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.515 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 111.159 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.239999999999995 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 62.32 111.114 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 74.299999999999997 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.975 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 111.118 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.450000000000003 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.310000000000002 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.547 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 54.009999999999998 111.113 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.439999999999998 111.099 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.041 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.010000000000005 110.96 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.041 HD21 HD12 ' A' ' 57' ' ' LEU . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 70.109999999999999 110.936 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 72.319999999999993 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 71.450000000000003 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 51.009999999999998 109.628 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.430000000000007 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 64.400000000000006 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 31' ' ' VAL . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 53.119999999999997 111.143 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 52.310000000000002 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 73.109999999999999 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 53.149999999999999 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.2 p-80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.229999999999997 110.859 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.109999999999999 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 44.530000000000001 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 71.329999999999998 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 111.109 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.504 HG21 ' CE1' ' A' ' 76' ' ' HIS . 31.2 mm . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 75.219999999999999 111.123 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.450000000000003 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 53.439999999999998 111.144 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.099999999999994 111.103 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.74 0.305 . . . . 62.439999999999998 111.109 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 74.519999999999996 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.439999999999998 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.084 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 54' ' ' VAL . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.430000000000007 110.898 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CE2' HG21 ' A' ' 70' ' ' VAL . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.979 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.329999999999998 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.439999999999998 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.727 ' CG1' HD22 ' A' ' 46' ' ' LEU . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.177 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.510000000000005 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 22' ' ' ILE . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 63.030000000000001 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.530000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 51.100000000000001 112.478 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 64.209999999999994 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 64.25 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.892 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.120000000000005 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 62.32 111.125 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 74.299999999999997 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.93 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 64.099999999999994 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 72.140000000000001 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.099999999999994 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 62.310000000000002 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 46' ' ' LEU . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.827 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.148 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 111.071 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.585 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.144 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.883 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 57' ' ' LEU . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 70.109999999999999 110.935 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 72.319999999999993 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.140000000000001 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 71.450000000000003 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 51.009999999999998 109.534 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.430000000000007 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.430000000000007 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 64.400000000000006 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 24' ' ' TRP . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 53.119999999999997 111.176 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 52.310000000000002 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 73.109999999999999 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.1 p-80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.875 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.109999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 44.530000000000001 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 76' ' ' HIS . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.019999999999996 111.123 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 63.109999999999999 111.127 179.977 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.757 0.313 . . . . 75.219999999999999 111.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.450000000000003 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 53.439999999999998 111.117 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.099999999999994 111.061 -179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.778 0.323 . . . . 62.439999999999998 111.068 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 74.519999999999996 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.409999999999997 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.608 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.131 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG2' HG12 ' A' ' 54' ' ' VAL . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.430000000000007 110.853 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.109999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 73.049999999999997 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.329999999999998 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 74.230000000000004 111.107 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 63.030000000000001 111.122 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.530000000000001 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 51.100000000000001 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 64.209999999999994 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 64.25 110.894 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.508 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 111.146 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 62.32 111.081 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.883 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.299999999999997 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.450000000000003 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.099999999999994 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 62.310000000000002 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.214 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 54.009999999999998 111.112 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.589 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.099 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.058 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.925 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.838 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.058 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 70.109999999999999 110.948 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 72.319999999999993 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.140000000000001 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 71.450000000000003 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 51.009999999999998 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.430000000000007 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.340000000000003 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 64.400000000000006 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 31' ' ' VAL . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 53.119999999999997 111.148 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 52.310000000000002 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 53.149999999999999 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.9 p-80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.229999999999997 110.842 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.109999999999999 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.109999999999999 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 44.530000000000001 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.530000000000001 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 71.329999999999998 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.019999999999996 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 63.109999999999999 111.085 179.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.48 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.4 mm . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.806 0.336 . . . . 75.219999999999999 111.158 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.93 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 53.439999999999998 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.127 179.929 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.783 0.325 . . . . 62.439999999999998 111.091 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.6 ' HD2' HG13 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 74.519999999999996 110.875 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.439999999999998 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.619 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.15 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.329999999999998 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.439999999999998 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.239999999999995 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.684 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 111.076 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.510000000000005 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 63.030000000000001 111.11 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.530000000000001 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 51.100000000000001 112.52 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 64.209999999999994 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' CB ' HD22 ' A' ' 59' ' ' LEU . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 64.25 110.871 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.503 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.886 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.503 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.099 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.506 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 62.32 111.153 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 74.299999999999997 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.684 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.96 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.299999999999997 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.099999999999994 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.450000000000003 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.099999999999994 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 62.310000000000002 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 46' ' ' LEU . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.519999999999996 110.916 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 54.009999999999998 111.083 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.56 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.139 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.010000000000005 110.944 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.904 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.941 HD21 HD12 ' A' ' 57' ' ' LEU . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 70.109999999999999 110.998 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 72.319999999999993 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.140000000000001 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 93' ' ' LEU . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 71.450000000000003 110.908 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 51.009999999999998 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.400000000000006 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 53.119999999999997 111.115 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.340000000000003 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 52.310000000000002 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 53.149999999999999 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.109999999999999 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.109999999999999 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 44.530000000000001 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.530000000000001 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 71.329999999999998 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 63.109999999999999 111.057 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.844 0.354 . . . . 75.219999999999999 111.201 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.922 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.450000000000003 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.93 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 53.439999999999998 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.6 HG13 ' HD2' ' A' ' 18' ' ' ARG . 95.7 t . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 111.152 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.79 0.329 . . . . 62.439999999999998 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.439999999999998 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.409999999999997 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.167 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.049999999999997 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.329999999999998 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.439999999999998 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 70' ' ' VAL . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 111.161 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 63.030000000000001 111.158 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.530000000000001 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.501 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 64.209999999999994 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 64.25 110.866 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.951 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.109999999999999 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.230000000000004 111.133 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 62.32 111.096 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.319999999999993 110.926 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 64.099999999999994 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.450000000000003 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 71.099999999999994 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 62.310000000000002 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 22' ' ' ILE . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.114 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 54.009999999999998 111.083 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 55' ' ' ALA . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 111.087 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 110.861 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.613 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.43 110.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 70.109999999999999 110.94 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 72.319999999999993 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.438 ' CG ' HD11 ' A' ' 93' ' ' LEU . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 71.450000000000003 110.886 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 51.009999999999998 109.624 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.430000000000007 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 64.400000000000006 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 31' ' ' VAL . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 53.119999999999997 111.155 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 52.310000000000002 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 53.149999999999999 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.449 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.7 p-80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.229999999999997 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.109999999999999 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.109999999999999 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.530000000000001 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 71.329999999999998 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 63.109999999999999 111.132 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 76' ' ' HIS . 25.8 mm . . . . . 0 N--CA 1.459 -0.01 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 111.081 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.938 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 53.439999999999998 111.093 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.128 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.819 0.342 . . . . 62.439999999999998 111.1 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 74.519999999999996 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.439999999999998 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.65 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.239999999999995 111.128 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CE2' HG21 ' A' ' 70' ' ' VAL . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 110.926 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 73.049999999999997 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.329999999999998 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.165 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 22' ' ' ILE . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.030000000000001 111.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.530000000000001 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 51.100000000000001 112.53 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 64.209999999999994 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 64.25 110.917 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.109999999999999 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.120000000000005 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' HG23 ' A' ' 33' ' ' ILE . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 62.32 111.103 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 74.299999999999997 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.924 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.299999999999997 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 64.099999999999994 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.140000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.450000000000003 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.099999999999994 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 46' ' ' LEU . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.846 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 54.009999999999998 111.057 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.127 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.935 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 110.97 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.868 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.935 HD21 HD12 ' A' ' 57' ' ' LEU . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 70.109999999999999 110.94 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 72.319999999999993 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.140000000000001 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 71.450000000000003 110.866 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 51.009999999999998 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.645 ' CG ' HD22 ' A' ' 93' ' ' LEU . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.430000000000007 110.859 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 64.400000000000006 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 HG22 ' A' ' 31' ' ' VAL . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 53.119999999999997 111.098 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.340000000000003 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 52.310000000000002 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 53.149999999999999 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.2 p-80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.819 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.109999999999999 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.109999999999999 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 44.530000000000001 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 71.329999999999998 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 76' ' ' HIS . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.116 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.109999999999999 111.168 179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.411 HG21 ' CE1' ' A' ' 76' ' ' HIS . 24.0 mm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.781 0.324 . . . . 75.219999999999999 111.144 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' CG ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.938 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 93' ' ' LEU . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 111.131 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.478 ' CD2' HD12 ' A' ' 93' ' ' LEU . 26.0 m-70 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.909 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.099999999999994 111.119 -179.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.824 0.345 . . . . 62.439999999999998 111.089 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 74.519999999999996 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.439999999999998 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.676 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 73.049999999999997 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.329999999999998 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 74.230000000000004 111.094 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 22' ' ' ILE . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.115 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 51.100000000000001 112.513 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 64.209999999999994 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 64.25 110.891 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 111.12 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 62.32 111.053 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 74.299999999999997 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.677 HD23 ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.899 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 64.099999999999994 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.140000000000001 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.450000000000003 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 71.099999999999994 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.310000000000002 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB3' HD23 ' A' ' 46' ' ' LEU . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.89 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 22' ' ' ILE . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.140000000000001 111.148 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.564 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 54.009999999999998 111.176 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.639 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.158 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.014 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.965 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 63.43 110.87 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 57' ' ' LEU . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 70.109999999999999 110.959 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 72.319999999999993 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.140000000000001 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 71.450000000000003 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 51.009999999999998 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.430000000000007 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 64.400000000000006 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 53.119999999999997 111.142 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 52.310000000000002 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.6 p-80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.813 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.109999999999999 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.530000000000001 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 71.329999999999998 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.019999999999996 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 63.109999999999999 111.095 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.2 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 111.122 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.450000000000003 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.140000000000001 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 53.439999999999998 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.068 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.836 0.351 . . . . 62.439999999999998 111.108 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.439999999999998 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.621 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.126 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.329999999999998 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.439999999999998 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.655 ' CG1' HD22 ' A' ' 46' ' ' LEU . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.135 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.510000000000005 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.030000000000001 111.097 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.530000000000001 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 51.100000000000001 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 64.209999999999994 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 64.25 110.863 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.109999999999999 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.513 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 111.156 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 72.239999999999995 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 62.32 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 74.299999999999997 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.655 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.319999999999993 110.924 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 111.147 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 64.099999999999994 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.450000000000003 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.310000000000002 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HB3' HD23 ' A' ' 46' ' ' LEU . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.924 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 22' ' ' ILE . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.151 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 54.009999999999998 111.149 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.633 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.099 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.002 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.010000000000005 110.979 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.875 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.002 HD21 HD12 ' A' ' 57' ' ' LEU . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 70.109999999999999 110.889 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 72.319999999999993 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.140000000000001 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 71.450000000000003 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 51.009999999999998 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.430000000000007 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.430000000000007 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 64.400000000000006 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 53.119999999999997 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.340000000000003 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 52.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 53.149999999999999 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.546 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.6 p-80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.229999999999997 110.824 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.109999999999999 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 44.530000000000001 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 71.329999999999998 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' CD2' ' A' ' 76' ' ' HIS . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.083 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 111.143 179.846 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.791 0.329 . . . . 75.219999999999999 111.111 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 53.439999999999998 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.230000000000004 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.099999999999994 111.149 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.752 0.31 . . . . 62.439999999999998 111.11 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 74.519999999999996 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.409999999999997 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.239999999999995 111.151 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.430000000000007 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 73.049999999999997 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.329999999999998 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.439999999999998 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.510000000000005 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.030000000000001 111.08 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.530000000000001 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 51.100000000000001 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 64.209999999999994 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 59' ' ' LEU . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 64.25 110.893 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.109999999999999 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 111.159 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 62.32 111.081 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 74.299999999999997 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.734 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.949 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.299999999999997 111.08 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 64.099999999999994 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 62.310000000000002 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 22' ' ' ILE . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 111.117 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 54.009999999999998 111.125 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.173 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.010000000000005 110.953 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 63.43 110.904 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 57' ' ' LEU . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 70.109999999999999 110.905 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.140000000000001 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 71.450000000000003 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.422 ' HD2' HG23 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 51.009999999999998 109.6 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.430000000000007 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.400000000000006 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 31' ' ' VAL . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 53.119999999999997 111.076 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 52.310000000000002 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 53.149999999999999 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.109999999999999 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.109999999999999 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 44.530000000000001 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 71.329999999999998 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.019999999999996 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 63.109999999999999 111.12 179.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.228 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 74.140000000000001 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 64' ' ' HIS . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 53.439999999999998 111.125 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.099999999999994 111.164 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.497 -0.241 . . . . 63.340000000000003 112.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.21 151.16 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 65.140000000000001 111.109 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.41 162.55 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.902 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.66 -155.78 53.37 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.81 -0.709 . . . . 74.439999999999998 112.471 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.19 158.61 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 72.310000000000002 111.185 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.94 -70.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.891 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -113.46 170.8 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 45.329999999999998 110.87 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -107.65 160.31 15.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 74.299999999999997 110.874 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.32 -26.26 11.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 74.450000000000003 110.894 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -74.11 173.56 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 60.539999999999999 110.854 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -152.33 155.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 73.329999999999998 111.096 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 70.11 79.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.589 0.709 . . . . 63.219999999999999 110.907 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -24.78 29.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.688 2.258 . . . . 71.310000000000002 112.359 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 p -51.87 167.11 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.179 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -74.31 -176.43 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 73.420000000000002 110.875 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -73.29 151.83 41.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 65.140000000000001 110.918 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -175.71 154.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 62.439999999999998 111.087 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 -77.19 157.6 80.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.627 0.727 . . . . 74.519999999999996 110.85 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 163.45 38.25 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.661 2.241 . . . . 71.439999999999998 112.331 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.9 t -93.22 156.38 16.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.115 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.91 99.36 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 111.101 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.613 HG12 HD12 ' A' ' 33' ' ' ILE . 1.1 mp -130.48 139.01 52.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.158 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -150.73 106.56 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.862 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -118.86 128.86 54.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.906 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.09 104.6 6.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 73.049999999999997 110.828 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.84 -64.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 73.25 110.88 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 38.53 0.43 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.499 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.51 -162.52 37.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.525 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.9 mtpt -99.7 -38.2 8.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 72.439999999999998 110.918 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.49 131.0 13.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 74.239999999999995 110.908 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.685 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.1 t -119.04 132.62 68.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 111.163 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.19 151.41 51.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 110.908 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.613 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -122.75 142.68 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 63.030000000000001 111.129 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t -150.72 139.08 20.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 65.530000000000001 110.848 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -165.56 12.34 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 51.100000000000001 112.449 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -73.0 -17.7 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.373 . . . . 64.209999999999994 110.865 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.45 -17.17 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 64.25 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -128.81 12.97 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.836 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 63.55 21.06 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 110.876 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m95 51.49 33.75 10.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.8 t -109.71 14.96 23.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 73.120000000000005 110.819 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.8 6.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 111.141 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -106.15 119.19 38.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 72.239999999999995 110.862 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.44 132.64 49.09 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.667 0.746 . . . . 62.32 111.101 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.83 36.33 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.653 2.235 . . . . 74.299999999999997 112.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.685 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -96.88 106.8 19.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.182 -0.463 . . . . 72.319999999999993 110.961 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.55 106.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.11 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -66.01 121.02 14.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 64.099999999999994 110.884 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.24 155.78 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.833 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -25.98 40.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.814 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -88.96 -49.51 6.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.099999999999994 110.881 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -172.68 -173.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 62.310000000000002 110.913 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HB3' HD23 ' A' ' 46' ' ' LEU . 66.7 m-85 -85.73 148.12 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.868 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -151.13 161.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 111.158 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.434 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -130.22 148.19 52.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 54.009999999999998 111.153 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.03 117.9 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 111.123 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.003 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.4 132.84 12.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 74.010000000000005 110.918 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.575 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 1.9 p30 -73.04 106.05 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.43 110.881 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.003 HD21 HD12 ' A' ' 57' ' ' LEU . 10.0 mt -111.89 152.4 44.19 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 70.109999999999999 110.916 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 154.51 67.43 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.659 2.239 . . . . 72.319999999999993 112.329 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.95 111.16 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 71.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.34 -162.52 36.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.773 -0.727 . . . . 75.140000000000001 112.5 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' CG ' HD11 ' A' ' 93' ' ' LEU . 29.5 tt0 -114.24 125.14 53.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 119.361 -0.352 . . . . 71.450000000000003 110.905 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 166.81 17.87 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.459 1.099 . . . . 51.009999999999998 109.633 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -124.1 125.24 44.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.039 -0.982 . . . . 75.430000000000007 110.922 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -120.39 177.69 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.951 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -151.18 143.51 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 110.905 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -90.94 151.59 21.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.510000000000005 110.891 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.91 95.33 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 64.400000000000006 110.885 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HG22 ' A' ' 31' ' ' VAL . 21.2 t -124.61 150.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 53.119999999999997 111.158 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.0 t70 63.52 31.43 14.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 64.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.37 83.01 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 72.25 112.524 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -157.73 151.89 24.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.744 0.307 . . . . 52.310000000000002 110.977 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.15 115.94 19.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.77 173.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 53.149999999999999 111.148 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.481 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.0 p-80 -153.83 158.66 41.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 63.229999999999997 110.889 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -97.78 133.95 22.87 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.595 0.712 . . . . 61.109999999999999 110.858 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -24.25 29.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 70.109999999999999 112.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -28.58 60.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 44.530000000000001 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -82.34 160.46 62.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.878 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 82.88 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.695 2.263 . . . . 71.329999999999998 112.364 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.401 HG11 ' CD2' ' A' ' 76' ' ' HIS . 34.7 m -91.78 159.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.019999999999996 111.113 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.28 143.1 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.109999999999999 111.113 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.489 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.8 m -79.77 108.43 13.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.126 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -58.43 171.67 0.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.27 -0.423 . . . . 72.230000000000004 110.871 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -62.88 -23.15 67.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 72.439999999999998 110.931 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.406 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.98 11.11 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.948 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 10.16 81.8 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.763 -0.732 . . . . 45.439999999999998 112.477 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.7 p -97.35 118.82 34.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.748 0.309 . . . . 52.509999999999998 111.088 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 84' ' ' THR . 27.0 mm -67.69 134.62 29.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 111.129 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.27 157.58 45.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.851 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -79.93 176.37 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 61.450000000000003 110.895 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' A' ' 63' ' ' GLU . 56.3 tp -138.1 135.26 35.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.916 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.13 144.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 53.439999999999998 111.145 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -127.78 112.39 14.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.827 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.0 t -102.93 144.1 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 71.099999999999994 111.074 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.81 -174.61 2.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 65.040000000000006 110.861 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.82 160.48 20.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.905 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -117.25 26.29 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 72.340000000000003 110.833 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -84.17 -31.84 24.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 72.120000000000005 110.875 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -101.09 -31.41 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 65.450000000000003 110.916 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -58.05 -24.95 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 64.109999999999999 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 105' ' ' ASP . 13.1 p -89.62 141.67 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 111.159 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -86.78 -31.46 20.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.855 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 103' ' ' VAL . 3.0 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 44.530000000000001 110.912 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.496 -0.242 . . . . 63.340000000000003 112.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.64 135.97 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 65.140000000000001 111.098 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.1 mmt -126.7 154.55 43.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.833 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.39 70.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.701 -0.761 . . . . 74.439999999999998 112.466 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -114.39 106.77 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.742 0.306 . . . . 72.310000000000002 111.18 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -84.04 126.79 33.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.953 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -106.39 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 45.329999999999998 110.959 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 m -111.57 179.88 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.299999999999997 110.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -81.1 -60.14 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 74.450000000000003 110.801 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.4 p -155.8 139.38 15.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.261 -0.427 . . . . 60.539999999999999 110.87 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.8 m -150.15 138.9 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.09 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -131.43 69.0 81.8 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.557 0.694 . . . . 63.219999999999999 110.961 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.59 -23.45 31.57 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.734 2.289 . . . . 71.310000000000002 112.355 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 p -101.31 171.3 7.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 73.25 111.165 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.24 -179.88 6.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 73.420000000000002 110.884 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -74.01 131.72 41.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 65.140000000000001 110.918 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -176.58 151.95 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 62.439999999999998 111.079 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.82 152.13 86.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.605 0.717 . . . . 74.519999999999996 110.86 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 164.01 36.08 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.747 2.298 . . . . 71.439999999999998 112.345 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.433 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -92.54 152.15 19.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 72.409999999999997 111.151 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.3 99.54 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 111.084 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.66 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.52 138.77 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.239999999999995 111.133 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.27 106.48 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.872 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -118.91 129.95 55.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.935 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -131.98 104.33 6.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.836 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 70' ' ' VAL . 45.4 tt0 -138.87 -68.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 73.25 110.888 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 42.33 0.28 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 63.32 112.532 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.6 -157.33 30.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.509 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -102.23 -34.46 9.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.666 0.27 . . . . 72.439999999999998 110.876 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.52 130.18 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.421 . . . . 74.239999999999995 110.869 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG11 HD22 ' A' ' 46' ' ' LEU . 42.2 t -113.94 137.17 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 111.094 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -138.8 146.77 41.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.825 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -119.76 142.7 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.030000000000001 111.095 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -148.29 139.18 23.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.125 -0.489 . . . . 65.530000000000001 110.889 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.08 -168.35 14.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.811 -0.709 . . . . 51.100000000000001 112.51 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -72.44 -18.27 61.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.908 0.385 . . . . 64.209999999999994 110.891 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.4 p90 -61.68 -18.04 57.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.2 12.91 7.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 73.109999999999999 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 63.76 20.21 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.909 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.6 m95 51.83 33.11 10.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 m -109.57 15.09 23.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 73.120000000000005 110.873 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.0 t -166.11 148.89 7.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.203 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -105.27 120.0 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.914 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.54 132.4 49.58 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.609 0.718 . . . . 62.32 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.11 34.55 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.674 2.249 . . . . 74.299999999999997 112.361 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -94.62 110.69 22.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.901 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.8 mm -51.21 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.299999999999997 111.157 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -67.91 118.11 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 64.099999999999994 110.887 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.5 t -110.58 157.48 19.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 72.140000000000001 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -56.19 -25.61 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 70.450000000000003 110.816 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -87.59 -56.37 3.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.099999999999994 110.814 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -166.49 -170.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 62.310000000000002 110.826 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HB3' HD23 ' A' ' 46' ' ' LEU . 41.6 m-85 -87.14 149.94 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 74.519999999999996 110.928 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 m -152.23 160.33 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.137 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.548 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -127.09 142.36 51.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.009999999999998 111.151 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.634 ' C ' HD23 ' A' ' 57' ' ' LEU . 40.9 mm -138.27 117.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.439999999999998 111.169 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.94 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.18 132.73 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.486 . . . . 74.010000000000005 110.909 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 52.2 m-20 -72.74 107.65 5.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 63.43 110.855 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.94 HD21 HD12 ' A' ' 57' ' ' LEU . 10.6 mt -112.56 152.5 44.7 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.597 0.713 . . . . 70.109999999999999 110.896 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 151.94 69.03 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 72.319999999999993 112.329 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.97 125.47 23.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.933 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 -141.4 8.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 75.140000000000001 112.456 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.418 ' CG ' HD11 ' A' ' 93' ' ' LEU . 36.6 tt0 -134.61 132.68 39.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.335 -0.364 . . . . 71.450000000000003 110.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.65 166.94 22.39 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.121 . . . . 51.009999999999998 109.606 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -124.82 125.52 44.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.998 -1.001 . . . . 75.430000000000007 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -119.61 176.14 5.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.955 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -150.87 144.55 25.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.944 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -92.63 145.78 24.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.215 -0.448 . . . . 74.510000000000005 110.876 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -129.81 95.38 3.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 64.400000000000006 110.839 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 31' ' ' VAL . 20.5 t -123.61 150.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 53.119999999999997 111.147 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 61.87 29.79 18.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.340000000000003 110.865 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.57 29.41 73.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.464 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -153.37 155.9 37.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.754 0.312 . . . . 52.310000000000002 110.944 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -84.1 114.23 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.888 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.86 168.24 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 53.149999999999999 111.167 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.0 p-80 -147.74 157.9 43.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 63.229999999999997 110.843 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.07 134.7 21.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 61.109999999999999 110.814 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.14 28.88 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.713 2.275 . . . . 70.109999999999999 112.309 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.0 t -74.63 -29.87 61.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 44.530000000000001 110.861 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.32 160.68 61.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.603 0.716 . . . . 74.530000000000001 110.882 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 81.67 0.82 Allowed 'Trans proline' 0 C--N 1.34 0.109 0 C-N-CA 122.65 2.233 . . . . 71.329999999999998 112.323 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.451 HG11 ' CD2' ' A' ' 76' ' ' HIS . 17.9 m -91.85 153.67 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 75.019999999999996 111.122 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.8 p -155.91 148.42 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 63.109999999999999 111.13 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -79.9 110.27 15.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.074 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 m -67.3 171.18 6.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 110.907 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -63.86 -16.1 60.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 72.439999999999998 110.907 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 87' ' ' LEU . 1.9 mm? -84.29 3.69 34.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.530000000000001 110.887 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.88 7.64 86.4 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.668 -0.777 . . . . 45.439999999999998 112.41 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.4 p -112.22 132.29 55.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 52.509999999999998 111.131 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 mm -66.12 147.21 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 111.062 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.14 155.97 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -79.16 171.88 14.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 61.450000000000003 110.917 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.418 HD11 ' CG ' ' A' ' 63' ' ' GLU . 38.5 tp -132.91 134.45 44.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 74.140000000000001 110.935 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.433 HD13 ' OG1' ' A' ' 20' ' ' THR . 1.5 tt -131.55 139.17 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 53.439999999999998 111.156 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -123.62 110.87 15.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.853 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.44 145.2 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 111.14 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.92 -175.46 2.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 65.040000000000006 110.923 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -93.1 161.74 14.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.868 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -117.74 6.1 12.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.872 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.27 -10.23 16.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 72.120000000000005 110.93 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -74.7 -55.87 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 65.450000000000003 110.873 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -68.08 -39.8 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 64.109999999999999 110.88 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.03 130.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 111.19 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.07 -36.21 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.872 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 44.530000000000001 110.881 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.475 -0.25 . . . . 63.340000000000003 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.0 164.9 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.335 . . . . 65.140000000000001 111.088 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.2 ttm -103.15 -59.57 1.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.5 110.881 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.15 167.13 21.3 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 74.439999999999998 112.457 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -97.82 105.35 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 72.310000000000002 111.1 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -125.87 47.23 2.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 110.888 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -103.44 -26.24 12.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 45.329999999999998 110.907 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m 62.84 49.23 3.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.854 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.9 -26.65 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 t -69.92 165.77 20.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 60.539999999999999 110.821 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.683 HG12 ' HD3' ' A' ' 13' ' ' PRO . 21.6 t -130.49 132.58 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.329999999999998 111.104 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -118.24 71.59 9.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.567 0.699 . . . . 63.219999999999999 110.893 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.683 ' HD3' HG12 ' A' ' 11' ' ' VAL . 53.9 Cg_endo -69.78 -20.2 35.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.338 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.01 165.18 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.099 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.3 mp0 -58.33 179.85 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 110.93 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -101.96 157.24 17.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 65.140000000000001 110.926 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -169.94 153.44 4.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 111.072 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 158.34 80.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.623 0.725 . . . . 74.519999999999996 110.865 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 162.99 39.88 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.277 . . . . 71.439999999999998 112.351 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.2 t -95.01 156.22 16.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 111.149 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.7 t -105.53 99.69 9.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 111.09 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.633 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.41 139.11 52.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.218 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -152.16 106.56 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 110.873 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -115.51 133.64 55.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.876 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.5 p -134.97 107.89 7.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 73.049999999999997 110.829 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -144.53 -65.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.86 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.57 38.8 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.681 -0.771 . . . . 63.32 112.446 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.17 -164.03 38.07 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 62.329999999999998 112.492 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -99.04 -39.38 8.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.439999999999998 110.95 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.93 131.29 15.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.872 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.714 ' CG1' HD22 ' A' ' 46' ' ' LEU . 45.4 t -116.72 136.7 52.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 111.129 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -138.0 147.01 43.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.510000000000005 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -120.34 142.71 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.030000000000001 111.188 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.4 m -148.12 139.14 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 65.530000000000001 110.788 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.7 -169.09 15.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.762 -0.732 . . . . 51.100000000000001 112.422 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -71.41 -17.6 62.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 64.209999999999994 110.834 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.0 p90 -62.08 -18.07 59.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.25 110.86 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -127.79 12.81 6.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 73.109999999999999 110.885 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 63.32 20.95 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.909 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.3 m95 51.62 34.11 12.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.951 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 t -110.38 14.73 22.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.871 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.516 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.14 146.37 6.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.119 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -102.93 119.52 38.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.972 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.88 132.35 51.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.703 . . . . 62.32 111.135 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 140.74 43.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.674 2.249 . . . . 74.299999999999997 112.341 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.714 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -101.31 110.28 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 110.839 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -50.97 115.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.299999999999997 111.131 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -78.48 117.5 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 64.099999999999994 110.895 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.17 161.62 15.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.831 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -60.39 -23.75 64.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.15 -57.48 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.099999999999994 110.894 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -166.38 -171.91 2.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.849 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB3' HD23 ' A' ' 46' ' ' LEU . 44.5 m-85 -86.23 146.57 26.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.904 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.4 t -150.12 143.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.140000000000001 111.16 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -115.32 145.36 42.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 54.009999999999998 111.141 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.641 ' C ' HD23 ' A' ' 57' ' ' LEU . 44.8 mm -138.44 122.3 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.162 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.035 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.73 135.48 14.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 74.010000000000005 110.966 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.25 105.27 4.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.893 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -113.25 152.52 45.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.551 0.691 . . . . 70.109999999999999 110.954 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.62 68.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.599 2.2 . . . . 72.319999999999993 112.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -63.24 118.25 7.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 71.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.55 -136.71 4.53 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 75.140000000000001 112.445 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -136.44 138.89 41.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.317 -0.373 . . . . 71.450000000000003 110.918 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.47 166.66 24.51 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 51.009999999999998 109.573 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.22 125.28 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.984 -1.007 . . . . 75.430000000000007 110.893 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.24 -178.9 3.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.877 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -154.95 143.24 20.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.934 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.47 146.92 23.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 110.918 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -131.12 95.33 3.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.400000000000006 110.893 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 31' ' ' VAL . 14.0 t -125.56 153.55 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 53.119999999999997 111.134 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 t0 64.04 20.45 12.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 64.340000000000003 110.92 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.08 29.36 58.89 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.495 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.54 157.34 35.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.783 0.325 . . . . 52.310000000000002 110.902 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -82.08 113.96 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 73.109999999999999 110.956 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.67 169.2 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 53.149999999999999 111.122 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.536 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.8 p-80 -151.82 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.872 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -94.27 134.3 25.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.574 0.702 . . . . 61.109999999999999 110.87 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -14.13 35.57 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.721 2.281 . . . . 70.109999999999999 112.378 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -80.61 -27.14 37.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 44.530000000000001 110.925 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.95 160.62 46.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.889 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 87.43 0.55 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 71.329999999999998 112.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 76' ' ' HIS . 26.9 m -94.76 147.93 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 75.019999999999996 111.074 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 p -143.58 140.87 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 63.109999999999999 111.124 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 HD13 ' A' ' 90' ' ' ILE . 2.9 m -80.53 117.27 21.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 73.200000000000003 111.125 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.74 166.06 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 72.230000000000004 110.813 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.2 pt20 -59.53 -22.73 62.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 110.931 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.518 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -84.75 3.39 37.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.955 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.55 77.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 45.439999999999998 112.483 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.6 p -107.07 124.84 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.784 0.326 . . . . 52.509999999999998 111.102 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.2 mm -74.95 131.95 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 111.157 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.84 156.66 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.918 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -79.77 178.1 8.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 61.450000000000003 110.961 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.3 tp -137.64 133.1 33.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 110.884 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.3 tt -128.38 144.54 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 53.439999999999998 111.164 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -128.6 109.93 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 110.892 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.65 141.07 17.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 111.126 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -115.91 -174.44 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 65.040000000000006 110.952 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -103.22 158.7 16.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.887 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.5 p -114.41 26.33 10.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.835 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.0 -19.79 13.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.888 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -98.93 -70.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 65.450000000000003 110.917 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -49.76 -38.94 36.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 110.842 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.4 t -88.89 124.89 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 63.240000000000002 111.11 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -96.55 -30.99 12.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.466 . . . . 72.439999999999998 110.887 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 44.530000000000001 110.822 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.94 48.52 10.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.715 0.293 . . . . 65.140000000000001 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mtt -108.37 141.15 40.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 74.5 110.922 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 5' ' ' ILE . . . -178.88 -179.47 48.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 74.439999999999998 112.463 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 4' ' ' GLY . 31.6 mm -121.36 129.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 72.310000000000002 111.14 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.8 ttp85 -112.58 59.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.219999999999999 110.874 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -101.65 156.9 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 45.329999999999998 110.943 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m 52.19 52.13 14.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.876 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -61.86 -52.24 64.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.848 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 t -169.76 173.74 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 60.539999999999999 110.864 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.4 m -148.15 153.74 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.118 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.1 68.34 9.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.557 0.694 . . . . 63.219999999999999 110.913 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -11.73 31.4 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.638 2.225 . . . . 71.310000000000002 112.311 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 p -54.34 174.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.25 111.133 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -57.41 -179.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -94.49 152.02 18.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 65.140000000000001 110.882 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.04 161.99 1.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 62.439999999999998 111.076 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -76.98 154.86 82.92 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.729 0.776 . . . . 74.519999999999996 110.779 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 164.23 35.35 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.346 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -96.68 156.42 16.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.81 99.6 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.152 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.62 138.77 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 75.239999999999995 111.093 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -151.89 106.69 3.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.886 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 -123.06 127.22 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.955 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -128.16 109.92 11.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 73.049999999999997 110.858 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -142.04 -69.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.116 -0.493 . . . . 73.25 110.847 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.8 33.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.684 -0.77 . . . . 63.32 112.466 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.26 -154.68 6.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 62.329999999999998 112.473 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -104.75 -34.3 8.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.753 0.311 . . . . 72.439999999999998 110.911 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -158.36 127.24 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 46' ' ' LEU . 41.5 t -112.13 132.8 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.211 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -133.31 150.57 51.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.9 tt -123.37 142.71 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 63.030000000000001 111.15 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 t -150.48 139.24 20.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.819 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.5 -165.98 12.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.81 -0.709 . . . . 51.100000000000001 112.536 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.3 p -73.01 -18.13 61.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 64.209999999999994 110.833 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.9 p90 -61.77 -17.86 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.948 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.91 12.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 73.109999999999999 110.89 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 63.39 20.83 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 110.883 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.8 m95 51.62 32.66 9.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.7 m -108.26 14.57 24.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 73.120000000000005 110.81 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.04 151.18 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 111.172 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -108.11 119.41 39.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.865 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.59 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.83 132.48 48.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.671 0.748 . . . . 62.32 111.108 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 140.07 42.04 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.299999999999997 112.36 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.598 HD22 HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -98.4 107.9 20.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.921 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -51.42 106.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 74.299999999999997 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -67.08 119.78 12.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.889 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.3 t -110.37 158.98 17.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 72.140000000000001 110.855 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -59.06 -26.23 64.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 70.450000000000003 110.83 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -87.6 -49.78 6.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 71.099999999999994 110.85 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -172.96 -172.83 0.88 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.185 -0.462 . . . . 62.310000000000002 110.886 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB3' HD23 ' A' ' 46' ' ' LEU . 64.9 m-85 -85.97 143.48 28.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.924 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -148.87 151.65 12.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.084 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -121.01 145.59 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 54.009999999999998 111.09 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.9 mm -138.28 121.66 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.128 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.037 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 136.3 15.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 74.010000000000005 110.867 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.7 p-10 -73.73 104.1 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.915 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 57' ' ' LEU . 8.5 mt -112.13 151.99 44.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.674 0.749 . . . . 70.109999999999999 110.884 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 152.96 69.86 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.643 2.228 . . . . 72.319999999999993 112.431 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -63.3 121.23 13.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 71.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.11 -140.24 6.74 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.71 -0.757 . . . . 75.140000000000001 112.454 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.89 132.67 38.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 119.313 -0.375 . . . . 71.450000000000003 110.897 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -137.97 166.24 24.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 51.009999999999998 109.568 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -123.52 125.82 45.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.948 -1.023 . . . . 75.430000000000007 110.867 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -120.94 178.19 4.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 110.927 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -151.73 143.26 23.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 75.430000000000007 110.904 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -91.09 148.6 22.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.927 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -132.68 95.29 3.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 64.400000000000006 110.881 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 31' ' ' VAL . 20.8 t -123.32 151.01 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.508 . . . . 53.119999999999997 111.18 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 60.88 34.28 19.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.238 -0.437 . . . . 64.340000000000003 110.854 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.05 82.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.806 -0.711 . . . . 72.25 112.502 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -156.13 152.33 27.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 52.310000000000002 110.941 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -81.7 115.52 20.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 73.109999999999999 110.85 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.8 170.06 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 53.149999999999999 111.079 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.476 ' CD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-80 -150.1 159.48 44.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 63.229999999999997 110.84 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -97.12 134.24 23.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 61.109999999999999 110.838 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -25.66 28.53 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.741 2.294 . . . . 70.109999999999999 112.33 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.78 -29.61 61.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.864 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -81.17 160.68 65.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.687 0.756 . . . . 74.530000000000001 110.934 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 81.57 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.765 2.31 . . . . 71.329999999999998 112.33 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 76' ' ' HIS . 29.7 m -91.92 154.22 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.134 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -155.81 148.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 63.109999999999999 111.147 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.71 110.76 15.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 73.200000000000003 111.139 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -67.46 173.39 4.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 72.230000000000004 110.841 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HG3' HD22 ' A' ' 87' ' ' LEU . 1.4 pt20 -65.35 -15.57 62.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.844 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD22 ' HG3' ' A' ' 86' ' ' GLN . 1.1 mm? -85.85 5.66 31.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.907 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.59 8.68 81.49 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.762 -0.733 . . . . 45.439999999999998 112.491 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.9 p -112.04 131.12 55.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.802 0.334 . . . . 52.509999999999998 111.119 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.8 mm -65.69 144.96 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 111.153 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.96 156.06 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.93 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -79.29 171.52 15.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 61.450000000000003 110.911 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.5 tp -132.9 133.09 42.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.911 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -129.36 140.43 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 53.439999999999998 111.124 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -124.55 106.21 9.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.230000000000004 110.864 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.0 t -96.77 145.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 71.099999999999994 111.111 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -121.14 -174.74 2.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.897 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -97.08 155.91 16.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 110.843 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 8.6 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 110.852 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.84 -11.85 16.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 72.120000000000005 110.876 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -73.86 -56.25 5.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 65.450000000000003 110.84 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.7 -33.61 76.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 64.109999999999999 110.835 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.39 122.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 111.117 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -88.74 -33.93 17.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 72.439999999999998 110.836 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 44.530000000000001 110.786 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.456 -0.257 . . . . 63.340000000000003 112.456 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.25 -52.62 63.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 65.140000000000001 111.124 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.8 ttt -68.07 136.9 54.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.906 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.47 -178.03 32.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.773 -0.727 . . . . 74.439999999999998 112.492 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.8 tp -172.53 133.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 72.310000000000002 111.175 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 61.45 51.35 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 110.851 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -60.39 166.33 3.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 45.329999999999998 110.93 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.22 -175.35 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.854 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.6 p30 -88.52 -29.35 20.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.947 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 p 46.19 54.95 7.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 60.539999999999999 110.884 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.63 HG22 ' OD1' ' A' ' 9' ' ' ASP . 12.1 m -113.11 123.13 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.07 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.09 73.52 77.86 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 63.219999999999999 110.908 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -16.47 37.23 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.609 2.206 . . . . 71.310000000000002 112.345 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -73.14 151.86 41.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 73.25 111.209 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 50.7 49.23 21.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 110.939 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -99.15 176.48 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.908 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -153.93 167.54 29.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 111.113 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -77.15 156.04 82.05 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 74.519999999999996 110.832 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 165.35 31.31 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.419 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -98.5 156.42 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.273 -0.422 . . . . 72.409999999999997 111.073 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 67.6 t -106.35 99.74 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 74.510000000000005 111.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.636 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.4 139.51 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 111.094 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -150.21 106.41 3.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.874 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -117.5 131.52 56.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 t -134.88 107.57 7.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 73.049999999999997 110.845 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -141.52 -64.58 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 73.25 110.885 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.15 36.74 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.819 -0.705 . . . . 63.32 112.494 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.85 -161.38 32.05 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 62.329999999999998 112.455 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -102.63 -27.48 12.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.771 0.319 . . . . 72.439999999999998 110.88 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.14 137.43 11.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.839 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.0 t -129.99 131.36 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.139 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.46 155.03 50.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -125.48 142.0 43.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 63.030000000000001 111.133 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -149.73 139.36 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 65.530000000000001 110.847 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.81 -164.18 11.35 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 51.100000000000001 112.465 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.3 p -72.84 -14.53 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.865 0.364 . . . . 64.209999999999994 110.884 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.405 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.1 p90 -65.48 -16.66 63.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 64.25 110.862 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.511 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -130.46 12.79 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 110.879 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 63.24 21.73 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.4 m95 51.33 38.26 21.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.949 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.1 t -112.81 14.11 19.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.54 147.9 6.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 111.111 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.09 118.05 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.892 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.553 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.57 132.31 55.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.617 0.722 . . . . 62.32 111.124 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 138.81 38.29 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.654 2.236 . . . . 74.299999999999997 112.346 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.18 108.71 21.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 72.319999999999993 110.922 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.6 mm -51.41 103.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 74.299999999999997 111.064 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -66.82 120.5 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.099999999999994 110.868 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.7 t -111.28 158.37 19.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 110.854 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -56.36 -24.96 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 70.450000000000003 110.889 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -54.74 3.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 71.099999999999994 110.871 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -166.81 -173.4 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 62.310000000000002 110.832 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.657 ' HB3' HD23 ' A' ' 46' ' ' LEU . 62.1 m-85 -85.74 142.67 28.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.519999999999996 110.944 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 22' ' ' ILE . 100.0 t -147.11 139.07 18.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.204 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -109.84 145.77 36.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 54.009999999999998 111.106 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.636 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.7 mm -138.29 121.51 19.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.04 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.39 137.63 16.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.944 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.33 104.57 4.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.799 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.04 HD21 HD12 ' A' ' 57' ' ' LEU . 8.8 mt -113.46 149.8 42.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 70.109999999999999 110.947 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 152.24 69.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.653 2.235 . . . . 72.319999999999993 112.407 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -63.16 124.61 21.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -134.8 4.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 75.140000000000001 112.515 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -138.11 138.93 39.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.324 -0.37 . . . . 71.450000000000003 110.869 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.45 166.69 24.4 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 51.009999999999998 109.6 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -123.97 125.12 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 75.430000000000007 110.919 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -120.64 177.52 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.952 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -151.79 142.65 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 75.430000000000007 110.884 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -90.71 149.53 22.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 74.510000000000005 110.877 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -134.03 95.53 3.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.400000000000006 110.898 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.558 HG22 HG22 ' A' ' 31' ' ' VAL . 17.2 t -123.46 152.28 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 53.119999999999997 111.171 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.9 37.75 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 110.863 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.44 31.55 70.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 72.25 112.575 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -157.78 162.9 38.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 52.310000000000002 110.945 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -85.52 116.68 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 m -123.94 168.63 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 53.149999999999999 111.117 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.2 p-80 -151.6 156.68 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.884 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -98.02 134.16 22.44 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.699 0.761 . . . . 61.109999999999999 110.859 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -21.1 33.65 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.675 2.25 . . . . 70.109999999999999 112.3 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -75.44 -30.18 59.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 44.530000000000001 110.813 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.84 160.68 65.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.583 0.706 . . . . 74.530000000000001 110.891 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 80.66 0.86 Allowed 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.685 2.257 . . . . 71.329999999999998 112.328 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.9 m -92.85 149.5 4.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.168 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.72 140.82 23.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 63.109999999999999 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -79.74 119.71 23.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 111.132 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 166.56 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 72.230000000000004 110.879 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -59.34 -24.06 63.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.89 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -84.02 3.1 35.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 110.919 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.23 17.23 79.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.743 -0.741 . . . . 45.439999999999998 112.497 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.8 p -105.4 121.8 44.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 52.509999999999998 111.134 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 ' CE1' ' A' ' 76' ' ' HIS . 28.8 mm -72.37 133.49 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 111.072 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -140.8 156.56 46.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 75.109999999999999 110.855 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -79.71 -179.74 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.853 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.93 133.02 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 74.140000000000001 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.3 tt -130.25 137.33 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 111.165 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -121.92 105.34 10.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.9 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.67 142.19 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.472 . . . . 71.099999999999994 111.147 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.13 156.88 45.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 65.040000000000006 110.881 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -113.17 160.14 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 p -110.24 25.41 11.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.855 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -106.06 -20.21 13.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.119 -0.492 . . . . 72.120000000000005 110.843 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -75.84 -64.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 65.450000000000003 110.894 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -51.15 -48.67 61.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 64.109999999999999 110.939 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.41 137.46 50.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 111.162 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -96.29 -25.75 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.951 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 44.530000000000001 110.903 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.489 -0.245 . . . . 63.340000000000003 112.489 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 151.95 48.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 65.140000000000001 111.1 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.5 ttm -167.93 146.91 4.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 74.5 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.64 79.05 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 74.439999999999998 112.515 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 tt -129.48 141.97 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 72.310000000000002 111.174 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -128.19 155.77 43.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 110.829 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -134.63 45.14 2.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 45.329999999999998 110.885 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t 62.76 41.63 8.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.487 . . . . 74.299999999999997 110.813 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -53.5 -57.38 10.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.866 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m 61.1 49.02 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 60.539999999999999 110.86 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 m -127.58 131.09 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 111.115 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -122.36 68.17 28.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 63.219999999999999 110.886 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -8.8 24.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.614 2.209 . . . . 71.310000000000002 112.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.2 m -51.52 146.64 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.126 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -58.76 -176.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 110.942 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.94 146.34 44.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 65.140000000000001 110.926 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -170.15 146.42 2.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 62.439999999999998 111.102 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 157.23 80.6 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.607 0.718 . . . . 74.519999999999996 110.858 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 162.53 41.7 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.715 2.276 . . . . 71.439999999999998 112.371 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.447 ' OG1' HD13 ' A' ' 94' ' ' ILE . 8.9 t -93.32 156.11 17.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.409999999999997 111.071 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.69 99.5 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 111.137 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.36 139.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 75.239999999999995 111.155 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.32 106.41 2.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.956 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.7 t-105 -121.12 127.38 51.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.963 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p -130.9 108.3 9.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 73.049999999999997 110.839 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -140.44 -65.05 0.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.858 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 37.41 0.48 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 63.32 112.443 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.54 -159.11 25.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 62.329999999999998 112.475 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.28 -30.96 9.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 72.439999999999998 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -158.04 132.1 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 74.239999999999995 110.927 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.724 ' CG1' HD22 ' A' ' 46' ' ' LEU . 43.8 t -121.26 132.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 111.105 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -134.66 151.19 50.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 75.510000000000005 110.909 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -121.75 142.86 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.48 . . . . 63.030000000000001 111.09 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.8 m -148.29 138.58 22.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.918 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -173.34 19.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.768 -0.729 . . . . 51.100000000000001 112.538 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -67.68 -17.25 64.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 64.209999999999994 110.814 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.7 p90 -62.33 -17.49 58.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.25 110.889 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.41 13.12 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.888 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 62.79 21.03 12.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.908 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.5 m95 51.56 34.34 12.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 75.109999999999999 110.988 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -107.93 13.26 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.822 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.465 HG22 ' OD1' ' A' ' 38' ' ' ASN . 7.6 t -166.21 146.76 6.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 74.230000000000004 111.155 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.66 118.41 36.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 110.94 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.475 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.26 132.61 52.57 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.587 0.708 . . . . 62.32 111.18 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 141.67 46.17 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.687 2.258 . . . . 74.299999999999997 112.344 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -100.05 106.7 18.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.319999999999993 110.972 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.41 106.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -67.33 120.24 13.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 64.099999999999994 110.891 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -111.13 160.28 17.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.916 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -57.51 -23.75 52.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 70.450000000000003 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -90.18 -49.79 6.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 71.099999999999994 110.858 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -174.89 -171.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 62.310000000000002 110.88 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.446 ' HB3' HD23 ' A' ' 46' ' ' LEU . 57.4 m-85 -85.79 146.71 26.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.887 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -150.58 160.15 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 111.112 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -129.57 146.0 51.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 54.009999999999998 111.135 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.1 mm -138.35 120.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 111.156 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.956 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.71 132.62 12.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.010000000000005 110.85 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 5.1 m-20 -71.96 107.24 4.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.909 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.956 HD21 HD12 ' A' ' 57' ' ' LEU . 15.3 mt -112.49 152.33 44.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.621 0.724 . . . . 70.109999999999999 110.94 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 153.4 69.02 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 72.319999999999993 112.337 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.39 118.32 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.62 -144.36 9.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 75.140000000000001 112.403 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -132.37 126.85 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 119.319 -0.372 . . . . 71.450000000000003 110.921 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 166.62 21.58 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 51.009999999999998 109.653 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -124.71 126.4 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.012 -0.995 . . . . 75.430000000000007 110.986 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.77 178.3 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.954 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -152.0 145.2 24.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 75.430000000000007 110.943 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.25 146.88 23.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.318 -0.401 . . . . 74.510000000000005 110.846 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -129.63 95.34 3.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 64.400000000000006 110.897 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 31' ' ' VAL . 21.1 t -122.43 150.35 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 53.119999999999997 111.128 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.5 t0 60.57 35.27 20.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.845 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.89 26.76 69.25 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.714 -0.755 . . . . 72.25 112.486 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -150.09 154.17 37.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 52.310000000000002 110.981 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.01 112.39 19.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.946 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.86 172.21 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 53.149999999999999 111.092 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -150.02 155.4 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 110.858 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -97.87 133.24 23.54 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 61.109999999999999 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.373 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.3 t -74.88 -30.96 61.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 44.530000000000001 110.8 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.78 160.35 64.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.599 0.714 . . . . 74.530000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 83.99 0.68 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.673 2.248 . . . . 71.329999999999998 112.356 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.4 162.73 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 111.068 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.2 140.28 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 63.109999999999999 111.136 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.1 m -79.98 115.39 19.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 73.200000000000003 111.159 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.07 166.48 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 72.230000000000004 110.831 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.498 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -59.23 -22.69 61.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 72.439999999999998 110.93 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -85.26 4.54 34.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.897 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.2 19.54 79.79 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.825 -0.702 . . . . 45.439999999999998 112.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -110.08 117.2 33.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.686 0.279 . . . . 52.509999999999998 111.138 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 84' ' ' THR . 29.9 mm -66.82 136.9 25.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 111.122 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -144.82 159.29 43.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 75.109999999999999 110.892 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -79.65 173.95 12.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 61.450000000000003 110.883 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 95' ' ' HIS . 0.5 OUTLIER -141.36 125.23 17.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 110.904 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.2 tt -122.7 144.41 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 53.439999999999998 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.679 ' CE1' HD22 ' A' ' 93' ' ' LEU . 15.6 m80 -131.65 113.81 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.909 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 74.5 t -99.88 142.45 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -115.35 179.63 3.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 65.040000000000006 110.884 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -113.81 159.94 19.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.836 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -117.73 35.46 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.814 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.93 11.95 31.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.168 -0.469 . . . . 72.120000000000005 110.922 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -115.21 -33.22 5.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 65.450000000000003 110.914 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -48.76 -35.47 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.159 -0.473 . . . . 64.109999999999999 110.901 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -81.9 124.07 38.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 63.240000000000002 111.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -86.55 -31.68 21.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 72.439999999999998 110.944 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 44.530000000000001 110.875 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.436 -0.266 . . . . 63.340000000000003 112.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.39 -70.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.353 . . . . 65.140000000000001 111.142 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.2 mtp -52.48 138.52 27.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.5 110.879 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.63 30.47 0.68 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.723 -0.751 . . . . 74.439999999999998 112.465 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -166.92 138.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 72.310000000000002 111.114 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -151.63 129.88 11.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 73.219999999999999 110.887 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -106.12 120.29 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 45.329999999999998 110.861 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -79.42 171.02 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 74.299999999999997 110.891 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.89 -36.06 8.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 110.913 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 61.35 51.68 4.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 60.539999999999999 110.846 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.51 136.04 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 73.329999999999998 111.13 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -140.43 69.26 32.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.62 0.724 . . . . 63.219999999999999 110.882 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -8.53 23.83 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.698 2.265 . . . . 71.310000000000002 112.299 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 p -51.52 167.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 73.25 111.117 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -54.33 169.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 73.420000000000002 110.913 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -99.94 154.67 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 65.140000000000001 110.906 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.45 145.69 0.34 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 62.439999999999998 111.022 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NE ' HG13 ' A' ' 96' ' ' VAL . 13.5 ptt85 -77.26 157.81 80.3 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.52 0.676 . . . . 74.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 18' ' ' ARG . 53.9 Cg_endo -69.67 163.59 37.61 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.69 2.26 . . . . 71.439999999999998 112.345 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.7 t -101.88 152.01 21.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.14 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -101.02 99.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 74.510000000000005 111.072 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -130.6 138.61 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 75.239999999999995 111.109 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -150.92 133.75 15.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -138.42 134.55 34.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 t -135.07 109.65 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.049999999999997 110.874 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -144.74 -62.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.896 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.54 32.21 0.78 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 63.32 112.54 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.12 -162.57 19.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.763 -0.732 . . . . 62.329999999999998 112.496 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -105.18 -30.08 9.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 72.439999999999998 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.04 133.93 11.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 74.239999999999995 110.872 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG11 HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.88 140.07 46.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 111.087 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -141.58 148.93 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 75.510000000000005 110.917 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 22' ' ' ILE . 6.8 tt -122.76 142.59 38.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.14 -0.482 . . . . 63.030000000000001 111.126 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.3 t -150.24 139.24 21.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 65.530000000000001 110.905 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.94 -164.74 11.73 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.757 . . . . 51.100000000000001 112.512 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.2 p -73.1 -18.0 61.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 64.209999999999994 110.861 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.5 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.2 p90 -61.7 -18.05 58.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 64.25 110.88 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.51 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -128.37 12.87 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.877 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 63.38 21.45 12.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.52 34.37 12.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -110.28 13.73 22.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.832 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.3 t -166.25 148.36 6.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.121 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.68 121.18 43.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.849 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.13 132.41 50.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.659 0.742 . . . . 62.32 111.148 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.52 35.72 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.725 2.283 . . . . 74.299999999999997 112.337 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -97.93 112.02 24.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.949 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -50.81 116.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -77.74 115.96 17.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 64.099999999999994 110.929 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -110.65 156.09 21.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 72.140000000000001 110.827 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -57.74 -22.97 49.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 70.450000000000003 110.893 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.51 -50.39 6.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -174.5 -170.78 0.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 62.310000000000002 110.909 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 46' ' ' LEU . 71.1 m-85 -85.5 142.78 28.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 110.924 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 22' ' ' ILE . 11.8 t -143.53 140.0 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 111.149 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -116.3 138.81 51.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 54.009999999999998 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.637 ' C ' HD23 ' A' ' 57' ' ' LEU . 45.9 mm -138.83 125.04 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.111 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.028 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.76 136.52 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.939 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.2 p-10 -73.06 105.34 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 63.43 110.85 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 57' ' ' LEU . 12.6 mt -112.42 152.7 44.77 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.616 0.722 . . . . 70.109999999999999 110.997 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 147.07 62.48 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.731 2.287 . . . . 72.319999999999993 112.385 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.4 108.58 0.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.974 0.416 . . . . 71.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.37 -139.91 5.34 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.679 -0.772 . . . . 75.140000000000001 112.466 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.7 133.95 38.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 119.396 -0.335 . . . . 71.450000000000003 110.854 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.63 166.8 23.84 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 51.009999999999998 109.603 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -121.99 127.84 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.95 -1.023 . . . . 75.430000000000007 110.961 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -121.02 174.75 6.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.876 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -149.81 144.34 25.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 110.877 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.98 150.76 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.88 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -135.75 95.12 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 110.904 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG22 ' A' ' 31' ' ' VAL . 21.4 t -124.05 150.37 28.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 53.119999999999997 111.133 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 61.42 36.97 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.818 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.58 33.63 82.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 72.25 112.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -157.79 152.88 25.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 52.310000000000002 110.874 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.48 115.71 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 73.109999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.08 173.4 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.208 -0.451 . . . . 53.149999999999999 111.124 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.3 p-80 -155.58 157.65 37.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.875 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.86 133.37 23.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.51 0.671 . . . . 61.109999999999999 110.895 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -22.07 32.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.694 2.263 . . . . 70.109999999999999 112.396 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.68 -29.94 61.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 44.530000000000001 110.911 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -81.67 160.64 63.73 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.64 0.733 . . . . 74.530000000000001 110.884 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.95 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.731 2.288 . . . . 71.329999999999998 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.74 159.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.082 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.73 143.45 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 63.109999999999999 111.09 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 90' ' ' ILE . 3.5 m -79.91 110.32 15.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 73.200000000000003 111.162 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -60.79 173.33 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.907 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.43 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -65.76 -22.51 66.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.881 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.16 9.91 23.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 74.530000000000001 110.965 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.34 13.13 81.75 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.718 -0.753 . . . . 45.439999999999998 112.457 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.0 p -102.34 118.73 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.731 0.301 . . . . 52.509999999999998 111.142 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 84' ' ' THR . 27.9 mm -66.45 141.88 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 111.162 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -149.36 156.8 42.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 75.109999999999999 110.885 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -79.41 173.55 12.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 61.450000000000003 110.875 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.39 131.61 38.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 74.140000000000001 110.901 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -132.64 145.51 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 53.439999999999998 111.12 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -134.37 100.38 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 74.230000000000004 110.842 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.431 HG13 ' NE ' ' A' ' 18' ' ' ARG . 95.6 t -85.01 138.89 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 71.099999999999994 111.084 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.52 -176.24 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 110.948 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -91.97 158.57 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.299 -0.41 . . . . 74.239999999999995 110.913 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -117.12 30.28 7.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.859 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.18 -21.22 13.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.821 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -73.51 -61.84 1.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 65.450000000000003 110.926 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -51.78 -43.23 62.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 64.109999999999999 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.78 144.06 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 63.240000000000002 111.169 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -93.4 -30.21 15.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 110.877 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 44.530000000000001 110.911 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.491 -0.244 . . . . 63.340000000000003 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.45 165.02 37.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 65.140000000000001 111.067 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.8 ptm -148.25 131.58 16.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.5 110.88 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.58 148.85 20.06 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.762 -0.733 . . . . 74.439999999999998 112.517 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt -75.85 89.96 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 72.310000000000002 111.203 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -121.03 82.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.219999999999999 110.871 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -124.91 168.31 13.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 45.329999999999998 110.964 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 p -129.91 176.23 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 74.299999999999997 110.909 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.599 ' HB2' HG22 ' A' ' 11' ' ' VAL . 3.4 p-10 -67.94 -45.01 75.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.875 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t 51.91 47.03 25.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 60.539999999999999 110.87 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 9' ' ' ASP . 23.0 m -133.98 128.03 52.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 111.071 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -127.77 74.3 78.46 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.582 0.705 . . . . 63.219999999999999 110.9 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -14.94 36.87 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.654 2.236 . . . . 71.310000000000002 112.393 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.4 p -71.27 90.43 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 73.25 111.119 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -128.94 179.97 5.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 73.420000000000002 110.906 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.28 130.54 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.949 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -170.85 149.61 3.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.1 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.17 155.32 82.32 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.649 0.737 . . . . 74.519999999999996 110.855 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 167.26 24.94 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.663 2.242 . . . . 71.439999999999998 112.388 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' HD13 ' A' ' 94' ' ' ILE . 7.5 t -103.11 154.63 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 111.147 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.24 99.72 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 74.510000000000005 111.12 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.638 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.46 139.67 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 111.115 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -151.97 132.77 14.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -141.09 130.29 23.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 74.109999999999999 110.949 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.4 p -135.22 100.66 4.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.862 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -136.4 -62.14 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 73.25 110.884 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.62 34.77 0.59 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.796 -0.716 . . . . 63.32 112.517 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.84 -163.01 29.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.683 -0.77 . . . . 62.329999999999998 112.551 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -104.61 -29.18 10.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.725 0.297 . . . . 72.439999999999998 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.25 136.06 12.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.852 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.633 ' CG1' HD22 ' A' ' 46' ' ' LEU . 39.8 t -125.81 131.95 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.106 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -134.48 149.25 50.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 110.887 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.638 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -120.74 142.51 36.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 63.030000000000001 111.066 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -149.31 138.97 21.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 110.869 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.77 -165.75 12.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.79 -0.719 . . . . 51.100000000000001 112.502 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -72.71 -18.83 61.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 64.209999999999994 110.85 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.8 p90 -61.19 -18.49 58.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.25 110.888 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.87 12.22 6.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.796 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.64 21.5 12.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 110.878 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.0 m95 51.67 30.3 6.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.949 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 t -105.73 14.34 28.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 110.881 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.11 152.74 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.176 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -109.53 119.35 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.937 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.613 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -83.33 132.44 49.99 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.614 0.721 . . . . 62.32 111.184 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 138.61 38.19 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 74.299999999999997 112.337 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.633 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -95.7 110.34 22.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.956 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.5 mm -51.4 103.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.105 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -66.21 120.11 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 64.099999999999994 110.867 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.7 t -111.37 155.37 23.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.85 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -22.75 49.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.872 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -90.84 -48.61 6.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 71.099999999999994 110.893 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -173.34 -174.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 62.310000000000002 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HB3' HD23 ' A' ' 46' ' ' LEU . 87.3 m-85 -85.83 149.48 25.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 74.519999999999996 110.896 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.4 m -153.07 158.54 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.03 140.72 51.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 54.009999999999998 111.069 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.647 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.3 mm -138.3 121.73 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.154 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.104 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.34 137.44 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 110.891 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 27.1 m-20 -74.14 100.65 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 63.43 110.854 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.104 HD21 HD12 ' A' ' 57' ' ' LEU . 9.7 mt -108.46 152.54 42.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 70.109999999999999 110.918 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 144.5 54.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.73 2.287 . . . . 72.319999999999993 112.345 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -57.87 113.48 1.88 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 71.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.02 -134.93 3.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.709 -0.758 . . . . 75.140000000000001 112.476 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -140.19 136.35 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 119.305 -0.379 . . . . 71.450000000000003 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 164.23 32.41 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.528 1.143 . . . . 51.009999999999998 109.557 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.66 127.65 53.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.026 -0.988 . . . . 75.430000000000007 110.941 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -122.7 172.38 8.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.267 -0.424 . . . . 74.340000000000003 110.927 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -147.43 144.63 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 75.430000000000007 110.894 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.93 147.33 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.510000000000005 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -131.03 95.39 3.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.055 -0.521 . . . . 64.400000000000006 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG22 HG22 ' A' ' 31' ' ' VAL . 21.3 t -124.32 150.33 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 53.119999999999997 111.092 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 61.36 34.51 18.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.846 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 24.01 67.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.25 112.488 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.84 152.79 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 52.310000000000002 110.931 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.63 113.69 20.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.937 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.66 174.92 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.5 p-80 -153.84 159.63 41.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 63.229999999999997 110.865 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.83 133.93 22.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.863 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 -25.95 27.72 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.648 2.232 . . . . 70.109999999999999 112.367 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.89 -28.02 60.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 44.530000000000001 110.871 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.4 160.29 65.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 74.530000000000001 110.831 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 84.28 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.252 . . . . 71.329999999999998 112.423 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 m -97.33 155.94 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.073 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -149.65 141.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 63.109999999999999 111.128 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.472 HG23 HD13 ' A' ' 90' ' ' ILE . 1.3 m -79.98 110.61 15.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 111.137 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -64.81 166.82 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 72.230000000000004 110.854 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.91 -16.81 60.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 72.439999999999998 110.929 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD22 ' H ' ' A' ' 87' ' ' LEU . 1.2 mm? -86.28 0.81 53.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.946 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 16.87 75.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 45.439999999999998 112.547 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.7 p -112.89 128.96 56.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.793 0.33 . . . . 52.509999999999998 111.157 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.472 HD13 HG23 ' A' ' 84' ' ' THR . 27.6 mm -75.04 136.14 25.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 111.147 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -143.06 157.58 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.956 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.22 167.14 20.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 61.450000000000003 110.853 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 123.46 21.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.140000000000001 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.462 HD13 ' OG1' ' A' ' 20' ' ' THR . 2.0 tt -120.13 145.42 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 53.439999999999998 111.192 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -131.65 102.35 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.230000000000004 110.864 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.53 141.74 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.099999999999994 111.141 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -115.79 -174.82 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.040000000000006 110.898 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -110.55 158.81 18.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.941 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.7 m -111.96 35.11 3.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.807 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -105.74 -24.32 12.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 72.120000000000005 110.848 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -73.87 -32.78 63.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 65.450000000000003 110.897 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -48.94 -35.39 14.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.41 142.49 20.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 63.240000000000002 111.183 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -95.6 -31.51 13.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.932 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 44.530000000000001 110.853 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.512 -0.235 . . . . 63.340000000000003 112.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.44 176.54 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.327 . . . . 65.140000000000001 111.083 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.26 164.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 74.5 110.899 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.19 -36.88 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 74.439999999999998 112.501 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.14 -31.78 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 72.310000000000002 111.143 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -106.98 85.1 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 73.219999999999999 110.929 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -89.26 -29.77 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 45.329999999999998 110.841 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 t -106.47 121.44 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 110.827 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.2 -26.24 52.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 74.450000000000003 110.856 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 p -95.38 86.9 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.443 . . . . 60.539999999999999 110.843 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.74 71.73 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.133 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -157.74 73.61 4.17 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.556 0.693 . . . . 63.219999999999999 110.939 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -43.36 2.65 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.713 2.275 . . . . 71.310000000000002 112.354 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.67 134.04 48.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.133 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -164.13 113.52 1.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 73.420000000000002 110.946 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -122.81 128.77 50.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 65.140000000000001 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -175.0 154.51 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 62.439999999999998 111.079 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 157.74 81.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 110.885 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 163.94 36.39 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.643 2.228 . . . . 71.439999999999998 112.355 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.0 t -98.94 156.45 16.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 111.109 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.3 t -105.58 99.52 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 74.510000000000005 111.141 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.35 138.62 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.136 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' HG12 ' A' ' 54' ' ' VAL . 80.6 mtt180 -151.89 119.22 5.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.885 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 70' ' ' VAL . 47.7 t-105 -125.89 135.1 51.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.908 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -135.39 108.68 7.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 73.049999999999997 110.801 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -144.02 -64.51 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 73.25 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.24 32.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 63.32 112.44 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.71 -161.25 19.23 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.8 -0.715 . . . . 62.329999999999998 112.441 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -104.1 -33.04 8.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 72.439999999999998 110.914 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -153.46 134.22 13.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.239999999999995 110.867 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.721 HG11 HD22 ' A' ' 46' ' ' LEU . 40.3 t -121.32 139.27 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 111.171 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -139.94 152.06 46.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 75.510000000000005 110.92 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 22' ' ' ILE . 7.1 tt -124.92 143.07 39.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 63.030000000000001 111.116 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 t -151.16 138.87 19.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 65.530000000000001 110.906 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.1 -165.46 12.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 51.100000000000001 112.504 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.5 t -72.88 -19.42 61.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.862 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CB ' HD22 ' A' ' 59' ' ' LEU . 42.0 p90 -60.18 -19.92 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 64.25 110.831 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.8 p30 -125.84 13.11 7.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 110.87 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 63.29 21.29 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.109999999999999 110.869 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.6 m95 51.32 32.79 8.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 110.911 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -109.03 14.46 24.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 73.120000000000005 110.898 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.34 149.21 7.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.230000000000004 111.13 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -106.0 118.54 36.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 72.239999999999995 110.833 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.5 132.46 52.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.623 0.725 . . . . 62.32 111.088 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 137.94 36.38 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.692 2.261 . . . . 74.299999999999997 112.247 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.721 HD22 HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -93.62 106.19 18.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.85 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 54' ' ' VAL . 50.0 mm -50.76 103.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.188 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -65.44 124.43 22.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 64.099999999999994 110.913 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.3 160.98 16.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 72.140000000000001 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -60.67 -19.79 59.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.450000000000003 110.85 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -94.9 -57.42 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 71.099999999999994 110.85 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.44 -171.44 2.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 62.310000000000002 110.88 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -85.45 147.33 26.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.962 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 23' ' ' ARG . 29.3 m -150.22 166.09 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.257 -0.429 . . . . 73.140000000000001 111.122 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -137.19 143.07 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 54.009999999999998 111.166 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.648 ' C ' HD23 ' A' ' 57' ' ' LEU . 47.4 mm -138.65 123.42 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.995 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.72 137.33 15.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 74.010000000000005 110.939 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.93 106.34 4.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 63.43 110.842 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.995 HD21 HD12 ' A' ' 57' ' ' LEU . 11.0 mt -115.13 152.26 46.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 70.109999999999999 110.877 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 150.23 68.31 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.702 2.268 . . . . 72.319999999999993 112.318 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.21 113.07 2.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.12 -138.71 5.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.799 -0.715 . . . . 75.140000000000001 112.505 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.41 137.61 42.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.417 -0.325 . . . . 71.450000000000003 110.972 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.94 166.07 27.1 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 51.009999999999998 109.588 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 132.9 54.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.978 -1.01 . . . . 75.430000000000007 110.877 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -127.6 -175.18 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.909 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -156.87 142.73 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 75.430000000000007 110.912 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.72 150.26 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.843 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.13 95.27 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 64.400000000000006 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 24' ' ' TRP . 21.4 t -122.79 150.46 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 53.119999999999997 111.123 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 60.59 35.92 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 64.340000000000003 110.869 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.5 33.5 85.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.726 -0.75 . . . . 72.25 112.505 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -157.28 153.45 27.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 52.310000000000002 110.893 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.6 115.41 21.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.974 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.91 169.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.149999999999999 111.111 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.502 ' CD2' HG11 ' A' ' 82' ' ' VAL . 8.6 p-80 -149.26 158.68 44.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 63.229999999999997 110.848 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -95.95 134.31 24.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.594 0.711 . . . . 61.109999999999999 110.88 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -26.35 27.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 m -74.45 -30.08 61.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 44.530000000000001 110.873 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -80.98 161.16 64.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.605 0.717 . . . . 74.530000000000001 110.919 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 83.29 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.698 2.265 . . . . 71.329999999999998 112.367 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 76' ' ' HIS . 28.6 m -91.61 155.25 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.116 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -155.82 146.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 63.109999999999999 111.197 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.3 m -79.92 112.2 16.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.200000000000003 111.202 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 m -69.34 171.59 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 72.230000000000004 110.872 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -63.77 -16.44 61.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 110.94 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 87' ' ' LEU . 1.8 mm? -84.0 2.97 36.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.908 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.57 86.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.696 . . . . 45.439999999999998 112.474 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.2 p -111.7 140.4 46.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.742 0.306 . . . . 52.509999999999998 111.191 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 mm -78.04 134.42 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.219999999999999 111.06 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.85 157.51 46.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.908 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -79.73 176.93 9.27 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 61.450000000000003 110.8 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.447 HD21 ' NE2' ' A' ' 95' ' ' HIS . 50.0 tp -137.92 144.07 41.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 74.140000000000001 110.91 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 93' ' ' LEU . 2.2 tt -140.3 144.93 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 53.439999999999998 111.176 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.447 ' NE2' HD21 ' A' ' 93' ' ' LEU . 32.6 m80 -129.55 109.64 11.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.866 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.6 t -98.38 141.28 16.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.099999999999994 111.152 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -125.0 -174.31 3.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 65.040000000000006 110.911 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -113.16 161.54 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.899 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.2 t -129.25 34.02 4.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.78 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.41 -24.0 12.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 72.120000000000005 110.917 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -106.15 -38.57 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 65.450000000000003 110.896 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.8 -23.08 50.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 64.109999999999999 110.925 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.633 HG22 ' H ' ' A' ' 105' ' ' ASP . 12.9 p -100.38 144.57 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 63.240000000000002 111.14 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -81.38 -29.24 34.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 110.911 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.633 ' H ' HG22 ' A' ' 103' ' ' VAL . 28.7 t70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 44.530000000000001 110.872 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.469 -0.252 . . . . 63.340000000000003 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.14 45.47 17.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.75 0.31 . . . . 65.140000000000001 111.083 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 tpt -105.35 63.96 0.7 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.907 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.06 -28.51 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 74.439999999999998 112.433 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.7 170.54 17.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.863 0.363 . . . . 72.310000000000002 111.098 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -109.73 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 73.219999999999999 110.875 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -111.17 173.99 6.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 45.329999999999998 110.889 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -65.91 105.89 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.299999999999997 110.798 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.38 -31.84 10.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 74.450000000000003 110.864 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.24 94.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 60.539999999999999 110.901 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 11' ' ' VAL . 4.0 p -75.48 113.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.329999999999998 111.063 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -148.77 68.2 9.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.58 0.705 . . . . 63.219999999999999 110.873 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -13.05 34.1 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.727 2.284 . . . . 71.310000000000002 112.306 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.2 p -51.65 111.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.117 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.96 179.23 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.420000000000002 110.855 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -93.12 140.65 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 65.140000000000001 110.909 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.745 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -162.22 148.85 13.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 62.439999999999998 111.121 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -77.3 158.02 79.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 74.519999999999996 110.869 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.63 164.65 33.62 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 71.439999999999998 112.37 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.2 t -95.65 156.3 16.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.162 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.6 t -105.61 99.57 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 74.510000000000005 111.115 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -130.49 138.95 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.239999999999995 111.111 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.22 106.54 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.834 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.9 t-105 -120.14 127.33 52.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.981 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.0 p -131.69 99.82 4.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.049999999999997 110.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -131.14 -63.27 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 73.25 110.943 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.76 33.99 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.733 . . . . 63.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.57 -161.19 27.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 62.329999999999998 112.504 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -101.26 -39.45 7.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.771 0.32 . . . . 72.439999999999998 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.19 130.65 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.915 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.72 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.6 t -116.08 134.96 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.230000000000004 111.153 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -136.65 147.84 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.852 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.628 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -120.44 142.97 33.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 63.030000000000001 111.112 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -149.16 138.96 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 65.530000000000001 110.835 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -150.19 -167.67 14.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 51.100000000000001 112.491 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -72.17 -18.14 61.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 64.209999999999994 110.85 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' CB ' HD22 ' A' ' 59' ' ' LEU . 39.0 p90 -61.41 -18.76 60.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 64.25 110.904 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.519 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -127.05 13.3 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 62.98 21.11 12.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 75.109999999999999 110.876 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.4 m95 51.44 33.91 11.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.934 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 t -110.19 15.01 22.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.819 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.519 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.24 150.18 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 111.111 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -106.42 119.17 38.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.953 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.571 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -84.07 132.27 48.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 62.32 111.171 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 143.41 50.67 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.262 . . . . 74.299999999999997 112.273 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -102.5 107.83 18.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 110.909 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mm -51.22 106.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 111.101 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -66.36 119.89 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 64.099999999999994 110.922 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 t -111.1 155.89 22.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.844 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -56.21 -26.04 49.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 70.450000000000003 110.816 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -88.37 -50.57 6.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 71.099999999999994 110.837 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.4 p30 -171.97 -173.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 62.310000000000002 110.812 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB3' HD23 ' A' ' 46' ' ' LEU . 63.4 m-85 -85.64 146.91 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.874 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -150.17 156.64 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 111.136 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -123.45 146.73 47.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 54.009999999999998 111.154 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.612 ' C ' HD23 ' A' ' 57' ' ' LEU . 34.1 mm -138.19 118.51 15.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.255 -0.43 . . . . 74.439999999999998 111.189 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.986 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.12 133.48 13.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.010000000000005 111.006 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.0 p-10 -71.65 106.14 3.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.986 HD21 HD12 ' A' ' 57' ' ' LEU . 21.5 mt -112.92 152.44 44.89 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.546 0.689 . . . . 70.109999999999999 110.954 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 149.01 66.02 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.72 2.28 . . . . 72.319999999999993 112.271 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.53 107.76 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 71.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.38 -136.94 3.87 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 75.140000000000001 112.479 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -136.78 137.45 39.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 119.417 -0.325 . . . . 71.450000000000003 110.833 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.406 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -146.53 163.09 36.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 51.009999999999998 109.577 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -119.62 128.26 53.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.962 -1.017 . . . . 75.430000000000007 110.904 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -121.58 -175.3 3.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.340000000000003 110.902 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -157.23 143.15 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.901 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -91.18 146.94 23.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 110.863 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -129.63 95.47 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 64.400000000000006 110.877 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 31' ' ' VAL . 22.0 t -124.98 149.75 29.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.08 -0.509 . . . . 53.119999999999997 111.14 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 t0 63.37 35.12 12.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.340000000000003 110.864 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.64 32.68 82.35 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.823 -0.703 . . . . 72.25 112.469 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -157.37 159.16 37.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.316 . . . . 52.310000000000002 110.908 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -85.92 112.99 21.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.936 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.2 m -118.91 172.07 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 53.149999999999999 111.198 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.7 p-80 -154.39 159.89 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.835 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -96.51 133.46 24.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.604 0.716 . . . . 61.109999999999999 110.877 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -28.44 25.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.363 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.86 -25.38 56.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 44.530000000000001 110.843 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -81.42 160.5 64.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.911 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 85.89 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.702 2.268 . . . . 71.329999999999998 112.315 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.75 160.18 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 75.019999999999996 111.156 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.1 p -155.45 140.6 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 63.109999999999999 111.132 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.515 HG23 HD13 ' A' ' 90' ' ' ILE . 1.3 m -80.69 108.92 14.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.096 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 p -60.19 163.91 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 72.230000000000004 110.83 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.52 -18.5 59.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.903 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 87' ' ' LEU . 1.3 mm? -84.02 0.93 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.948 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.2 15.41 76.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.751 -0.738 . . . . 45.439999999999998 112.484 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.0 p -111.64 129.85 55.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 52.509999999999998 111.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 84' ' ' THR . 27.2 mm -74.71 146.09 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.82 158.94 41.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.937 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -79.7 177.99 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.450000000000003 110.897 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.0 tp -140.73 134.27 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.882 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -130.83 142.07 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.439999999999998 111.127 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -126.46 103.68 7.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.901 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -91.27 136.24 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 71.099999999999994 111.146 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.08 -179.07 4.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 65.040000000000006 110.842 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -105.37 160.87 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.892 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.7 p -117.31 25.09 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.85 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -105.47 -20.3 13.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.892 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -74.45 -63.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 65.450000000000003 110.909 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -53.04 -29.01 27.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 64.109999999999999 110.977 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.69 141.29 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.240000000000002 111.133 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -83.59 -45.47 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.919 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.89 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.01 145.03 51.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.339 . . . . 65.140000000000001 111.14 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mmt 55.61 49.8 15.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 74.5 110.975 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.36 121.09 24.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.639 -0.791 . . . . 74.439999999999998 112.539 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 pt -119.67 44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 72.310000000000002 111.126 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.75 71.99 8.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 110.883 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -147.49 -175.97 5.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 45.329999999999998 110.863 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 t -87.91 69.85 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 74.299999999999997 110.855 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -69.62 -42.52 74.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 74.450000000000003 110.811 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.8 m -69.21 133.37 47.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 60.539999999999999 110.871 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.81 HG22 ' HD3' ' A' ' 13' ' ' PRO . 9.9 p -174.25 136.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 73.329999999999998 111.068 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -148.92 74.55 10.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.634 0.731 . . . . 63.219999999999999 110.94 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.81 ' HD3' HG22 ' A' ' 11' ' ' VAL . 53.5 Cg_endo -69.77 -39.2 6.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.76 2.307 . . . . 71.310000000000002 112.335 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.55 171.59 13.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.25 111.094 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -105.03 180.0 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 110.917 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.43 157.01 37.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 65.140000000000001 110.866 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.81 148.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.129 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -77.17 159.58 77.74 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.635 0.731 . . . . 74.519999999999996 110.912 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 164.95 32.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.637 2.225 . . . . 71.439999999999998 112.384 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -97.02 155.79 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.409999999999997 111.109 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.1 99.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.510000000000005 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.596 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.31 138.92 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.13 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.03 106.68 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.849 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 51.0 t-105 -113.31 132.28 55.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -130.94 108.46 9.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 73.049999999999997 110.862 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -147.12 -68.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 73.25 110.854 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.19 41.16 0.38 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 63.32 112.421 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.9 -163.12 38.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.752 . . . . 62.329999999999998 112.522 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -98.78 -37.19 9.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.697 0.284 . . . . 72.439999999999998 110.852 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -151.04 133.4 15.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.689 ' CG1' HD22 ' A' ' 46' ' ' LEU . 44.2 t -120.35 138.24 51.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 111.134 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.61 151.03 46.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 75.510000000000005 110.822 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.596 HD12 HG12 ' A' ' 22' ' ' ILE . 7.0 tt -123.85 142.73 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 63.030000000000001 111.184 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -150.62 139.22 20.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.530000000000001 110.861 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.97 -164.7 11.96 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.758 -0.734 . . . . 51.100000000000001 112.48 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.4 p -73.29 -17.48 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 64.209999999999994 110.83 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.512 ' CB ' HD22 ' A' ' 59' ' ' LEU . 36.8 p90 -62.12 -17.67 58.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 64.25 110.873 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.504 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -128.72 12.81 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.89 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 63.37 21.3 12.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.942 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.1 m95 51.67 34.59 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.932 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -110.7 13.81 22.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.437 . . . . 73.120000000000005 110.858 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.504 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.8 t -166.31 146.1 6.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 74.230000000000004 111.219 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -103.75 120.02 40.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 72.239999999999995 110.851 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.511 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.95 132.5 50.81 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.678 0.751 . . . . 62.32 111.14 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 138.08 36.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.269 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -96.42 110.64 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.945 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mm -51.29 108.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.299999999999997 111.156 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -69.47 116.95 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 64.099999999999994 110.927 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.49 166.27 10.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 72.140000000000001 110.874 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -67.54 -20.85 65.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 70.450000000000003 110.793 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -97.29 -57.48 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 71.099999999999994 110.825 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -158.71 -176.15 5.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 62.310000000000002 110.931 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB3' HD23 ' A' ' 46' ' ' LEU . 40.8 m-85 -85.56 147.61 26.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 74.519999999999996 110.868 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 22' ' ' ILE . 97.3 t -149.85 142.64 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 111.166 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -113.71 145.88 40.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 54.009999999999998 111.102 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' C ' HD23 ' A' ' 57' ' ' LEU . 39.4 mm -138.46 120.96 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.171 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.54 134.87 14.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.010000000000005 110.847 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 14.5 m-20 -72.59 105.79 4.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 63.43 110.917 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 15.7 mt -113.7 152.59 45.64 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.683 0.754 . . . . 70.109999999999999 110.869 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.6 63.36 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.631 2.221 . . . . 72.319999999999993 112.382 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.13 110.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 71.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.69 -137.63 4.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.677 -0.773 . . . . 75.140000000000001 112.482 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -136.04 138.23 41.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.349 -0.357 . . . . 71.450000000000003 110.934 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.417 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -145.27 166.73 24.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.009999999999998 109.632 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.29 125.76 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.993 -1.003 . . . . 75.430000000000007 110.919 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -121.62 179.0 4.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -152.66 143.53 22.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.917 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.88 148.84 22.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 74.510000000000005 110.872 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -133.13 95.33 3.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 64.400000000000006 110.878 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 31' ' ' VAL . 21.6 t -124.19 150.15 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 53.119999999999997 111.083 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t70 62.18 34.6 16.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.5 32.0 81.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.733 -0.746 . . . . 72.25 112.49 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -157.0 151.51 25.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 52.310000000000002 110.954 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -80.26 115.82 20.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 73.109999999999999 110.946 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.0 m -121.5 171.34 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 53.149999999999999 111.094 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.7 p-80 -152.66 159.06 43.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 63.229999999999997 110.778 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -98.01 134.19 22.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.605 0.717 . . . . 61.109999999999999 110.865 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.88 -23.96 29.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.309 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -29.67 61.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 44.530000000000001 110.822 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.2 160.66 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.825 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 81.86 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.688 2.258 . . . . 71.329999999999998 112.333 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.9 158.83 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 111.202 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.72 143.86 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 63.109999999999999 111.139 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.5 m -80.12 109.25 14.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 73.200000000000003 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.2 p -59.82 179.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.878 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.441 ' HG2' HD22 ' A' ' 87' ' ' LEU . 1.4 pm0 -77.59 -4.23 44.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.973 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.441 HD22 ' HG2' ' A' ' 86' ' ' GLN . 1.2 mm? -103.08 9.28 38.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.530000000000001 110.91 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.99 15.99 80.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.779 -0.724 . . . . 45.439999999999998 112.5 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.4 p -112.23 122.94 49.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 52.509999999999998 111.054 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 84' ' ' THR . 31.2 mm -69.74 137.99 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 75.219999999999999 111.137 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -141.83 158.66 43.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 75.109999999999999 110.886 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.86 178.68 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.450000000000003 110.874 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.4 tp -139.85 126.13 20.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.937 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.8 tt -124.06 143.36 37.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 53.439999999999998 111.081 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -133.62 102.0 5.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.876 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.98 142.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 71.099999999999994 111.176 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.15 175.88 8.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 65.040000000000006 110.929 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -108.3 161.59 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 t -127.49 6.79 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.471 . . . . 72.340000000000003 110.9 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.24 -7.64 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.504 . . . . 72.120000000000005 110.858 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -73.74 -31.29 63.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 65.450000000000003 110.823 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -56.28 -25.2 47.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.88 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.84 123.13 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 63.240000000000002 111.184 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -90.57 -28.61 18.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 72.439999999999998 110.924 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 44.530000000000001 110.847 179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 63.340000000000003 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.28 -35.73 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 65.140000000000001 111.156 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.9 mmm -76.12 78.8 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 74.5 110.93 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.9 113.87 0.93 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.743 . . . . 74.439999999999998 112.473 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.3 tt -163.2 147.81 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.34 . . . . 72.310000000000002 111.135 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -77.39 -174.95 3.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.219999999999999 110.871 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.26 163.34 34.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 45.329999999999998 110.904 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.2 p -139.88 130.64 25.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 74.299999999999997 110.838 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -108.47 -36.35 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 74.450000000000003 110.841 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.0 p -75.75 132.94 40.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 60.539999999999999 110.854 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.49 135.66 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -172.48 68.7 0.4 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.595 0.712 . . . . 63.219999999999999 110.869 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -14.33 35.73 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.622 2.215 . . . . 71.310000000000002 112.289 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.8 p -51.75 163.2 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.171 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -68.62 179.61 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 73.420000000000002 110.883 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -89.44 149.78 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 65.140000000000001 110.84 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.82 147.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 62.439999999999998 111.133 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.86 158.77 80.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.565 0.698 . . . . 74.519999999999996 110.882 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 163.88 36.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.342 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 t -96.28 154.65 17.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 111.163 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.85 99.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 74.510000000000005 111.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.27 139.41 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.054 -0.521 . . . . 75.239999999999995 111.095 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -151.05 106.46 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 73.430000000000007 110.922 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -116.0 133.36 56.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.931 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.3 p -133.53 114.61 13.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 73.049999999999997 110.875 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -148.82 -67.45 0.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 73.25 110.892 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.71 39.43 0.4 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.779 -0.724 . . . . 63.32 112.501 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.42 -160.5 34.43 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 62.329999999999998 112.497 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -102.62 -29.85 11.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.717 0.294 . . . . 72.439999999999998 110.882 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -156.76 137.34 13.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.826 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.743 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.3 t -126.22 134.52 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 74.230000000000004 111.109 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.4 152.45 50.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.902 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.617 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -124.33 142.15 42.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.030000000000001 111.114 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.9 t -150.04 139.4 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 65.530000000000001 110.896 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.93 -162.49 10.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.702 -0.761 . . . . 51.100000000000001 112.501 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -73.25 -15.97 61.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 64.209999999999994 110.88 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.45 ' CB ' HD22 ' A' ' 59' ' ' LEU . 35.2 p90 -64.08 -16.07 60.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.25 110.85 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.515 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -131.2 13.4 5.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.857 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 63.69 20.54 12.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.912 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.1 m95 51.53 40.39 26.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 75.109999999999999 110.888 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 t -116.25 14.55 15.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 110.826 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.515 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.2 t -166.51 146.23 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 111.159 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 120.53 40.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 72.239999999999995 110.94 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.48 132.5 52.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 62.32 111.114 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 136.08 31.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.711 2.274 . . . . 74.299999999999997 112.35 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.5 mp -95.81 107.66 19.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.975 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -51.04 112.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 111.118 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.85 126.74 30.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 64.099999999999994 110.872 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.51 168.82 9.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.773 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -72.12 -9.47 58.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 70.450000000000003 110.909 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.13 -45.5 3.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.906 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -170.95 -171.56 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.310000000000002 110.813 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -85.35 152.2 23.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.961 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.82 160.09 4.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 111.106 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.547 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -132.97 142.89 49.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 54.009999999999998 111.113 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.624 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.6 mm -138.64 122.7 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.421 . . . . 74.439999999999998 111.099 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.041 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.25 135.56 14.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 74.010000000000005 110.96 179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 105.97 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.88 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.041 HD21 HD12 ' A' ' 57' ' ' LEU . 9.6 mt -114.08 152.53 45.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.576 0.703 . . . . 70.109999999999999 110.936 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.57 69.1 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 72.319999999999993 112.361 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -63.28 117.75 7.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 71.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.85 -137.22 4.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 75.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -136.0 138.83 42.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.306 -0.378 . . . . 71.450000000000003 110.914 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.65 166.73 24.35 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.452 1.095 . . . . 51.009999999999998 109.628 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -123.16 126.91 47.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.965 -1.016 . . . . 75.430000000000007 110.908 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -122.02 178.19 5.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.42 142.86 22.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 75.430000000000007 110.879 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -90.6 149.87 21.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.898 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -135.47 96.07 3.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 64.400000000000006 110.953 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.456 HG22 HG22 ' A' ' 31' ' ' VAL . 18.4 t -123.46 151.49 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 53.119999999999997 111.143 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 t0 63.54 38.34 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.863 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.56 33.28 71.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.812 -0.709 . . . . 72.25 112.484 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -157.91 159.95 37.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.733 0.301 . . . . 52.310000000000002 110.949 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -85.01 116.47 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 73.109999999999999 110.881 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -123.75 167.81 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 53.149999999999999 111.138 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.2 p-80 -151.46 156.78 41.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 63.229999999999997 110.859 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.12 134.14 22.38 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.57 0.7 . . . . 61.109999999999999 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -20.42 34.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.678 2.252 . . . . 70.109999999999999 112.393 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.95 -30.81 61.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 44.530000000000001 110.941 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.08 160.52 65.62 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.6 0.714 . . . . 74.530000000000001 110.868 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 82.5 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.757 2.304 . . . . 71.329999999999998 112.291 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.9 m -91.84 157.55 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -154.41 139.83 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 63.109999999999999 111.109 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.457 HG23 HD13 ' A' ' 90' ' ' ILE . 2.7 m -80.04 111.46 16.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.198 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.71 171.09 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.903 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.428 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -62.84 -23.04 67.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 72.439999999999998 110.892 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 86' ' ' GLN . 4.0 mm? -89.48 9.78 25.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 110.95 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.13 12.38 81.57 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 45.439999999999998 112.468 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.7 p -98.08 116.49 30.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 52.509999999999998 111.154 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.504 HG21 ' CE1' ' A' ' 76' ' ' HIS . 31.2 mm -67.03 142.63 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 75.219999999999999 111.123 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.17 153.85 34.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 75.109999999999999 110.931 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -79.87 178.67 8.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 61.450000000000003 110.855 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.9 tp -137.36 133.72 35.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 74.140000000000001 110.908 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.9 tt -129.48 143.38 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 53.439999999999998 111.144 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -127.91 109.99 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.918 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.8 t -100.19 142.04 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.099999999999994 111.103 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -119.54 -174.38 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.892 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -113.92 161.49 17.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 74.239999999999995 110.903 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.2 t -95.73 29.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.811 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.58 -18.37 14.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.883 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -86.02 -64.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 65.450000000000003 110.868 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.572 ' HG3' HG23 ' A' ' 103' ' ' VAL . 18.0 pt-20 -51.3 -48.21 62.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 64.109999999999999 110.885 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.572 HG23 ' HG3' ' A' ' 102' ' ' GLU . 15.3 t -80.09 119.29 29.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 63.240000000000002 111.191 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -93.22 -32.55 14.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 72.439999999999998 110.894 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.4 t70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 44.530000000000001 110.856 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.418 -0.273 . . . . 63.340000000000003 112.418 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.42 119.25 14.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.304 . . . . 65.140000000000001 111.049 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.73 121.69 13.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.887 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.71 105.36 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.778 -0.725 . . . . 74.439999999999998 112.565 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.7 tp -175.18 137.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 72.310000000000002 111.098 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -138.84 148.1 43.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 73.219999999999999 110.841 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -163.35 131.53 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 45.329999999999998 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.2 p -162.21 158.47 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.907 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -108.35 -34.17 6.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.450000000000003 110.836 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 63.19 52.5 2.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.449 . . . . 60.539999999999999 110.861 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -149.94 129.77 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 73.329999999999998 111.164 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.57 68.3 9.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 63.219999999999999 110.942 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -14.27 35.96 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.716 2.277 . . . . 71.310000000000002 112.368 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -125.36 178.34 5.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 73.25 111.188 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -51.81 169.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.420000000000002 110.931 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -161.34 129.16 4.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.428 . . . . 65.140000000000001 110.921 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . -90.32 132.66 35.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 62.439999999999998 111.109 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.1 mtt-85 -67.23 157.99 83.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 74.519999999999996 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 161.07 47.36 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 71.439999999999998 112.374 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -92.7 156.14 17.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.27 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t -105.52 99.45 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 74.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.665 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.39 139.24 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.084 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 54' ' ' VAL . 33.0 mtt180 -152.28 119.22 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 73.430000000000007 110.898 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CE2' HG21 ' A' ' 70' ' ' VAL . 26.7 t-105 -129.36 126.65 39.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.979 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.4 p -131.93 100.77 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.834 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -133.75 -61.71 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 73.25 110.846 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.83 33.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 63.32 112.422 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.92 -162.88 29.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 62.329999999999998 112.545 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -102.95 -32.2 9.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.758 0.313 . . . . 72.439999999999998 110.841 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.47 134.04 13.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.866 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.727 ' CG1' HD22 ' A' ' 46' ' ' LEU . 38.8 t -124.11 131.08 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.177 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.34 150.17 49.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 75.510000000000005 110.85 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 22' ' ' ILE . 6.1 tt -120.74 142.29 37.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.485 . . . . 63.030000000000001 111.119 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.5 m -146.68 138.71 24.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 65.530000000000001 110.845 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.54 -170.83 17.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.758 -0.734 . . . . 51.100000000000001 112.478 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.6 m -69.51 -17.61 63.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.924 0.392 . . . . 64.209999999999994 110.885 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -61.33 -20.79 63.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 64.25 110.856 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.0 p30 -125.89 14.03 7.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.892 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 61.65 21.39 12.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 110.847 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 m95 51.39 37.48 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 110.899 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 t -110.09 11.16 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 73.120000000000005 110.871 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -166.48 149.1 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 74.230000000000004 111.115 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 119.71 39.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 110.893 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.52 132.57 54.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.711 . . . . 62.32 111.125 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 140.05 41.72 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.658 2.239 . . . . 74.299999999999997 112.359 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.2 mp -98.52 108.19 20.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.93 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -51.46 110.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 111.118 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -72.17 119.18 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 64.099999999999994 110.924 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 t -110.88 160.61 16.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 72.140000000000001 110.799 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -55.94 -25.73 44.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.779 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -88.03 -55.46 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 71.099999999999994 110.852 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.04 -169.53 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 62.310000000000002 110.912 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' HB3' HD23 ' A' ' 46' ' ' LEU . 77.9 m-85 -85.76 150.73 24.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.827 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.7 m -151.6 162.76 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.148 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -129.34 144.65 51.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 111.071 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.585 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.2 mm -138.54 116.57 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.144 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.83 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -152.74 133.06 13.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.664 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.3 p-10 -70.19 112.32 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 110.883 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.83 HD21 HD12 ' A' ' 57' ' ' LEU . 24.3 mt -120.21 152.41 54.61 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 70.109999999999999 110.935 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 149.05 66.75 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 72.319999999999993 112.332 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.0 103.62 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.4 -138.91 4.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 75.140000000000001 112.512 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.84 136.86 46.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.318 -0.372 . . . . 71.450000000000003 110.907 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -143.71 166.66 24.25 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.548 1.155 . . . . 51.009999999999998 109.534 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.67 126.66 46.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.99 -1.004 . . . . 75.430000000000007 110.881 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -121.89 -178.14 3.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.889 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -154.56 143.32 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.519 . . . . 75.430000000000007 110.87 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -92.28 144.31 25.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.901 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -127.55 96.05 4.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 64.400000000000006 110.888 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 24' ' ' TRP . 16.9 t -124.16 152.64 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 53.119999999999997 111.176 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.76 37.73 9.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 110.887 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.41 28.2 64.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 72.25 112.47 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -153.64 171.0 19.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 52.310000000000002 110.912 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -92.47 116.57 29.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 73.109999999999999 110.901 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.92 167.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.109 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.1 p-80 -148.26 158.96 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.229999999999997 110.875 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.1 133.52 23.99 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.642 0.735 . . . . 61.109999999999999 110.883 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -24.18 30.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 70.109999999999999 112.385 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -74.71 -30.57 61.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 44.530000000000001 110.819 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -81.0 160.66 65.5 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.58 0.705 . . . . 74.530000000000001 110.886 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 81.9 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.398 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 76' ' ' HIS . 29.8 m -91.74 154.99 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 75.019999999999996 111.123 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -155.91 147.58 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 63.109999999999999 111.127 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -79.81 109.6 14.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 111.165 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -66.34 170.72 5.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 72.230000000000004 110.858 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -63.55 -16.47 60.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.909 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.46 3.11 33.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.156 -0.475 . . . . 74.530000000000001 110.891 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.52 7.74 87.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.735 -0.745 . . . . 45.439999999999998 112.524 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.3 p -111.74 135.29 52.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 52.509999999999998 111.156 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.75 145.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 111.175 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.8 157.08 43.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 75.109999999999999 110.903 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -78.84 174.28 11.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 61.450000000000003 110.885 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.4 tp -133.66 134.13 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.901 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 64' ' ' HIS . 1.6 tt -132.1 144.87 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 53.439999999999998 111.117 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -135.66 103.15 5.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 74.230000000000004 110.843 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.3 t -90.58 142.55 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 71.099999999999994 111.061 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.06 177.04 6.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.895 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.02 158.14 16.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.951 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.2 t -121.45 2.99 10.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 72.340000000000003 110.859 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.39 -6.85 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 72.120000000000005 110.885 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -73.58 -26.38 60.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 65.450000000000003 110.904 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -58.22 -22.75 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 64.109999999999999 110.964 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.47 124.02 37.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 63.240000000000002 111.177 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -94.38 -32.26 13.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 72.439999999999998 110.886 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.530000000000001 110.881 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.453 -0.259 . . . . 63.340000000000003 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.79 170.0 15.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.834 0.349 . . . . 65.140000000000001 111.08 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -150.91 177.6 9.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.885 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.11 82.35 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 74.439999999999998 112.519 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.5 tt -116.72 -26.26 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.389 . . . . 72.310000000000002 111.197 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -52.93 148.69 7.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.908 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -167.07 172.76 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 45.329999999999998 110.857 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 p 52.19 36.15 18.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 74.299999999999997 110.909 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.5 -38.43 6.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 74.450000000000003 110.848 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.9 p -71.46 -175.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 60.539999999999999 110.858 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -133.97 113.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 73.329999999999998 111.095 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -173.66 71.45 0.36 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.571 0.7 . . . . 63.219999999999999 110.894 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 -46.82 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.702 2.268 . . . . 71.310000000000002 112.373 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.35 107.54 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 73.25 111.141 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -130.26 129.01 42.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 73.420000000000002 110.974 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -132.28 128.51 37.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 65.140000000000001 110.932 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.741 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -174.44 152.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.068 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.32 158.4 79.39 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.65 0.738 . . . . 74.519999999999996 110.839 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.62 23.85 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.699 2.266 . . . . 71.439999999999998 112.396 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.3 t -104.36 156.18 18.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 72.409999999999997 111.182 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -105.27 99.88 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 111.13 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.608 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.15 139.1 52.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.131 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' HG2' HG12 ' A' ' 54' ' ' VAL . 26.4 mtt-85 -151.59 122.27 7.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.430000000000007 110.853 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -128.45 132.98 48.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 74.109999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.1 p -135.2 107.43 7.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 73.049999999999997 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.19 -62.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.79 37.42 0.48 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.806 -0.711 . . . . 63.32 112.48 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.33 -163.06 33.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 62.329999999999998 112.488 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -103.83 -35.2 8.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 110.892 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -150.84 132.45 14.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.854 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 46' ' ' LEU . 42.6 t -120.7 134.89 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 74.230000000000004 111.107 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -137.75 151.16 47.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 75.510000000000005 110.84 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -123.63 142.6 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 63.030000000000001 111.122 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 t -149.89 139.1 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 65.530000000000001 110.819 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.13 -164.8 11.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 51.100000000000001 112.475 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 94.0 p -73.19 -17.35 61.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 64.209999999999994 110.813 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.1 p90 -62.53 -17.24 59.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 64.25 110.894 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.31 12.99 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.895 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.0 t30 63.35 21.3 12.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.872 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.4 m95 51.71 34.45 12.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 75.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 t -110.22 13.58 23.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.852 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.508 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.4 t -166.38 146.16 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 111.146 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.11 120.04 40.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.547 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.81 132.35 54.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.639 0.733 . . . . 62.32 111.081 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.35 32.93 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.37 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.7 OUTLIER -94.11 108.91 20.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 110.883 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.25 104.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 74.299999999999997 111.152 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -65.14 118.52 9.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.099999999999994 110.856 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 t -101.41 166.39 10.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 72.140000000000001 110.919 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -66.71 -21.51 66.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 70.450000000000003 110.899 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -97.23 -57.91 2.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 71.099999999999994 110.903 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -154.2 -169.7 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 62.310000000000002 110.875 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -89.85 151.24 21.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.85 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HG2' ' A' ' 23' ' ' ARG . 16.6 m -151.54 159.54 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 73.140000000000001 111.214 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' A' ' 22' ' ' ILE . . . -130.77 142.34 50.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 54.009999999999998 111.112 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.589 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.56 122.66 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.099 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.058 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.09 137.38 16.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 110.925 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 8.0 p-10 -74.06 101.96 4.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.838 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.058 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -111.41 152.51 43.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.566 0.698 . . . . 70.109999999999999 110.948 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 144.63 54.56 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.629 2.219 . . . . 72.319999999999993 112.361 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.84 106.11 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 71.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.78 -132.13 1.91 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.725 -0.75 . . . . 75.140000000000001 112.492 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -142.47 136.42 29.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 119.335 -0.364 . . . . 71.450000000000003 110.885 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.18 166.7 27.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.509 1.131 . . . . 51.009999999999998 109.611 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -119.49 127.58 53.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.959 -1.019 . . . . 75.430000000000007 110.953 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -121.27 174.52 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 74.340000000000003 110.949 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -148.86 143.63 26.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -90.93 147.74 22.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.865 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -130.5 95.33 3.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 64.400000000000006 110.823 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG22 HG22 ' A' ' 31' ' ' VAL . 24.8 t -123.76 149.09 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 53.119999999999997 111.148 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t0 61.22 38.64 16.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.835 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.89 24.89 60.92 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 72.25 112.537 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -149.51 150.75 32.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 52.310000000000002 110.825 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -79.93 114.89 19.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 110.911 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.34 172.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 53.149999999999999 111.101 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 90' ' ' ILE . 9.9 p-80 -154.85 159.09 40.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 63.229999999999997 110.842 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -97.31 133.46 23.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 61.109999999999999 110.891 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -27.02 27.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.729 2.286 . . . . 70.109999999999999 112.318 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.7 t -74.65 -26.91 60.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 44.530000000000001 110.862 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -81.0 160.68 65.47 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.713 . . . . 74.530000000000001 110.907 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 80.73 0.88 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.662 2.241 . . . . 71.329999999999998 112.312 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.73 156.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 75.019999999999996 111.043 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.22 143.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.064 -0.517 . . . . 63.109999999999999 111.085 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -80.25 117.23 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 73.200000000000003 111.125 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -69.22 168.28 14.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 72.230000000000004 110.885 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.447 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.1 pt20 -59.5 -23.02 62.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 72.439999999999998 110.928 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.9 mm? -88.11 8.08 28.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 74.530000000000001 110.932 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.67 81.43 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 45.439999999999998 112.45 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.4 p -101.37 119.06 38.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 52.509999999999998 111.148 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.48 HG21 ' CE1' ' A' ' 76' ' ' HIS . 27.4 mm -67.77 139.13 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 111.158 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -146.37 157.72 43.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.93 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.61 176.2 9.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.822 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 26.0 tp -138.76 127.93 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.140000000000001 110.881 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.6 tt -125.65 139.92 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 53.439999999999998 111.076 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.1 103.5 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 74.230000000000004 110.903 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.04 139.64 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 71.099999999999994 111.127 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.84 150.41 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 65.040000000000006 110.917 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -72.58 160.57 32.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 74.239999999999995 110.927 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.0 p -122.51 29.6 6.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.845 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -107.08 -21.51 12.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 110.888 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -97.1 -70.95 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.450000000000003 110.888 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -49.66 -38.85 34.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 64.109999999999999 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.58 126.0 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 63.240000000000002 111.178 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -84.44 -31.35 24.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 72.439999999999998 110.899 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 44.530000000000001 110.88 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.495 -0.242 . . . . 63.340000000000003 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.36 125.36 6.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 65.140000000000001 111.075 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 45.0 mtm -64.65 -67.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.897 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.27 106.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.505 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.24 138.15 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.845 0.355 . . . . 72.310000000000002 111.132 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -106.83 131.51 53.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.835 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -80.4 164.05 23.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 45.329999999999998 110.856 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -53.93 165.84 0.42 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 74.299999999999997 110.876 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.1 -42.72 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 110.843 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 p -156.7 130.87 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 60.539999999999999 110.858 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.9 m -147.83 142.49 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 73.329999999999998 111.093 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.1 70.24 67.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.653 0.74 . . . . 63.219999999999999 110.918 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -17.62 37.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 71.310000000000002 112.386 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.05 162.1 14.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 73.25 111.152 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -66.54 179.84 0.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 110.946 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -98.33 137.34 37.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 65.140000000000001 110.902 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . . . -171.14 146.04 2.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 62.439999999999998 111.091 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.6 ' HD2' HG13 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -73.3 153.41 90.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 74.519999999999996 110.875 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 157.76 59.26 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.629 2.219 . . . . 71.439999999999998 112.399 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.1 t -86.57 156.11 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.141 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.11 99.82 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 111.141 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.619 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.99 138.75 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 111.15 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -151.53 106.46 3.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.861 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -120.72 127.44 52.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.13 105.11 7.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 73.049999999999997 110.856 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -136.29 -67.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 73.25 110.929 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.02 38.59 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 63.32 112.456 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.82 -150.89 12.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 62.329999999999998 112.529 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.99 -44.88 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.681 0.277 . . . . 72.439999999999998 110.821 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.6 126.96 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 74.239999999999995 110.839 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.684 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.8 t -112.96 133.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 111.076 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -136.18 150.89 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 75.510000000000005 110.904 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.619 HD12 HG12 ' A' ' 22' ' ' ILE . 6.4 tt -122.22 141.95 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 63.030000000000001 111.11 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -148.7 139.07 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 65.530000000000001 110.775 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.42 -165.59 12.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 51.100000000000001 112.52 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -72.95 -17.26 61.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 64.209999999999994 110.829 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' CB ' HD22 ' A' ' 59' ' ' LEU . 33.3 p90 -62.67 -17.03 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 64.25 110.871 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.503 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -129.37 12.52 5.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.886 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 63.28 21.55 12.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.917 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.48 35.21 13.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.109999999999999 110.828 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -109.64 13.49 23.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.887 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.503 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 147.43 6.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.099 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -104.21 118.39 36.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 72.239999999999995 110.884 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.506 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -81.08 132.56 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.638 0.733 . . . . 62.32 111.153 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 137.43 35.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.658 2.239 . . . . 74.299999999999997 112.313 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.684 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.96 108.25 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.96 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -51.73 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 74.299999999999997 111.121 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -67.67 119.34 12.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.099999999999994 110.906 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 t -111.28 157.17 20.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.853 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.64 -25.54 39.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 70.450000000000003 110.897 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -89.04 -49.38 6.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 71.099999999999994 110.817 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -174.22 -172.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 62.310000000000002 110.794 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 46' ' ' LEU . 67.5 m-85 -85.67 148.99 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 74.519999999999996 110.916 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.1 m -150.27 166.49 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.116 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.45 146.17 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 54.009999999999998 111.083 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.56 ' C ' HD23 ' A' ' 57' ' ' LEU . 43.1 mm -138.34 114.47 10.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 111.139 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -151.25 130.89 13.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 74.010000000000005 110.944 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.6 p-10 -73.36 110.02 7.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 63.43 110.904 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.941 HD21 HD12 ' A' ' 57' ' ' LEU . 9.1 mt -113.64 152.53 45.54 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.588 0.709 . . . . 70.109999999999999 110.998 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 150.74 68.3 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.703 2.269 . . . . 72.319999999999993 112.334 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.27 113.37 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 71.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.76 -160.9 34.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 75.140000000000001 112.489 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' CG ' HD11 ' A' ' 93' ' ' LEU . 31.7 tt0 -116.73 125.42 51.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 119.395 -0.336 . . . . 71.450000000000003 110.908 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 166.95 18.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.447 1.092 . . . . 51.009999999999998 109.624 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -124.84 125.9 44.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 110.876 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -118.43 -179.11 3.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 110.892 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -155.73 143.78 19.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 75.430000000000007 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -91.11 149.08 21.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.510000000000005 110.88 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -133.52 95.2 3.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.400000000000006 110.894 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -125.13 150.16 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 53.119999999999997 111.115 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 63.16 34.06 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 64.340000000000003 110.838 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 63.84 25.89 69.57 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.715 -0.755 . . . . 72.25 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -151.31 151.55 31.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.785 0.326 . . . . 52.310000000000002 110.911 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -81.04 113.81 19.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.58 171.73 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 53.149999999999999 111.083 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -153.81 157.84 39.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 110.833 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.93 133.44 23.27 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.572 0.701 . . . . 61.109999999999999 110.871 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -25.36 28.27 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.693 2.262 . . . . 70.109999999999999 112.32 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.6 t -74.92 -27.63 60.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 44.530000000000001 110.872 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.74 160.53 66.51 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.613 0.721 . . . . 74.530000000000001 110.886 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 80.94 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.694 2.263 . . . . 71.329999999999998 112.333 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.7 m -93.73 159.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 75.019999999999996 111.144 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.9 p -150.6 139.33 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 63.109999999999999 111.057 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.449 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.1 m -80.64 111.43 17.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 73.200000000000003 111.148 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 165.45 17.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.851 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.489 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -59.26 -21.89 60.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.8 mm? -86.52 5.84 33.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.943 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.1 19.31 79.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 45.439999999999998 112.519 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 p -107.09 120.09 41.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 52.509999999999998 111.16 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 84' ' ' THR . 26.5 mm -73.6 126.35 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 111.201 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 158.28 42.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.922 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.63 172.24 14.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 61.450000000000003 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.4 tp -134.44 133.01 40.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.93 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.88 138.53 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 53.439999999999998 111.155 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.8 m80 -121.98 109.09 14.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.230000000000004 110.817 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.6 HG13 ' HD2' ' A' ' 18' ' ' ARG . 95.7 t -97.43 144.37 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.127 -0.488 . . . . 71.099999999999994 111.152 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -118.37 -174.49 2.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 65.040000000000006 110.91 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -108.27 160.55 15.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 74.239999999999995 110.925 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.9 m -128.46 38.48 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 110.858 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.2 -29.54 21.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 72.120000000000005 110.903 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -87.52 -32.41 19.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 65.450000000000003 110.918 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.64 -25.74 54.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 64.109999999999999 110.866 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.5 t -83.92 148.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 63.240000000000002 111.163 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -90.65 -38.52 13.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 110.854 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 t0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 44.530000000000001 110.898 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.527 -0.229 . . . . 63.340000000000003 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.48 166.47 11.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 65.140000000000001 111.134 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 mtm -80.8 123.35 28.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 74.5 110.918 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.41 -166.76 41.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.794 -0.717 . . . . 74.439999999999998 112.449 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 tt -151.55 148.85 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.333 . . . . 72.310000000000002 111.105 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -158.4 117.12 3.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 73.219999999999999 110.918 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -174.73 177.73 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 45.329999999999998 110.947 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -79.24 133.4 36.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.299999999999997 110.852 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.32 -45.14 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 74.450000000000003 110.92 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.6 t -68.23 117.44 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 60.539999999999999 110.911 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -145.06 147.87 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.443 . . . . 73.329999999999998 111.085 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 69.87 4.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.608 0.718 . . . . 63.219999999999999 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.66 -48.33 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.747 2.298 . . . . 71.310000000000002 112.294 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.1 p -125.8 -177.37 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 73.25 111.166 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.65 179.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 110.916 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -93.58 134.34 35.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 65.140000000000001 110.904 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -174.8 146.69 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.439999999999998 111.09 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -71.35 159.52 85.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.916 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.83 36.82 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.676 2.251 . . . . 71.439999999999998 112.383 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 t -95.44 151.49 19.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 72.409999999999997 111.143 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.62 99.77 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.094 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -130.06 139.6 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 75.239999999999995 111.167 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -150.77 106.27 3.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.876 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -115.64 139.82 49.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.935 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -135.5 115.26 12.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 73.049999999999997 110.881 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -152.15 -61.34 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 73.25 110.838 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.15 38.26 1.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 63.32 112.423 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.57 -155.41 26.91 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 62.329999999999998 112.457 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -98.86 -46.78 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.75 0.31 . . . . 72.439999999999998 110.918 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -156.27 126.18 6.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 110.945 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 70' ' ' VAL . 2.9 m -112.68 143.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 111.161 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -130.61 150.99 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.831 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 5.7 tt -121.85 141.5 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 63.030000000000001 111.158 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 t -146.77 138.72 24.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 65.530000000000001 110.845 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -148.34 -168.31 14.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.501 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 t -69.97 -17.37 63.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.922 0.391 . . . . 64.209999999999994 110.819 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.4 p90 -62.35 -17.32 58.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 64.25 110.866 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.5 p30 -129.81 12.08 5.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.951 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 63.36 21.76 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 75.109999999999999 110.888 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.7 m95 51.49 36.12 16.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 75.109999999999999 110.954 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.0 t -111.82 14.33 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.831 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.506 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.9 t -166.28 152.88 9.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 74.230000000000004 111.133 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -107.41 131.38 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.884 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -95.1 132.12 28.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.612 0.72 . . . . 62.32 111.096 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 133.99 26.8 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.643 2.229 . . . . 74.299999999999997 112.392 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.583 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -105.99 87.53 2.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 72.319999999999993 110.926 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.8 mm -50.97 107.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 111.113 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -66.53 136.93 56.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 64.099999999999994 110.814 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.9 t -111.86 170.04 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.785 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -59.41 -19.63 48.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.1 -0.5 . . . . 70.450000000000003 110.924 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.87 -52.81 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 71.099999999999994 110.858 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -173.61 -167.06 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 62.310000000000002 110.841 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.42 142.08 30.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.903 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 22' ' ' ILE . 96.9 t -150.68 145.87 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.140000000000001 111.114 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . . . -115.92 150.26 37.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 54.009999999999998 111.083 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 55' ' ' ALA . 33.6 mm -138.46 116.75 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.439999999999998 111.087 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.046 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.5 134.24 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 110.861 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.613 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 5.4 p-10 -73.79 107.02 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.43 110.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 57' ' ' LEU . 10.5 mt -112.53 152.17 44.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.589 0.709 . . . . 70.109999999999999 110.94 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 153.73 68.4 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.63 2.22 . . . . 72.319999999999993 112.346 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.49 108.94 1.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 71.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 169.7 -158.66 31.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 75.140000000000001 112.478 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.438 ' CG ' HD11 ' A' ' 93' ' ' LEU . 35.4 tt0 -119.9 124.62 46.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 119.353 -0.356 . . . . 71.450000000000003 110.886 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -132.6 166.9 21.05 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 51.009999999999998 109.624 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -120.16 128.65 53.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.001 -1.0 . . . . 75.430000000000007 110.887 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -119.46 175.88 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.937 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -150.23 143.05 24.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.949 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.91 151.25 20.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.913 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -135.26 94.84 3.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 64.400000000000006 110.819 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 31' ' ' VAL . 5.1 t -121.94 151.26 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 53.119999999999997 111.155 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 t0 61.53 38.98 15.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 110.879 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.65 33.03 70.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.485 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -157.7 156.02 30.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.725 0.298 . . . . 52.310000000000002 110.954 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -83.23 116.18 22.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.926 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.06 170.09 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 53.149999999999999 111.104 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.449 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.7 p-80 -152.02 156.88 40.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 63.229999999999997 110.914 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.64 133.3 23.71 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.672 0.748 . . . . 61.109999999999999 110.857 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -22.3 32.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.703 2.269 . . . . 70.109999999999999 112.38 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 m -74.83 -29.32 61.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 44.530000000000001 110.853 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -81.11 160.47 65.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.676 0.75 . . . . 74.530000000000001 110.89 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 82.08 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.743 2.295 . . . . 71.329999999999998 112.32 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.2 m -91.7 161.81 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 75.019999999999996 111.149 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.87 138.1 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 63.109999999999999 111.132 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.467 ' HA ' HD13 ' A' ' 90' ' ' ILE . 2.6 m -80.02 110.83 15.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 73.200000000000003 111.138 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 164.86 16.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 72.230000000000004 110.901 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.535 ' CG ' HD22 ' A' ' 87' ' ' LEU . 1.1 pt20 -59.06 -21.78 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.915 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.535 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.7 mm? -85.32 4.57 34.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.89 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.36 18.39 79.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 45.439999999999998 112.483 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -107.76 123.87 49.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 52.509999999999998 111.196 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 84' ' ' THR . 25.8 mm -76.37 131.52 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 111.081 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -138.74 156.01 47.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.904 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -79.64 174.66 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.939 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 ' CG ' ' A' ' 63' ' ' GLU . 55.5 tp -134.98 136.48 42.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 110.938 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' HIS . 2.0 tt -132.48 145.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 53.439999999999998 111.093 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -129.13 109.49 11.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.838 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.1 t -100.93 144.19 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.128 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.48 -174.68 2.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 65.040000000000006 110.876 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -117.61 161.28 19.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.868 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.1 m -122.91 26.14 8.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 110.811 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -58.69 -34.55 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 72.120000000000005 110.852 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -78.87 -32.74 46.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 65.450000000000003 110.906 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.71 -24.74 64.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 64.109999999999999 110.891 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.12 148.58 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 63.240000000000002 111.12 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -101.95 -28.71 12.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 110.815 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 44.530000000000001 110.846 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.502 -0.239 . . . . 63.340000000000003 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.72 47.1 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 65.140000000000001 111.107 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.0 ptm -134.18 177.16 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 74.5 110.894 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.05 21.74 56.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 74.439999999999998 112.506 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.26 95.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 72.310000000000002 111.154 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -106.6 57.68 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.92 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -92.37 145.96 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 45.329999999999998 110.89 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -70.9 110.57 5.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 74.299999999999997 110.907 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -59.26 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 74.450000000000003 110.895 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.7 t -158.52 167.35 29.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 60.539999999999999 110.902 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.0 m -117.66 125.64 74.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 73.329999999999998 111.106 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -144.52 71.42 15.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 63.219999999999999 110.852 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -48.46 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 71.310000000000002 112.371 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.73 124.27 7.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 73.25 111.154 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -171.35 125.97 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 73.420000000000002 110.861 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -125.68 129.06 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 65.140000000000001 110.881 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.1 141.04 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 62.439999999999998 111.1 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -75.52 159.5 81.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.65 0.738 . . . . 74.519999999999996 110.862 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 163.05 39.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.439999999999998 112.34 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 t -93.74 156.18 16.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.152 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.09 99.74 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.147 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.65 HG12 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -129.98 139.04 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 75.239999999999995 111.128 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -150.43 106.38 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.854 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CE2' HG21 ' A' ' 70' ' ' VAL . 25.6 t-105 -120.41 124.1 44.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 110.926 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.9 p -128.76 100.69 5.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 73.049999999999997 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -130.32 -69.74 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 73.25 110.913 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.95 37.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 63.32 112.467 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.79 -153.44 21.58 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 62.329999999999998 112.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -103.47 -33.87 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 110.931 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.31 135.37 12.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.927 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.697 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.5 t -123.16 131.57 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.165 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -134.62 150.38 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 110.873 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.65 HD12 HG12 ' A' ' 22' ' ' ILE . 6.3 tt -120.41 142.14 37.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.030000000000001 111.08 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -147.64 138.97 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 65.530000000000001 110.87 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.0 -168.17 14.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 51.100000000000001 112.53 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 p -71.79 -15.63 62.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 64.209999999999994 110.809 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.465 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.7 p90 -63.64 -19.6 65.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 64.25 110.917 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 35' ' ' GLY . 4.2 p30 -126.52 11.99 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.898 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 63.27 21.2 12.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.109999999999999 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.7 m95 51.51 37.11 18.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.897 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.37 3.27 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 73.120000000000005 110.856 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -159.3 153.14 23.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.230000000000004 111.151 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.9 119.99 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 72.239999999999995 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' HG23 ' A' ' 33' ' ' ILE . 1.8 mp -82.08 132.57 53.23 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.663 0.744 . . . . 62.32 111.103 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 137.46 35.65 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.584 2.189 . . . . 74.299999999999997 112.37 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD22 ' CG1' ' A' ' 31' ' ' VAL . 1.1 mp -95.04 107.0 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.924 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.1 mm -51.27 106.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 74.299999999999997 111.133 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -66.59 119.67 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 64.099999999999994 110.931 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.1 t -110.71 157.91 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 72.140000000000001 110.889 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -56.19 -25.05 45.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 70.450000000000003 110.838 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -89.99 -48.06 7.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.099999999999994 110.906 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -175.32 -172.31 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.310000000000002 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HB3' HD23 ' A' ' 46' ' ' LEU . 55.0 m-85 -85.68 149.17 25.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.846 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.8 m -151.43 166.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.181 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.571 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -134.47 146.87 50.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 54.009999999999998 111.057 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.8 mm -138.34 118.07 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.127 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.935 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.41 132.4 12.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 110.97 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.2 p-10 -72.88 107.28 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 63.43 110.868 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.935 HD21 HD12 ' A' ' 57' ' ' LEU . 9.5 mt -112.02 152.33 44.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.674 0.75 . . . . 70.109999999999999 110.94 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 153.97 68.66 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.763 2.309 . . . . 72.319999999999993 112.31 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.53 123.66 19.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 71.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.79 -136.6 5.25 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 75.140000000000001 112.47 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -135.16 140.13 45.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 119.359 -0.353 . . . . 71.450000000000003 110.866 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.37 167.36 22.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 51.009999999999998 109.592 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' CG ' HD22 ' A' ' 93' ' ' LEU . 1.5 mt-30 -127.09 125.32 41.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.997 -1.001 . . . . 75.430000000000007 110.859 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -119.99 179.19 4.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 110.944 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -153.56 144.27 22.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.911 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.73 144.31 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 110.874 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -128.04 95.69 4.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 64.400000000000006 110.927 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.562 HG22 HG22 ' A' ' 31' ' ' VAL . 15.3 t -124.37 153.08 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 53.119999999999997 111.098 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.9 t70 63.57 37.58 10.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 64.340000000000003 110.922 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.43 28.49 64.86 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.768 -0.729 . . . . 72.25 112.442 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -153.79 170.06 21.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.78 0.324 . . . . 52.310000000000002 110.904 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.46 116.59 29.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.939 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.36 168.44 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 53.149999999999999 111.161 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.2 p-80 -147.59 144.68 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.819 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -90.29 134.47 31.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.619 0.723 . . . . 61.109999999999999 110.927 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.37 37.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 70.109999999999999 112.361 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -74.81 -26.06 59.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 44.530000000000001 110.909 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -93.07 161.79 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.693 0.759 . . . . 74.530000000000001 110.872 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 90.06 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 71.329999999999998 112.374 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 76' ' ' HIS . 30.8 m -98.37 143.77 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 111.116 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.33 146.31 25.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 63.109999999999999 111.168 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.574 HG23 HD13 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -79.61 125.29 29.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.167 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 p -75.07 -169.25 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.92 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -70.95 -34.06 71.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.904 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.2 mm? -90.68 16.96 8.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.935 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.523 ' HA2' HG22 ' A' ' 84' ' ' THR . . . 73.6 5.58 68.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 45.439999999999998 112.506 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.5 p -79.86 112.03 16.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 52.509999999999998 111.18 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 84' ' ' THR . 24.0 mm -68.15 129.17 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 111.144 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -135.82 159.25 42.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.878 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -79.26 169.68 17.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.865 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' CG ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -130.66 137.6 49.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 74.140000000000001 110.938 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 93' ' ' LEU . 1.8 tt -138.03 141.19 39.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 53.439999999999998 111.131 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.478 ' CD2' HD12 ' A' ' 93' ' ' LEU . 26.0 m-70 -129.72 112.71 13.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.909 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -99.1 141.92 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.099999999999994 111.119 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -100.86 -174.32 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 65.040000000000006 110.929 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -94.7 161.44 14.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.239999999999995 110.855 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.6 p -126.62 27.68 6.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.836 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -106.05 -20.56 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -73.99 -59.84 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.255 -0.429 . . . . 65.450000000000003 110.82 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.45 -38.91 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 64.109999999999999 110.93 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.37 135.71 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 63.240000000000002 111.102 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -102.57 -33.27 9.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 110.92 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 44.530000000000001 110.853 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.532 -0.227 . . . . 63.340000000000003 112.532 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.23 25.57 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.317 . . . . 65.140000000000001 111.107 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.2 mmm -96.62 111.0 23.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.898 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.29 65.96 0.55 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.829 -0.7 . . . . 74.439999999999998 112.5 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.3 mm -84.82 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 72.310000000000002 111.112 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -105.65 172.44 6.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 110.822 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -74.08 126.91 31.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 45.329999999999998 110.869 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.0 p -78.85 167.61 20.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.299999999999997 110.897 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.37 -59.6 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.875 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.8 p -164.64 136.66 4.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 60.539999999999999 110.845 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.634 HG22 ' HD3' ' A' ' 13' ' ' PRO . 11.8 p -173.14 136.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.124 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.29 69.44 0.8 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.502 0.668 . . . . 63.219999999999999 110.861 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.634 ' HD3' HG22 ' A' ' 11' ' ' VAL . 54.1 Cg_endo -69.73 -14.18 35.8 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.7 2.267 . . . . 71.310000000000002 112.361 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.87 157.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 73.25 111.141 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.03 172.26 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 73.420000000000002 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -100.27 144.49 29.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 65.140000000000001 110.967 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -172.15 159.68 4.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.439999999999998 111.089 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.3 157.23 80.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.689 0.757 . . . . 74.519999999999996 110.881 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.64 164.86 32.84 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.742 2.295 . . . . 71.439999999999998 112.34 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 t -96.46 156.21 16.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 111.098 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -107.21 99.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.510000000000005 111.185 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.676 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -130.53 139.43 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -149.67 106.48 3.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.925 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -117.89 127.9 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.965 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 p -134.08 103.2 5.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.4 . . . . 73.049999999999997 110.867 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -136.65 -62.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.904 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.65 35.96 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.748 . . . . 63.32 112.441 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.41 -165.08 38.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 62.329999999999998 112.463 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -101.73 -34.19 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 110.868 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.894 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' CG1' HD22 ' A' ' 46' ' ' LEU . 40.3 t -125.48 132.55 70.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 74.230000000000004 111.094 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -134.15 157.59 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.510000000000005 110.904 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 22' ' ' ILE . 6.5 tt -127.67 142.02 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 111.115 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -150.25 139.45 21.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.87 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.82 -164.12 11.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 51.100000000000001 112.513 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 p -72.46 -11.61 60.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 64.209999999999994 110.879 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CB ' HD22 ' A' ' 59' ' ' LEU . 34.9 p90 -68.55 -15.37 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.502 . . . . 64.25 110.891 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.512 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.3 p30 -132.22 12.56 4.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.91 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 63.48 21.8 12.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.109999999999999 110.88 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.4 m95 51.15 38.36 20.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 75.109999999999999 110.982 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.2 t -112.75 13.91 19.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.889 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.512 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.3 t -166.75 147.64 6.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 111.12 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 118.21 36.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.855 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.02 132.4 53.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.673 0.749 . . . . 62.32 111.053 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 139.08 39.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.291 . . . . 74.299999999999997 112.352 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.677 HD23 ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -97.61 106.42 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.899 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.4 mm -51.43 106.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 111.113 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -68.93 121.67 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 64.099999999999994 110.917 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 t -110.84 161.98 15.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.140000000000001 110.908 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -56.99 -24.45 53.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 70.450000000000003 110.838 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -91.01 -52.93 4.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 71.099999999999994 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -169.59 -169.8 0.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 62.310000000000002 110.861 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB3' HD23 ' A' ' 46' ' ' LEU . 73.9 m-85 -85.77 144.6 27.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.89 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 22' ' ' ILE . 93.8 t -150.27 136.6 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 73.140000000000001 111.148 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.564 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -107.55 147.66 30.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 54.009999999999998 111.176 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.639 ' C ' HD23 ' A' ' 57' ' ' LEU . 35.4 mm -138.43 121.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.158 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.014 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.42 135.77 14.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.965 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 p30 -72.91 106.51 4.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 63.43 110.87 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 57' ' ' LEU . 11.9 mt -115.56 149.68 43.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.609 0.719 . . . . 70.109999999999999 110.959 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 144.23 53.95 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.735 2.29 . . . . 72.319999999999993 112.385 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 122.32 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.288 -0.415 . . . . 71.0 110.88 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 161.45 -127.2 1.7 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 75.140000000000001 112.493 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -148.23 136.15 20.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.332 -0.365 . . . . 71.450000000000003 110.831 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.06 167.3 23.72 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.594 1.184 . . . . 51.009999999999998 109.602 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.1 133.1 54.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.971 -1.013 . . . . 75.430000000000007 110.919 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -127.46 -176.78 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.964 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -156.4 142.75 18.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.833 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -90.84 150.33 21.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.872 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -133.68 96.8 3.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 64.400000000000006 110.864 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 17.3 t -124.12 151.96 29.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 53.119999999999997 111.142 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 63.65 38.35 9.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 64.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.27 30.76 68.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 72.25 112.461 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -158.18 160.02 36.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.762 0.315 . . . . 52.310000000000002 110.943 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -81.69 117.32 21.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.917 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.1 m -124.34 170.61 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 53.149999999999999 111.138 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' HG21 ' A' ' 90' ' ' ILE . 10.6 p-80 -154.02 157.58 39.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.813 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -97.95 133.69 22.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.507 0.67 . . . . 61.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -26.94 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.681 2.254 . . . . 70.109999999999999 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.3 m -74.53 -27.81 60.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.883 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -80.75 160.74 65.98 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.601 0.715 . . . . 74.530000000000001 110.919 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 86.99 0.56 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.728 2.285 . . . . 71.329999999999998 112.341 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -102.12 162.85 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 75.019999999999996 111.131 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.71 141.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 63.109999999999999 111.095 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.438 HG23 HD13 ' A' ' 90' ' ' ILE . 2.1 m -80.63 117.81 21.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 73.200000000000003 111.114 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.26 -178.71 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.899 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -71.01 -22.93 62.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 72.439999999999998 110.92 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 86' ' ' GLN . 3.9 mm? -88.0 7.86 29.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.530000000000001 110.8 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.22 13.82 81.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.813 -0.708 . . . . 45.439999999999998 112.48 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.3 p -99.48 120.73 40.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.738 0.304 . . . . 52.509999999999998 111.142 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 84' ' ' THR . 27.2 mm -73.11 132.42 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 111.122 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.5 161.61 36.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 75.109999999999999 110.826 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -79.06 -179.21 6.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.450000000000003 110.94 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.4 tp -143.92 125.84 15.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 74.140000000000001 110.943 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 tt -125.45 133.83 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 53.439999999999998 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -124.05 105.66 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 110.844 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.48 145.3 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 111.068 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.3 165.15 24.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 65.040000000000006 110.934 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -90.04 161.35 15.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.917 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.3 m -129.54 31.44 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 72.340000000000003 110.874 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.6 -35.76 33.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.841 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -91.63 -32.06 15.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 65.450000000000003 110.9 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -57.82 -25.4 60.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 64.109999999999999 110.891 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.486 HG22 ' H ' ' A' ' 105' ' ' ASP . 14.8 p -94.37 144.61 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.240000000000002 111.14 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -87.78 -31.08 19.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 103' ' ' VAL . 26.0 t0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 44.530000000000001 110.894 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.504 -0.238 . . . . 63.340000000000003 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.85 119.62 21.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.769 0.318 . . . . 65.140000000000001 111.03 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.5 ptp -67.95 -32.2 72.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.915 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.34 75.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.623 -0.798 . . . . 74.439999999999998 112.461 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.0 mt -101.86 114.89 42.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 72.310000000000002 111.119 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 176.64 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 110.853 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 63.01 25.55 15.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 45.329999999999998 110.853 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 110.846 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -103.54 -30.56 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 74.450000000000003 110.911 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 m 51.88 88.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 60.539999999999999 110.843 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.6 t -146.07 109.74 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.113 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.68 76.99 0.29 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.51 0.671 . . . . 63.219999999999999 110.861 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -11.01 29.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.704 2.269 . . . . 71.310000000000002 112.377 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -111.1 163.31 14.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 73.25 111.141 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -95.81 163.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 110.889 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -99.96 130.39 46.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 65.140000000000001 110.914 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -178.09 141.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 62.439999999999998 111.108 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 159.1 79.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.603 0.716 . . . . 74.519999999999996 110.929 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 161.74 44.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.779 2.32 . . . . 71.439999999999998 112.319 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 t -92.76 156.4 17.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 111.163 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -106.04 99.69 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 74.510000000000005 111.104 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.621 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -130.26 139.11 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.126 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -153.07 106.37 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -116.45 131.9 56.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.929 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -131.04 109.58 10.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -145.74 -69.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.492 . . . . 73.25 110.882 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.93 40.94 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.808 -0.711 . . . . 63.32 112.511 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.59 -160.19 34.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.705 -0.76 . . . . 62.329999999999998 112.517 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 mmtm -97.99 -40.77 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 72.439999999999998 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.3 133.0 14.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.655 ' CG1' HD22 ' A' ' 46' ' ' LEU . 41.7 t -116.03 136.67 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 111.135 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.85 149.45 47.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 75.510000000000005 110.932 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.61 HD12 HG12 ' A' ' 22' ' ' ILE . 6.7 tt -122.57 142.58 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 63.030000000000001 111.097 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.9 t -149.51 139.21 21.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 65.530000000000001 110.884 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.41 -166.26 13.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 51.100000000000001 112.565 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.4 p -72.95 -18.34 61.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 64.209999999999994 110.804 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CB ' HD22 ' A' ' 59' ' ' LEU . 37.3 p90 -61.7 -17.99 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 64.25 110.863 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.6 p30 -127.79 13.44 6.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.905 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 63.19 20.83 12.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.869 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.0 m95 51.61 33.13 10.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.109999999999999 110.967 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -109.59 14.74 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.837 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.513 HG22 ' OD1' ' A' ' 38' ' ' ASN . 9.7 t -166.28 147.16 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 111.156 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -104.46 119.44 38.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 72.239999999999995 110.855 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.85 132.5 51.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.636 0.731 . . . . 62.32 111.138 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 139.15 39.78 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 74.299999999999997 112.311 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.655 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -97.8 111.49 23.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 72.319999999999993 110.924 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -51.23 113.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 74.299999999999997 111.147 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.06 115.83 14.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 64.099999999999994 110.937 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -109.99 156.83 19.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.825 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -25.85 58.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.450000000000003 110.867 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.89 -55.53 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 71.099999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -167.82 -171.92 1.72 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 62.310000000000002 110.914 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HB3' HD23 ' A' ' 46' ' ' LEU . 52.7 m-85 -85.65 144.52 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.924 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 22' ' ' ILE . 95.6 t -149.33 140.31 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.151 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -110.92 145.57 38.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 54.009999999999998 111.149 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.633 ' C ' HD23 ' A' ' 57' ' ' LEU . 50.0 mm -138.55 120.37 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 111.099 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.002 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.56 132.73 12.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 74.010000000000005 110.979 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 7.1 p-10 -73.2 106.24 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 63.43 110.875 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.002 HD21 HD12 ' A' ' 57' ' ' LEU . 9.2 mt -111.85 152.54 44.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.575 0.703 . . . . 70.109999999999999 110.889 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 144.51 53.95 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.69 2.26 . . . . 72.319999999999993 112.327 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -54.79 124.52 16.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.53 -135.16 4.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.724 -0.751 . . . . 75.140000000000001 112.466 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -140.59 137.23 33.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.371 -0.347 . . . . 71.450000000000003 110.918 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.98 166.94 23.27 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 51.009999999999998 109.599 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.7 126.39 46.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.005 -0.998 . . . . 75.430000000000007 110.91 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -121.33 175.77 5.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 110.859 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -149.94 143.97 25.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 75.430000000000007 110.845 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.66 146.8 23.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.861 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -131.06 95.19 3.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 64.400000000000006 110.954 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 t -122.58 151.4 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 53.119999999999997 111.11 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 59.88 32.42 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 64.340000000000003 110.851 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.68 73.85 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.683 -0.77 . . . . 72.25 112.436 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -151.45 154.11 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 52.310000000000002 110.91 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.99 114.37 21.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 110.872 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.0 m -121.22 170.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 53.149999999999999 111.155 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.546 ' CD2' HG11 ' A' ' 82' ' ' VAL . 9.6 p-80 -150.39 152.98 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 63.229999999999997 110.824 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -96.41 134.49 23.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.586 0.708 . . . . 61.109999999999999 110.865 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.88 -15.2 36.55 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.59 2.193 . . . . 70.109999999999999 112.372 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.86 -30.59 61.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 44.530000000000001 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -89.51 160.85 41.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 74.530000000000001 110.871 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.68 87.24 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.721 2.281 . . . . 71.329999999999998 112.415 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' CD2' ' A' ' 76' ' ' HIS . 18.2 m -91.68 154.28 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.083 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.91 148.31 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 111.143 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.9 m -79.8 110.2 14.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 73.200000000000003 111.144 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 m -66.48 170.82 5.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 110.839 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -63.84 -16.02 60.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 72.439999999999998 110.934 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.0 mm? -84.0 3.41 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.945 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.99 8.08 86.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 45.439999999999998 112.456 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 p -112.56 132.09 55.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 52.509999999999998 111.14 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.2 mm -65.52 147.02 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 75.219999999999999 111.111 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.32 157.03 42.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.901 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -79.19 172.8 13.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 110.867 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.7 tp -134.08 132.1 39.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 74.140000000000001 110.859 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.11 143.1 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 53.439999999999998 111.13 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.7 109.3 11.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 74.230000000000004 110.831 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.86 144.4 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.422 . . . . 71.099999999999994 111.149 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -133.24 156.82 46.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 65.040000000000006 110.878 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 161.21 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.891 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.2 t -115.86 32.29 6.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 72.340000000000003 110.862 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.7 -18.54 17.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.888 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -73.89 -57.79 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 65.450000000000003 110.863 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -65.56 -32.09 73.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 64.109999999999999 110.816 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.15 122.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.240000000000002 111.161 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -81.04 -31.1 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.833 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 44.530000000000001 110.881 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.445 -0.262 . . . . 63.340000000000003 112.445 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.23 34.84 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.348 . . . . 65.140000000000001 111.081 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -29.52 70.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.922 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.39 -164.09 1.6 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.769 -0.729 . . . . 74.439999999999998 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 tp -74.65 135.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 72.310000000000002 111.093 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 -117.56 154.57 31.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -64.56 167.17 7.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.44 . . . . 45.329999999999998 110.857 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t 59.67 27.13 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.901 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.41 -26.02 67.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 74.450000000000003 110.899 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.11 112.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 60.539999999999999 110.895 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HD3' ' A' ' 13' ' ' PRO . 5.3 p -95.87 119.24 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.11 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -149.32 73.57 9.94 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 63.219999999999999 110.92 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HD3' HG22 ' A' ' 11' ' ' VAL . 54.1 Cg_endo -69.68 -9.13 25.38 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.744 2.296 . . . . 71.310000000000002 112.351 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m -94.77 35.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 73.25 111.14 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -87.08 124.45 33.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.95 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -105.11 127.83 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 65.140000000000001 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.708 ' HB1' ' O ' ' A' ' 59' ' ' LEU . . . -177.45 141.38 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 62.439999999999998 111.11 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -76.69 159.94 78.06 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.544 0.687 . . . . 74.519999999999996 110.855 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 168.55 21.27 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.712 2.275 . . . . 71.439999999999998 112.309 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 t -101.06 152.49 20.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.409999999999997 111.089 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.14 99.21 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 111.131 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -130.71 139.41 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 75.239999999999995 111.151 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.68 106.37 2.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 73.430000000000007 110.89 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -115.87 129.99 56.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.911 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -129.55 107.36 9.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 73.049999999999997 110.871 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.09 -67.17 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 73.25 110.883 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.9 37.88 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 63.32 112.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.0 -162.26 33.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.77 -0.728 . . . . 62.329999999999998 112.491 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -101.25 -34.34 9.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.73 0.3 . . . . 72.439999999999998 110.904 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.59 134.16 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 110.886 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' CG1' HD22 ' A' ' 46' ' ' LEU . 46.8 t -120.76 134.21 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -135.47 149.19 49.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.510000000000005 110.869 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.623 HD12 HG12 ' A' ' 22' ' ' ILE . 6.6 tt -122.34 142.63 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.030000000000001 111.08 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 t -149.92 139.17 21.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.123 -0.489 . . . . 65.530000000000001 110.866 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' H ' ' ND2' ' A' ' 38' ' ' ASN . . . -149.44 -165.42 12.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.728 -0.749 . . . . 51.100000000000001 112.444 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -73.11 -17.56 61.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.85 0.357 . . . . 64.209999999999994 110.841 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' CB ' HD22 ' A' ' 59' ' ' LEU . 38.6 p90 -62.76 -16.88 59.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 64.25 110.893 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 42' ' ' THR . 4.7 p30 -129.14 12.92 6.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.944 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 63.58 20.94 12.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 75.109999999999999 110.935 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.8 m95 51.64 31.83 8.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.467 . . . . 75.109999999999999 110.944 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.8 t -108.39 14.43 24.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.120000000000005 110.837 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.498 HG22 ' OD1' ' A' ' 38' ' ' ASN . 10.1 t -166.35 145.29 5.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 111.159 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -103.26 119.56 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.934 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD22 ' A' ' 57' ' ' LEU . 1.8 mp -82.31 132.32 53.27 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 62.32 111.081 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 134.44 27.98 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.707 2.271 . . . . 74.299999999999997 112.344 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.734 HD22 ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -92.23 104.16 16.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 72.319999999999993 110.949 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 47' ' ' ILE . 1.5 mp -50.6 110.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 74.299999999999997 111.08 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 ttmm -65.54 132.18 48.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 64.099999999999994 110.863 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 t -112.2 169.69 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.865 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -68.97 -12.11 61.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.450000000000003 110.859 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -110.11 -57.55 2.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 71.099999999999994 110.928 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -154.27 -171.31 3.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 62.310000000000002 110.892 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.51 147.36 26.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.934 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 22' ' ' ILE . 89.0 t -150.52 142.9 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.140000000000001 111.117 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' O ' HD13 ' A' ' 56' ' ' ILE . . . -114.63 143.93 44.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 54.009999999999998 111.125 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.644 ' C ' HD23 ' A' ' 57' ' ' LEU . 49.8 mm -138.56 122.83 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.173 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -153.48 135.63 14.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 74.010000000000005 110.953 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 3.8 p-10 -73.18 102.31 3.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 63.43 110.904 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 57' ' ' LEU . 9.3 mt -108.42 152.34 41.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.562 0.696 . . . . 70.109999999999999 110.905 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 151.62 69.27 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 72.319999999999993 112.365 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.07 118.98 8.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 71.0 110.925 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.83 -137.56 5.03 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.723 -0.751 . . . . 75.140000000000001 112.482 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.14 138.14 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 119.348 -0.358 . . . . 71.450000000000003 110.828 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.422 ' HD2' HG23 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -144.58 165.94 26.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 51.009999999999998 109.6 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -123.61 125.79 45.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.968 -1.014 . . . . 75.430000000000007 110.891 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -122.32 173.59 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.901 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -147.36 144.83 29.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.912 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -91.11 149.13 21.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 110.862 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -134.2 95.15 3.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.400000000000006 110.816 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 31' ' ' VAL . 18.7 t -123.21 151.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 53.119999999999997 111.076 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.0 t0 60.77 34.58 19.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.55 33.59 86.96 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.476 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -157.27 153.57 27.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.812 0.339 . . . . 52.310000000000002 110.938 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -82.94 114.66 21.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.906 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 m -122.31 174.32 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 53.149999999999999 111.114 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -151.27 157.81 43.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.885 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -97.91 134.04 22.66 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 61.109999999999999 110.884 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -26.23 27.57 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.751 2.301 . . . . 70.109999999999999 112.26 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 m -74.9 -28.71 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 44.530000000000001 110.893 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -81.2 160.48 65.4 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.764 . . . . 74.530000000000001 110.825 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.24 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.682 2.255 . . . . 71.329999999999998 112.383 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.4 m -94.56 159.92 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.019999999999996 111.079 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.2 142.72 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.465 . . . . 63.109999999999999 111.12 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 90' ' ' ILE . 1.4 m -80.42 111.22 16.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 73.200000000000003 111.141 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 p -61.85 178.09 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.844 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.51 ' HG2' HD22 ' A' ' 87' ' ' LEU . 9.8 pt20 -75.79 -5.99 48.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 72.439999999999998 110.894 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 ' HG2' ' A' ' 86' ' ' GLN . 2.3 mm? -98.56 0.1 44.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.530000000000001 110.908 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.24 9.03 80.63 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.702 -0.761 . . . . 45.439999999999998 112.457 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 p -106.53 128.52 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 52.509999999999998 111.123 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 84' ' ' THR . 28.6 mm -74.39 143.61 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 111.228 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.28 157.98 43.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.878 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -80.04 168.2 19.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 61.450000000000003 110.941 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.85 122.7 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 74.140000000000001 110.876 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 64' ' ' HIS . 2.2 tt -115.88 143.76 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 53.439999999999998 111.125 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -130.19 101.05 5.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.863 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.1 t -91.15 143.84 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 71.099999999999994 111.164 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -114.17 -174.43 2.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 65.040000000000006 110.949 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -104.69 160.52 14.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 74.239999999999995 110.901 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -131.0 30.01 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.340000000000003 110.829 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.38 -22.29 12.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.120000000000005 110.87 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -101.86 -28.51 12.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 65.450000000000003 110.899 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -58.54 -22.25 54.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.109999999999999 110.884 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 105' ' ' ASP . 11.7 p -88.28 150.96 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.240000000000002 111.173 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -89.34 -30.49 18.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 72.439999999999998 110.865 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.578 ' H ' HG22 ' A' ' 103' ' ' VAL . 5.1 t0 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 44.530000000000001 110.827 -179.998 . . . . . . . . 1 1 . 1 stop_ save_